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IL-13 production by CD4+ T helper type 2 (TH2) cells, immunoglobulin E (IgE) production by B cells, and
the recruitment of effector cells to sites of tissue inflammation. In addition to host genetic polymorphisms and
environmental triggers, studies in patients and model systems suggest that commensal bacterial-derived
signals influence susceptibility to TH2 cytokine-mediated allergic inflammation. For example, patients with
allergies display altered commensal bacterial populations and antibiotic treatment increases allergy
susceptibility. However, the influence of antibiotic treatment on intestinal bacterial communities, and
subsequent effects on innate immune cells that influence the development of allergic inflammation, are poorly
defined. Chapter 2 describes the development and characterization of a new murine antibiotic treatment
model using 454 deep sequencing techniques and details antibiotic-induced temporal and spatial alterations
to bacterial communities colonizing the murine intestine. Having characterized the effects of antibiotic
treatment on commensal populations, Chapter 3 and Chapter 4 examine the cellular and molecular
mechanisms through which innate immune cells respond to commensal-derived signals and regulate TH2
cytokine-mediated allergic responses. Data in Chapter 3 describe antibiotic-induced steady-state elevations in
serum IgE levels and circulating basophil populations, an innate granulocyte implicated in contributing to
allergic TH2 cell responses, as well as exaggerated basophil-mediated inflammation in models of allergic
disease. Data in Chapter 4 indicate that circulating basophil populations correlate with serum IgE levels in
mice and patients with hyper-IgE syndrome, and that B cell-intrinsic MyD88 expression limits murine IgE
levels and basophil responses. These results provide novel mechanistic insights into how commensal bacterial-
derived signals influence TH2 cytokine-mediated allergic inflammation, and have implications for the
development of new preventative or therapeutic interventions for allergic disease.
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ABSTRACT 
 
MICROBIAL REGULATION OF ALLERGIC INFLAMMATION 
 
David Andrew Hill 
 
Mentor: David Artis, Ph.D. 
 
Allergic diseases have reached pandemic levels and represent a significant 
source of morbidity, mortality and healthcare cost. These chronic inflammatory 
diseases are characterized by interleukin (IL)-4, IL-5, IL-9 and IL-13 production 
by CD4+ T helper type 2 (TH2) cells, immunoglobulin E (IgE) production by B 
cells, and the recruitment of effector cells to sites of tissue inflammation. In 
addition to host genetic polymorphisms and environmental triggers, studies in 
patients and model systems suggest that commensal bacterial-derived signals 
influence susceptibility to TH2 cytokine-mediated allergic inflammation. For 
example, patients with allergies display altered commensal bacterial populations 
and antibiotic treatment increases allergy susceptibility. However, the influence of 
antibiotic treatment on intestinal bacterial communities, and subsequent effects 
on innate immune cells that influence the development of allergic inflammation, 
are poorly defined. Chapter 2 describes the development and characterization of 
a new murine antibiotic treatment model using 454 deep sequencing techniques 
and details antibiotic-induced temporal and spatial alterations to bacterial 
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communities colonizing the murine intestine. Having characterized the effects of 
antibiotic treatment on commensal populations, Chapter 3 and Chapter 4 
examine the cellular and molecular mechanisms through which innate immune 
cells respond to commensal-derived signals and regulate TH2 cytokine-mediated 
allergic responses. Data in Chapter 3 describe antibiotic-induced steady-state 
elevations in serum IgE levels and circulating basophil populations, an innate 
granulocyte implicated in contributing to allergic TH2 cell responses, as well as 
exaggerated basophil-mediated inflammation in models of allergic disease. Data 
in Chapter 4 indicate that circulating basophil populations correlate with serum 
IgE levels in mice and patients with hyper-IgE syndrome, and that B cell-intrinsic 
MyD88 expression limits murine IgE levels and basophil responses. These 
results provide novel mechanistic insights into how commensal bacterial-derived 
signals influence TH2 cytokine-mediated allergic inflammation, and have 
implications for the development of new preventative or therapeutic interventions 
for allergic disease.  
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Chapter 1: An introduction to commensal 
bacteria and the immune system 
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Microbes are the most abundant life form on earth. While many are free living, some 
have evolved to participate in close and often long-lasting interactions with multicellular 
hosts. Though some of these microbes have evolved as pathogens, others have evolved 
commensal relationships that are essential to normal host development and physiology. 
The existence of such symbiotic relationships with microbes is a conserved feature of 
multicellular organisms including plants (Paszkowski 2006), insects (Muyskens, 
Guillemin 2008), nematodes (Rae et al. 2008), fish (Bates et al. 2007), birds (Brisbin, 
Gong & Sharif 2008), and mammals (Hill, Artis 2010). The mammalian intestine is 
colonized by both the largest and most complex symbiotic microbial community 
comprised of approximately 1014 bacteria and numerous viral and parasitic microbes. In 
mammals, these microbes supply essential nutrients, aid in the digestion of otherwise 
indigestible compounds, promote angiogenesis and enteric nerve function, defend 
against opportunistic pathogens, and influence the development and homeostasis of the 
immune system (Hill, Artis 2010, Hooper, Gordon 2001, Macpherson, Harris 2004). 
To maintain immunologic homeostasis, the mammalian immune system has 
evolved complex immunosurveillance networks able to respond to pathogens while 
maintaining tolerance to commensals and environmental antigens. When these 
mechanisms fail, host immune responses to commensal-derived signals can contribute 
to the development of multiple human diseases including inflammatory bowel disease 
(IBD) (Manichanh et al. 2006, Hanauer 2006), obesity (Ley et al. 2005), cancer (Moore, 
Moore 1995), diabetes (Bollyky et al. 2009), and allergy (Penders et al. 2007, Marra et 
al. 2009). This thesis focuses on commensal bacteria that colonize the mammalian 
intestine, and the role that commensal bacterial-derived signals play in limiting TH2 
cytokine-dependent allergic responses. Understanding the mechanisms by which 
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commensal-derived signals influence the mammalian immune system is essential to 
both fully understand mammalian physiology, and to better define the etiology of human 
inflammatory diseases in an effort to develop new preventative or therapeutic 
approaches. 
Potentially detrimental alterations to commensal bacterial communities that result 
from antibiotic exposure are of particular medical relevance given recent epidemiological 
associations between antibiotic treatment and the development of allergic disease 
(Marra et al. 2009, Kummeling et al. 2007). However, the influence of oral antibiotic 
treatment on qualitative and quantitative measures of commensal bacterial communities 
is poorly defined. Therefore, Chapter 2 of this thesis describes the development of a 
new murine oral antibiotic treatment model and the characterization of the subsequent 
effects on commensal bacterial communities that colonize the murine intestine. Having 
characterized the effects of antibiotic treatment on intestinal bacterial communities, the 
remainder of this thesis utilizes oral antibiotic treatment and germ-free mouse models to 
investigate the influence of commensal bacterial-derived signals on innate granulocyte 
populations known to contribute to the initiation or propagation of TH2 cytokine-
dependent allergic responses. Data in Chapter 3 indicate that antibiotic treatment 
results in steady-state increases in serum IgE levels and circulating basophil 
populations, an innate granulocyte implicated in contributing to the development or 
propagation of TH2 cell responses. Consistently, antibiotic-treatment resulted in 
exaggerated basophil-mediated inflammation in three murine models of allergic disease. 
Finally, the molecular and cellular mechanisms by which the mammalian immune 
system recognizes commensal bacterial-derived signals and limits circulating basophil 
populations are the focus of Chapter 4. Circulating basophil populations correlated with 
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serum IgE levels in mice and DOCK8- humans, and B cell-intrinsic MyD88 expression 
was identified as a regulatory pathway that limits murine IgE levels and basophil 
responses. Together, these results provide novel mechanistic insights into how 
commensal bacterial-derived signals influence TH2 cytokine-mediated allergic 
inflammation, and have broad implications for the development of new preventative or 
therapeutic interventions for allergic disease. 
In the remainder of Chapter 1, I first review previously published data supporting 
a role for commensal bacteria in influencing the development or progression of human 
disease. I then give an overview of commensal bacterial acquisition and detection of 
commensal bacterial-derived signals by the host immune system. Next, I discuss data 
from germ-free or antibiotic-treated mouse models that indicate a role for commensal-
derived signals in influencing the development and/or homeostasis of specific host 
immune cell populations. Finally, I review basophil physiology and what is known of how 
basophils cooperate with other innate immune cell types to influence the development 
and/or propagation of TH2 cytokine-dependent inflammatory responses. 
 
1.1 Intestinal bacteria in health and disease 
Over the past century, studies of humans and animal models have identified important 
roles for commensal bacterial communities in promoting the optimal digestion of food 
(Hooper, Midtvedt & Gordon 2002), maintenance of epithelial homeostasis (Artis 2008), 
modulating fat metabolism (Backhed et al. 2004), promoting angiogenesis 
(Stappenbeck, Hooper & Gordon 2002) and enteric nerve function (Husebye, Hellstrom 
& Midtvedt 1994), supporting resistance to infection (Sekirov et al. 2008) and promoting 
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normal development and homeostasis of the host immune system (Hill, Artis 2010, 
Cebra 1999) (Figure 1). Given these important roles for commensal-derived signals in 
maintaining normal host physiology, it is not surprising that perturbations to commensal 
communities have been implicated as both a bio-marker for, and a potential contributing 
factor to multiple human diseases. In this section, what is known of the role that 
commensal bacterial-derived signals play in the pathophysiology of inflammatory bowel 
disease and allergy are discussed as models of intestinal and systemic human disease 
states, respectively. 
 
Figure 1: Intestinal bacteria in mammalian health and disease 
Schematic of the known influences of intestinal bacteria on normal mammalian physiology and 
disease states. Adapted from (Hill, Artis 2010). 
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Inflammatory bowel disease (IBD; Crohn’s Disease and Ulcerative Colitis) is 
thought to result in part from inappropriate and ongoing mucosal immune responses to 
commensal intestinal bacteria (Podolsky 2002). IBD patients have altered commensal 
bacterial communities compared to healthy individuals and tolerance to intestinal 
bacteria is broken in IBD leading to inappropriate local and systemic immune responses 
to commensal-derived signals (Macpherson et al. 1996)(Manichanh et al. 2006, 
Macpherson et al. 1996, Duchmann et al. 1995, Lodes et al. 2004, Adams et al. 2008). 
For example, IBD patients display aberrant cytokine production, T cell activation, and 
mucosal and systemic antibody responses to intestinal bacterial-derived antigens 
(Macpherson et al. 1996, Duchmann et al. 1995). Consistent with commensal-bacterial 
derived signals being a precipitating factor in IBD, antibiotic therapy designed to deplete 
the commensal bacterial load is a component of IBD therapeutic regimens (Talley et al. 
2011). Despite these findings, the molecular and cellular causes of the dysregulated 
immune responses to commensal bacteria observed in IBD patients are not fully 
understood, however, polymorphisms in innate pattern recognition receptors are 
associated with susceptibility to IBD. Most notably, mutations in NOD2, a component of 
the innate immune system that is important for immune recognition and responses to 
intracellular bacteria, are associated with increased risk of IBD development (Ogura et 
al. 2001, Hugot et al. 2001, Hisamatsu et al. 2003). These findings implicate 
inappropriate recognition of commensal-derived signals, and subsequent priming and 
activation of the adaptive immune system, as central to IBD pathogenesis.   
Animal models have supported a role for inappropriate immune responses to 
commensal bacterial-derived signals in contributing to IBD pathogenesis. For example, 
akin to the antibiotic treatment in human IBD patients, reducing commensal stimulation 
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in several murine models of IBD, achieved by rearing animals under germ-free 
conditions or via oral antibiotic treatment, ameliorates intestinal disease. This is the case 
with IL-2-deficient mice that spontaneously develop intestinal inflammation when raised 
under conventional conditions, but have a delayed and more mild disease course when 
raised under germ-free conditions (Schultz et al. 1999). Similarly, IL-10-deficient mice 
also develop spontaneous colitis associated with inappropriate T cell responses when 
maintained under conventional conditions, but are protected against disease when 
maintained under germ-free conditions or when treated with oral antibiotics (Dianda et 
al. 1997, Sellon et al. 1998, Madsen et al. 2000, Hoentjen et al. 2003). These findings 
support the view that inappropriate immune responses to commensal-derived signals 
contribute to the development or progression of disease in these immunologically 
impaired hosts. 
Pathogenic commensal communities can also initiate disease states in hosts with 
an intact immune system. For example, immunodeficient mice deficient in the 
inflammatory transcription factor T-bet and the recombinase-activating gene RAG2 
(TRUC mice) develop spontaneous colitis that is ameliorated by antibiotic treatment 
(Garrett et al. 2007). Importantly, when wild-type mice are fostered by or co-housed with 
TRUC mice they develop colitis, indicating that vertical or horizontal transmission of 
colitogenic bacterial communities can cause disease in immunocompetent animals 
(Garrett et al. 2007). This observation indicates that alterations in commensal bacterial 
communities might not only be a consequence of disease, but that normal commensal 
communities may protect against the development of colitis in healthy individuals.  
Consistent with this, disruption of commensal communities via antibiotic treatment 
increases patient risk of developing Clostridium difficile colitis, and alteration of 
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commensal populations has been implicated in precipitating IBD in select cases (De La 
Cochetiere et al. 2008, Hviid, Svanstrom & Frisch 2011). 
In addition to influencing intestinal inflammatory responses, commensal-derived 
signals have also been implicated in influencing susceptibility to asthma and other 
systemic atopic disorders in humans (Penders et al. 2007). Allergic diseases have 
reached pandemic levels and represent a significant source of morbidity, mortality, and 
healthcare cost (Eder, Ege & von Mutius 2006, Bahadori et al. 2009). The development 
of allergies is determined by interactions between genetic and environmental factors. For 
example, allergy susceptibility is associated with genetic polymorphisms in more than 33 
genes including HLA alleles and components of allergic cytokine signaling pathways 
(Vercelli 2008). Additionally, environmental stimuli including pollutants, diet, and infection 
history can influence susceptibility to allergic disease (Gilliland 2009, Zeiger 2003, 
Harnett, Harnett 2010). More recently, alterations in the composition or quantity of 
intestinal commensal bacterial communities have been implicated in contributing to 
allergy susceptibility (Hill, Artis 2010, Round, Mazmanian 2009). However, the cellular 
and molecular mechanisms by which commensal bacteria influence allergic inflammation 
are poorly understood.  
Allergic patients display altered commensal bacterial community structure in the 
intestine, and infants who go on to develop allergies display altered commensal bacterial 
community structure early in life (Penders et al. 2007, Kalliomaki et al. 2001). 
Additionally, antibiotic exposure modifies commensal bacterial community structure of 
the intestine and significantly correlates with increased risk of allergy development in 
children, implicating commensal bacterial-derived signals in influencing susceptibility to 
allergic diseases (Marra et al. 2009, Kummeling et al. 2007, Hill et al. 2009). In some 
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cases, specific bacterial groups have been identified as potential contributors to allergy 
susceptibility. For example, associations have been found between colonization with 
Bifidobacterium, C.  difficile or Escherichia coli, and the development of eczema in 
humans (Penders et al. 2007, Gore et al. 2008, Penders et al. 2008). 
Animal models have provided additional insights into defined species of 
commensal bacteria, and specific commensal-derived signals, which influence allergic 
responses. Antibiotic treatment of mice results in exaggerated food allergy-like 
symptoms characterized by increased levels of allergen-specific IgE in the serum 
compared to conventionally-reared mice (Sudo et al. 1997). TLR4 signaling is important 
for commensal bacterial-derived signals to promote oral tolerance as TLR4-deficient 
mice display similar levels of food allergy compared to mice treated with oral antibiotics 
(Bashir et al. 2004). Similarly, commensal bacterial-derived signals also seem to limit 
disease in models of allergic asthma. Antibiotic treatment resulted in the selective 
outgrowth of fungal microbes in the intestine and worse disease outcomes in an IL-13-
dependent mechanism (Noverr et al. 2005). Despite these strong epidemiologic and 
experimental associations between alterations in commensal bacterial populations and 
allergic inflammation, relatively little is known about the molecular and cellular 
mechanisms by which the innate immune system recognizes commensal bacterial-
derived signals and influences the development TH2 cytokine-dependent allergic 
inflammation. 
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1.2 Commensal bacteria and the mammalian host 
1.2.1 The bacterial composition and colonization dynamics of the mammalian 
intestine 
After birth, the epithelial surfaces of mammals are colonized with viruses, fungi, bacteria, 
protozoa, and helminth parasites creating complex microbial communities in multiple 
environmental niches. Several terms have been used to describe relationships between 
microbes that colonize multicellular organisms, but for the purposes of this thesis 
―commensal‖ is used to describe a mutualistic relationship within which the microbe 
provides some benefit to the host. The mammalian gastrointestinal (GI) tract is the best 
studied of these microbial environments. By adulthood, the GI tract is colonized by 
members of all three domains of life; though intestinal bacterial communities are both the 
most abundant and best characterized of microbial community (Whitman, Coleman & 
Wiebe 1998), and as a result are the primary focus of this thesis. 
Though exposed to bacteria throughout life, mammals are thought to undergo 
two dominant phases of intestinal colonization; the first during breast milk or formula 
feeding and the second upon weaning to solid foods. Mammalian breast milk is both a 
source of defined microbes and of passive immunity in the form of immunoglobulins and 
other maternal-derived molecules that shape developing intestinal communities (Diaz et 
al. 2004, Martin et al. 2007b, Martin et al. 2007a). The temporal and spatial patterns of 
intestinal colonization in infants are variable between individuals (Palmer et al. 2007) 
and dependent upon multiple factors including country of birth (Benno et al. 1986), 
length of gestation (Penders et al. 2006, Stark, Lee 1982a, Blakey et al. 1982), mode of 
delivery (Penders et al. 2006, Gronlund et al. 1999), history of hospitalization (Penders 
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et al. 2006), antibiotic use (Penders et al. 2006) and feeding practices (Penders et al. 
2006, Hayashi, Sakamoto & Benno 2002a, Harmsen et al. 2000, Lundequist, Nord & 
Winberg 1985, Stark, Lee 1982b, Yoshioka, Iseki & Fujita 1983, Penders et al. 2005). 
For example, vaginally born and breast-fed infants have a predominance of 
Bifidobacteria in their intestine, with lower contributions of E. coli, Bacteroides, and 
Clostridia species while infants delivered by cesarean section have delayed colonization 
kinetics compared to vaginally born infants and persistent changes to bacterial 
communities including lower burdens of Bifidobacteria and Bacteroides groups, and 
higher burdens of C. difficile (Penders et al. 2006, Gronlund et al. 1999, Bullen, Tearle & 
Willis 1976). Though these individuals likely acquire normal adult bacterial communities 
upon transition to solid foods, these differences may not be without consequence as 
associations between early alterations to intestinal bacterial communities and increased 
risk of allergic disease have been identified (Renz-Polster et al. 2005, Salam et al. 
2006).  
At maturity, the bacterial burden of the mammalian GI tract is estimated at over 
100 trillion individual organisms at a density of 1011 to 1014 cells per gram of luminal 
contents (Whitman, Coleman & Wiebe 1998, Eckburg, Lepp & Relman 2003). Studies 
carried out as early as the 1960’s using culture-based and microbiological identification 
methods identified Lactobacilli, Streptococci and members of the Bacteroides genus as 
residents of the normal adult human intestine (Dubos et al. 1965). However, a large 
percentage of intestinal bacteria are anaerobes that lack the enzymes necessary for the 
detoxification of oxygen.  As such, even under ideal conditions it is estimated that only 
half of intestinal bacteria are culturable indicating that these early studies were limited in 
their sensitivity (Adlerberth, Wold 2009). 
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More recently, molecular advances in DNA bar coding and 454 pyrosequencing 
of 16S ribosomal RNA gene segments are allowing previously unattainable insights into 
both culturable and non-culturable bacterial communities of the mammalian intestine 
(Hayashi, Sakamoto & Benno 2002b, Hold et al. 2002, Wang et al. 2003, Eckburg et al. 
2005). These studies have identified the Firmicutes and Bacteroidetes phyla as the 
major bacterial groups present in the mammalian intestine (Figure 2) but are placing 
total species estimates from conservative numbers of 1000-2000 to numbers as high as 
15,000-40,000 individual members (Hayashi, Sakamoto & Benno 2002b, Hold et al. 
2002, Wang et al. 2003, Eckburg et al. 2005, Frank, Pace 2008). Of the Firmicutes, 95% 
belong to the Clostridia class, while there are large variations in the Bacteroidetes 
phylotypes among individuals (Hayashi, Sakamoto & Benno 2002b, Hold et al. 2002, 
Eckburg et al. 2005, Finegold, Sutter & Mathisen 1983). Other phyla present in relatively 
low abundance include the Proteobacteria, Actinobacteria, Fusobacteria, and 
Verrucomicrobia (Hayashi, Sakamoto & Benno 2002b, Wang et al. 2003, Eckburg et al. 
2005, Finegold, Sutter & Mathisen 1983, Suau et al. 1999). The complexity of intestinal 
bacterial communities suggests intimate coevolution between commensal communities 
and mammalian hosts, and supposes that alterations in commensal bacterial 
communities could impact numerous facets of mammalian physiology. 
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Figure 2: The composition of bacterial communities along the length and between luminal and 
mucosal compartments of the mammalian intestine 
Stool pellet, luminal content, or mucosal-associated communities were sterilely collected. Total 
sample DNA was extracted and bacterial 16S rDNA fragments were PCR amplified with bar code-
tagged primers, subjected to pyrosequencing, and taxonomic assignments for each sequence 
were determined using RDP Classifier. (a) Commonly found bacteria in the murine colon. (b) 
Relative frequencies and distribution of bacteria along the length of the murine colon. (c) 
Relative frequencies and distribution of bacteria between luminal and mucosal-associated 
compartments of the murine colon. Adapted from (Hill, Artis 2010). 
 
Intestinal bacterial communities exhibit differences along the length of the colon 
and differ significantly between the luminal and tissue attached microenvironments 
suggesting that defined microbial communities at different anatomical locations may be 
important for distinct aspects of normal mammalian physiology (Figure 2b,c) (Eckburg 
et al. 2005, Zoetendal et al. 2002, McKenna et al. 2008). For example, while Lactobacilli 
have been cited for potential probiotic effects, and can be isolated from approximately 
80% of adults, they represent a relatively low proportion of luminal bacteria (Finegold, 
Sutter & Mathisen 1983, Kuitunen et al. 2009). However, this group represents a 
significant proportion (up to 13%) of mucosal-associated bacteria (Figure 2) indicating 
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that colonization of this anatomical niche may be important for Lactobacilli’s potentially 
beneficial physiologic effects for the host (Hill et al. 2009). To maintain homeostasis with 
colonizing bacteria, mammals have evolved complex compensatory responses to 
commensal-derived signals (Hill, Artis 2009). The host immune response to microbial 
colonization will be discussed in the next section.  
 
1.2.2 The host immune response to microbial colonization 
The initial immune response to bacterial colonization by the mammalian host 
peaks within a week of birth and subsequently stabilizes over the first year of life (Shroff, 
Meslin & Cebra 1995). Initially, the host mounts an innate immune response to bacterial 
colonization that is important for maintenance of the mucosal barrier (reviewed in (Dann, 
Eckmann 2007)). This includes direct detection of commensal-derived signals by 
intestinal epithelial cells via cell-autonomous MyD88 activation resulting in increased 
expression of the antimicrobial peptides REGIIIγ and RELMβ (Wang et al. 2005, 
Vaishnava et al. 2008). Additionally, the host mounts an adaptive immune response 
characterized by production and secretion of IgA into the intestinal lumen (Macpherson 
2006). IgA production occurs in response to small numbers of intestinal bacteria that 
initially penetrate the intestinal epithelium where they are phagocytosed by DCs that 
initiate IgA responses through T cell-dependent and -independent mechanisms 
(Renshaw et al. 1994, Macpherson et al. 2000, Macpherson, Uhr 2004a, MacPherson et 
al. 2004, Macpherson, Uhr 2004b, Bergqvist et al. 2006). In contrast to disease states 
such as IBD, these B cell responses are limited to the mesenteric lymph nodes (mLNs) 
and do not occur in systemic secondary lymphoid structures, indicating that induction of 
this commensal-specific IgA response is compartmentalized to mucosal tissues under 
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normal physiological conditions (Macpherson, Uhr 2004b, Konrad et al. 2006). Secretion 
of IgA into the intestinal lumen acts as a homeostatic feedback loop to reduce epithelial 
penetration by intestinal bacteria, and subsequent host inflammatory responses 
(Macpherson et al. 2001). The initiation of these homeostatic responses is critically 
dependent on recognition of commensal-derived signals by immune cells via innate 
pattern recognition receptors. Innate recognition of commensal bacterial-derived signals 
by pattern recognition receptors is reviewed in the next section.  
 
1.3 Recognition of commensal-derived signals by pattern recognition 
receptors 
As discussed above, the colonization of the mammalian intestine results in a rapid 
compensatory response by the mucosal immune system that is important for maintaining 
mucosal integrity and immune homeostasis. A component of this innate response is the 
recognition of microbial-derived cell wall components, DNA segments, and metabolites 
by host pattern recognition receptors (PRRs) including Toll-like receptors, Nod-like 
receptors, and G protein coupled receptors. This section reviews commensal bacterial-
derived signals, the innate receptors that recognize them, and focuses on the role that 
intestinal epithelial cells (IECs) and dendritic cells (DCs) play in responding to these 
signals and modulating subsequent immune responses. 
 
1.3.1 Recognition of commensal-derived signals by Toll-like receptor ligands 
Toll-like receptors (TLRs) are innate pattern recognition receptors that bind evolutionarily 
conserved motifs found in bacteria and other microbes (Medzhitov, Preston-Hurlburt & 
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Janeway 1997). TLRs have evolved to recognize multiple microbial-derived signals 
including double-stranded viral RNA (TLR3), gram-negative lipopolysaccharide (LPS) 
(TLR4), and gram-negative and gram-positive flagellin (TLR5) (West, Koblansky & 
Ghosh 2006). Most TLRs are expressed on the surface of cells with the exception of 
TLR3, 7, 8, and 9 which are localized to endolysosomal compartments (Medzhitov 
2007). 
Studies in humans and animal models have implicated TLRs as important 
modulators of both physiologic and pathologic host immune responses to commensal 
bacteria. In some cases, recognition of commensal-derived signals by TLRs contributes 
to disease states. For example, dominant-negative TLR5 polymorphisms in humans 
result in reduced responses to flagellin, and protect against the development of Crohn’s 
disease (Gewirtz et al. 2006). Consistent with these findings, studies in animal models 
have shown that recognition of bacterial flagellin by TLR5 influences proinflammatory 
gene expression by intestinal epithelial cells (Gewirtz et al. 2001). However, recognition 
of bacterial-derived signals by TLRs can also be protective in other settings. For 
example, LPS administration signals through TLRs to protect against chemically-induced 
experimental colitis while treatment with flagellin (which signals via TLR5) protects 
against chemical, bacterial, viral, and radiation-induced mortality in multiple animal 
models (Rakoff-Nahoum et al. 2004, Vijay-Kumar et al. 2008). Finally, administration of 
the TLR9 ligand CpG reduces severity of food allergy in TLR4-deficient mice (Bashir et 
al. 2004). The potential protective roles for TLR signaling in disease have spurred 
interest in TLR ligands as therapeutic agents and TLR ligands are currently being 
investigated as treatments for both human allergy and as adjuvant therapies for cancer 
(Racila, Kline 2005, Krieg 2007). 
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1.3.2 Recognition of commensal-derived signals by NOD-like receptors 
NOD-like receptors (NLRs) detect intracellular ligands and have been identified as key 
mediators of proinflammatory and immunoregulatory responses in animals and humans 
(Fritz et al. 2006). NLRs recognize several commensal bacterial-derived signals 
including peptidoglycan containing meso-diaminopimelic acid (NOD1) and muramyl 
dipeptide (NOD2) (Carneiro et al. 2008). In the setting of an invading pathogen, NOD2 
ligation initiates NF-κB activation and upregulation of proinflammatory cytokines (Fritz et 
al. 2006). Consistently, NOD-1 dependent recognition of commensal-derived signals has 
been shown to be important for normal neutrophil-mediated killing of pathogenic bacteria 
(Clarke et al. 2010). However, NOD-dependent signaling can also play a protective role 
in various disease states. In humans, approximately 15% of patients with Crohn's 
disease have homozygous or compound heterozygous mutations in the gene that 
encodes NOD2 (CARD15) implicating NOD signaling in a protective role (Ogura et al. 
2001, Hugot et al. 2001). Consistent with this hypothesis, chronic stimulation of NOD2 
has been shown to mediate tolerance to bacterial products and NOD2-deficient mice 
have an increased susceptibility to experimental colitis (Watanabe et al. 2006, Hedl et al. 
2007, Watanabe et al. 2008). The mechanisms by which NOD-dependent signals can 
have such diverse immunomodulatory outcomes are an active area of research. One 
likely explanation is that NOD-dependent signals have different immune outcomes 
depending on the broader immunological context in which they are acting (Watanabe et 
al. 2006, Watanabe et al. 2004). 
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1.3.3 Recognition of commensal-derived signals by GPCRs and other receptors 
In addition to the TLR and NOD ligands, immunoregulatory G protein coupled receptor 
(GPCR) ligands such as the purine adenosine (Ado) are of growing interest in the fields 
of IBD and other inflammatory diseases (Jacobson, Gao 2006). Ado may function as an 
endogenously generated regulator of inflammation with different immune outcomes 
depending on the receptor it binds. For example, an Ado A2A receptor agonist did not 
alter the course of chemical colitis while Ado A2B-deficient mice have increased 
susceptibility to chemical colitis (Selmeczy et al. 2007, Frick et al. 2009). More recently, 
intestinal bacteria were found to be a source of adenosine triphosphate (ATP) that can 
drive TH17 cell differentiation in the lamina propria by inducing IL-6 and IL-23p19 
production by a population of CD70 (high) CD11c (low) cells (Atarashi et al. 2008). 
Accordingly, germ-free mice exhibit lower concentrations of luminal ATP, as well as 
fewer numbers of TH17 cells in the LP, a defect that could be reversed through the 
systemic or rectal administration of ATP (Atarashi et al. 2008). 
 Commensal bacteria that colonize the mammalian intestine also produce 
significant amounts of butyrate, as well as other short chain fatty acids (Pryde et al. 
2002). The receptor for butyrate, GPR109A, is expressed on IECs and is down regulated 
in human colon cancer, in a mouse model of intestinal/colon cancer, and in colon cancer 
cell lines (Avivi-Green et al. 2000, Hague et al. 1995). Consistent with the hypothesis 
that GPR109A signaling suppresses tumor development or progression, expressing 
GPR109A in colon cancer cells induces apoptosis in the presence of butyrate 
(Thangaraju et al. 2009). Butyrate has been shown to have an immunoregulatory role in 
the steady-state by signaling through GPR109A on IECs to suppress NF-κB signaling 
(Thangaraju et al. 2009, Kumar et al. 2009). Consistent with a primarily 
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immunoregulatory role, butyrate reduces production of TNFα, TNFβ, IL-6, and IL-1β by 
lamina propria lymphocytes (LPLs) of IBD patients (Luhrs et al. 2002, Segain et al. 
2000). Together, these findings indicate that butyrate inhibits tumorigenesis and limits 
proinflammatory responses in the intestine. 
Succinate, a component of the citric acid cycle, is a commensal metabolite that 
has been shown to modulate dendritic cell function by signaling through the extracellular 
GPCR GPR91. In one study, succinate signaling triggered intracellular calcium release, 
induced DC migratory responses, and acted in synergy with TLR ligands to induce the 
production of proinflammatory cytokines by DCs (Rubic et al. 2008). Succinate also 
enhanced antigen-specific activation of human and mouse helper T cells, while GPR91-
deficient mice had reduced Langerhan cell migration to draining lymph nodes and 
impaired tetanus toxoid-specific recall T cell responses (Rubic et al. 2008). Together, 
these results implicate the sensing of succinate through GPR91 as an important signal 
of immunologic danger. 
Finally, bacterial adhesion via surface proteins can directly modulate immune cell 
function. For example, Lactobacillus acidophilus NCFM attaches to DCs resulting in 
production of IL-10 and IL-12p70 (Konstantinov et al. 2008). The bacterial surface 
component surface layer A protein (SlpA) was found to be sufficient for this 
immunomodulatory function as purified SlpA protein bound and activated DCs directly 
(Konstantinov et al. 2008). Consistently, T cells primed with DCs that were stimulated 
with L. acidophilus NCFM lacking SlpA produced less IL-4 than those stimulated with 
wild-type L. acidophilus NCFM (Konstantinov et al. 2008). In summary, commensal-
derived signals can have proinflammatory or immunoregulatory effects depending on the 
immunologic context in which they act. I will next discuss how recognition of commensal-
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derived signals by IECs and DCs via innate PRRs influences the development of local 
and systemic immune responses. 
 
1.4 Recognition of commensal-derived signals by innate immune cells 
1.4.1 Recognition of commensal-derived signals by intestinal epithelial cells  
The intestinal epithelium has a diverse set of physiologic functions including digestion 
and absorption of nutrients, the maintenance of a physical barrier from the external 
environment, and immunological surveillance of intestinal bacteria and potential 
pathogens. Intestinal epithelial cells (IECs) are continually replaced from a pool of Lgr5+ 
multipotent stem cells that reside in crypts of the intestine (Gordon, Hermiston 1994, 
Sato et al. 2009). IECs utilize intercellular tight junctions to prevent paracellular traffic 
and actin-rich microvillar extensions to create an apical brush border that impedes 
microbial attachment and invasion (Shen, Turner 2006). As a result, selective uptake of 
macromolecules, particulate antigens, and microorganisms across the intestinal epithelia 
occurs primarily via active vesicular transport across epithelial cells, and as such is 
restricted by multiple cellular and molecular mechanisms (reviewed in (Neutra, Pringault 
& Kraehenbuhl 1996)). 
In addition to physical adaptations that control transport across the epithelium, 
biochemical adaptations have evolved including goblet cells, a cell type that produces a 
heavily glycosylated, mucin-rich secretion that creates a relatively impermeable apically 
adhered glycocalyx (Frey et al. 1996). The epithelium also produces antimicrobial 
peptides including defensins, cathelicidins, and calprotectins that confer broad-spectrum 
antimicrobial properties through the formation of pores in the bacterial cell wall (Ganz 
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2003). These adaptations are consistent with the view that IECs, in addition to promoting 
digestion and absorption of nutrients, perform essential barrier functions that obstruct the 
entry of beneficial and pathogenic microorganisms into the underlying lamina propria. 
IECs are in continuous contact with beneficial and pathogenic bacteria and, as a 
result, are ideally located for ―immunologic surveillance‖ of the intestinal lumen. IECs 
express TLRs, NLRs, and GPCRs that recognize microbial components and modulate 
cellular responses (Figure 3) (Hisamatsu et al. 2003, Gewirtz et al. 2001, Cario, 
Podolsky 2000). For example, IEC expression of innate pattern recognition receptors is 
important for mounting immune responses to pathogenic microbes (Carneiro et al. 2008, 
Zilbauer et al. 2007) by mediating the expression of pro-inflammatory cytokines, 
chemokines, and antimicrobial peptides, as well as the modulating of other immune cell 
types including the direct induction of IgA class switching by B cells (Macpherson et al. 
2000, Medzhitov 2007, Fritz et al. 2006, He et al. 2007, Xu et al. 2007). Responses by 
IECs to intestinal bacteria are not uniform however. IECs selectively initiate pro-
inflammatory response to pathogenic bacteria while promoting tolerance to beneficial 
bacteria (Shen, Turner 2006, Zilbauer et al. 2007, Jung et al. 1995). For example, the 
gram-negative bacteria Bacteroides thetaiotaomicron which induces IEC expression of 
the antimicrobial peptide REGIIIγ, while the gram-positive Bifidobacterium longum, a 
common component of intestinal communities, does not (Cash et al. 2006, Sonnenburg, 
Chen & Gordon 2006). 
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Figure 3: Innate receptors and signaling cascades of mammalian intestinal epithelial cells 
Schematic shows the location of innate pattern-recognition receptors and their signaling 
cascades in mammalian IECs. Innate pattern-recognition receptors converge on a common NF-
κB signaling cascade to regulate transcription of proinflammatory or immunoregulatory 
cytokines and chemokines. Adapted from (Hill, Artis 2010). 
 
Two mechanisms by which IECs may discriminate between beneficial and 
pathogenic bacteria are through subcellular sequestering of pattern-recognition 
receptors away from luminal signals and by differential receptor expression. For 
example, TLR5 (which recognizes bacterial flagellin) has been reported to be expressed 
exclusively on the basolateral surfaces of IECs (Gewirtz et al. 2001). Additionally, TLR3, 
7, 8 and 9 are expressed exclusively in intracellular endosomal organelles, while NLRs 
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are localized to the cytoplasm. In all these cases, reducing exposure of these receptors 
to luminal bacterial-derived signals limits pro-inflammatory responses to primarily 
pathogenic settings (Medzhitov 2007, Philpott, Girardin 2004, Uehara et al. 2007). In 
addition, under steady-state conditions, IECs are reported to express little or no TLR2, 
TLR4, or CD14 further minimizing the recognition of bacterial LPS from beneficial 
bacteria (Abreu et al. 2001, Melmed et al. 2003). However, subcellular localization and 
differential expression alone cannot account for all discrimination between beneficial and 
pathogenic bacteria by IECs as GPCRs that recognize and mount inflammatory 
responses to bacterial products are continuously expressed on their apical surface. As 
such, further investigation is necessary to fully understand how IECs operate in the 
context of the mucosal immune system to discriminate against beneficial and pathogenic 
bacteria. 
The recognition of bacterial signals by IECs is essential to mucosal homeostasis 
implicating IECs as central modulators of subsequent adaptive responses (Rakoff-
Nahoum et al. 2004, Bouskra et al. 2008, Cario, Gerken & Podolsky 2007). One 
mechanism by which IECs can influence proinflammatory or immunoregulatory 
responses is by influencing DCs, macrophages, and lymphocytes through the local 
expression of immunoregulatory cytokines including thymic stromal lymphopoietin 
(TSLP), IL-10, transforming growth factor β (TGFβ), prostaglandin E2 (PGE2), retinoic 
acid or IL-25 (Zaph et al. 2008, Brown et al. 2007, Dignass, Podolsky 1993, Rimoldi et 
al. 2005a, Rimoldi et al. 2005b, Taylor et al. 2009, Zeuthen, Fink & Frokiaer 2008a, 
Zeuthen, Fink & Frokiaer 2008a). For example, monocyte-derived or circulating DCs 
conditioned with supernatants from IECs isolated from healthy patients induced Foxp3+ 
Treg differentiation, while IECs from Crohn’s disease patients did not suggesting that 
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IECs may condition DCs to have primarily immunoregulatory phenotypes under 
physiologic conditions (Iliev et al. 2009b). This effect was dependent on the production 
of TGFβ and retinoic acid by IECs, but not TSLP, as DCs deficient in the TSLP receptor 
(TSLPR-/-) and wild-type DCs had a similar ability to convert naïve T cells into Treg cells 
(Iliev et al. 2009a). Indeed, a population of intestinal DCs induced FoxP3+ Tregs in a 
TGFβ and retinoic acid-dependent manner in vitro further implicating epithelial derived 
signals in the conditioning of DCs and subsequent adaptive responses, while deletion of 
NF-κB signaling specifically in IECs resulted in the dysregulated expression of DC-
derived proinflammatory cytokines and the development of spontaneous or infection-
induced intestinal inflammation (Nenci et al. 2007, Zaph et al. 2007, Sun et al. 2007, 
Coombes et al. 2007). Together, these findings indicate that IECs play a crucial role in 
conditioning intestinal DC responses. 
Epithelial—derived TSLP has been shown to have important immunomodulatory 
roles. High levels of Tslp mRNA are expressed by epithelial cells at the mucosal 
surfaces of the skin, airways, and intestine and expression can be upregulated by 
infection, inflammation or tissue injury in an NF-κB-dependent manner (Rimoldi et al. 
2005b, Zaph et al. 2007, Li et al. 2006, Allakhverdi et al. 2007, Bogiatzi et al. 2007, Kato 
et al. 2007, Lee, Ziegler 2007).  In vitro studies have shown that TSLP-conditioned 
human DCs can promote TH2 cell responses through the inhibition of IL-12 production 
and the induction of OX40L expression (Rimoldi et al. 2005b, Soumelis et al. 2002, Al-
Shami et al. 2005, Ito et al. 2005, Liu 2007).  In vivo studies in the skin and lung have 
shown that transgenic overexpression of TSLP in cutaneous or pulmonary epithelial cells 
results in the onset of TH2 cytokine–mediated inflammation resembling atopic dermatitis 
or asthma, respectively, suggesting that TSLP is both necessary and sufficient for the 
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initiation of TH2 cytokine–driven inflammation in some settings (Soumelis et al. 2002, Al-
Shami et al. 2005, Yoo et al. 2005, Zhou et al. 2005) (reviewed in (Ziegler, Liu 2006)). 
Consistently, TSLP expression and TSLP-TSLPR interactions are important for immunity 
to the intestinal nematode Trichuris muris, and protection against experimental colitis 
through the in vivo inhibition of IL-12/23p40 production by DCs (Taylor et al. 2009, Zaph 
et al. 2007). Another mechanism by which TSLP may influence TH2 cell responses is via 
regulation of basophil development. It has recently been shown that TSLP enhances the 
development of a bone marrow-resident basophil precursor in an IL-3-independent 
manner (Siracusa et al. In Press). Compared to IL-3-elicited basophils, TSLP-elicited 
basophils produce more IL-4 upon stimulation with IL-18 or IL-33, and were sufficient to 
recover TH2 cell-dependent immunity to T. muris infection in a susceptible host model 
system (Siracusa et al. In Press). Together, these results highlight the role of this 
important epithelial-derived cytokine in mediating normal TH2 cytokine-dependent 
allergic responses. 
Finally, IECs are in direct contact with intraepithelial lymphocytes and express all 
the molecular machinery required for antigen processing and presentation including 
proteolytically active cathepsins, the invariant chain, and MHC class II molecules 
(Hershberg, Mayer 2000). In vitro studies showed that rodent IECs, although less potent 
than professional antigen-presenting cells, can process and present antigen through the 
MHC class II pathway (Telega, Baumgart & Carding 2000). Supporting a role in directly 
promoting T cell responses, IECs isolated from patients with IBD express MHC class II 
molecules and can localize exogenous antigens to the late endosome on their 
basolateral surfaces (Buning et al. 2006). However, the lack of costimulatory molecule 
expression by IECs suggests IECs cannot prime naïve T cells under normal conditions, 
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though memory T cells exhibit less stringent requirements for co-stimulation and may 
therefore be influenced by IEC-intrinsic antigen presentation (Sanderson et al. 1993, 
Arens et al. 2011). Finally, IECs may deliver inhibitory or tolerogenic signals directly to T 
cells consistent with their known role in controlling B cell responses (Xu et al. 2007). 
Taken together, these studies describe how IEC-mediated recognition of commensal-
derived signals may influence the development and propagation of local or systemic 
immune responses. 
 
1.4.2 Recognition of commensal-derived signals by dendritic cells 
Dendritic cells (DCs) are perhaps the most efficient modulators of adaptive immune 
responses and they represent an important link between the innate and adaptive 
immune systems (Trombetta, Mellman 2005). DCs that survey mucosal tissues take on 
specific phenotypic characteristics and perform distinct functions depending on their 
anatomical location. In the small intestine, DCs reside both in organized lymphoid 
structures such as Peyer’s patches (PP) and are present directly beneath the epithelial 
layer in the intestinal lamina propria (LP DCs) (Figure 4) (Coombes, Powrie 2008). 
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Figure 4: The mucosal immune system of the mammalian intestine 
Innate recognition of signals from intestinal bacteria takes place at the intestinal epithelium, in 
the lamina propria and in gut-associated lymphoid tissues such as Peyer’s patches and isolated 
lymphoid follicles. Specialized intestinal epithelial cells known as M (microfold) cells overlie 
Peyer’s patches and lymphoid follicles and facilitate luminal sampling and transport of microbial 
components to professional antigen-presenting cells present in the subepithelial dome (SED). 
Dendritic cells (DCs) in the SED and perifollicular area (PFA) acquire antigens and influence 
adaptive responses. Additionally, specialized DC subsets directly sample luminal antigens. 
Intestinal DCs transport antigens to mesenteric lymph nodes through the afferent lymphatic 
system. DCs in the mesenteric lymph node promote differentiation of regulatory and effector T 
lymphocytes, as well as class switching of B lymphocytes, which then exit through the efferent 
lymph into the systemic circulation. Some of these cells home back to the intestine where they 
exert effector functions. Adapted from (Hill, Artis 2010). 
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Peyer’s patch DCs are divided into three groups based on chemokine receptor 
expression, anatomical location, and functional characteristics. CX3CR1+ PP DCs are 
found in close contact with the follicle-associated epithelium (FAE) where they 
participate in a close functional relationship with the epithelial M cell to sample luminal 
antigens in a pattern recognition receptor-dependent manner (Milling, Cousins & 
MacPherson 2005, Tyrer et al. 2006). CCR6+ PP DCs are found in the sub-epithelial 
dome but can quickly migrate to the FAE in response to microbial stimulation, and 
CCR7+ PP DCs are found in T cell areas where they orchestrate helper T cell responses 
(Iwasaki, Kelsall 1999, Iwasaki, Kelsall 2000, Salazar-Gonzalez et al. 2006), T cell 
migration (Johansson-Lindbom et al. 2005, Mora et al. 2003), and IgA in response to 
microbial signals production (Spalding et al. 1984, George, Cebra 1991, Powrie 2004). 
While DCs resident in the PP are important mediators of immune function, PPs 
are relatively rare along the length of the intestinal tract. BrdU pulse-chase experiments 
suggest that circulating DCs have evolved to migrate directly to the lamina propria (LP) 
of the small intestine through the expression of CD103 (Jaensson et al. 2008). These LP 
DCs express tight-junction proteins that allow for direct luminal sampling through the 
extension of dendrites between IECs, a process that is dependent on the CX3C-
chemokine receptor 1 (CX3CR1) and TLR ligation (Rescigno et al. 2001, Niess et al. 
2005, Chieppa et al. 2006). Accordingly CX3CR1-/- mice exhibit defective luminal 
sampling by DCs and impaired resistance to Salmonella typhimurium infection, 
implicating a crucial role for luminal sampling in the development of protective immune 
responses in the intestine (Niess et al. 2005). 
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Intestinal DCs recognize bacteria through the expression of innate pattern 
recognition receptors (Medzhitov 2007) which can modify luminal sampling (Chieppa et 
al. 2006), migration (Turnbull et al. 2005, Yrlid et al. 2006), and the induction of T cell 
differentiation (Minns et al. 2006, Uematsu et al. 2006, Uematsu et al. 2008). Intestinal 
resident DCs are thought to be tolerogenic compared to systemically circulating DCs, a 
phenotype that may be important for controlling inflammatory immune responses to 
beneficial intestinal bacteria (Sun et al. 2007, Coombes et al. 2007). For example, 
stimulation of intestinal DCs with the TLR4 ligand lipopolysaccharide (LPS) resulted in 
elevated IL-10 production, while stimulation of systemic DCs resulted in pro-
inflammatory activation (Monteleone et al. 2008, Takenaka et al. 2007). The 
mechanisms by which intestinal DCs may be skewed towards a tolerogenic phenotype 
are still under investigation and include reduced TLR expression (Monteleone et al. 
2008, Takenaka et al. 2007), hyporesponsiveness to TLR stimulation (Cerovic et al. 
2009), and/or negative regulation of the NF-κB pathway via NOD2 signaling (see section 
1.3.2) (Watanabe et al. 2006, Watanabe et al. 2008, Watanabe et al. 2004, Zeuthen, 
Fink & Frokiaer 2008b, Yang et al. 2007). Finally, as discussed in section 1.4.1, IECs 
may play an active role in promoting the tolerogenic phenotype of intestinal DCs via 
direct or indirect mechanisms (Iliev et al. 2009b). 
Intestinal resident DC populations regulate local T cell responses in part through 
the production of IL-12 and IL-23. IL-12 is a key regulatory cytokine that induces TH1 cell 
differentiation and plays an important role TH1-mediated experimental models of 
autoimmune diseases including inflammatory bowel disease (Neurath et al. 1995, 
Simpson et al. 1998, Davidson et al. 1998, Trinchieri 2003, Elson et al. 2005). IL-23 is a 
heterodimer cytokine composed of a p40 subunit (that is shared with IL-12) and a unique 
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p19 subunit (Oppmann et al. 2000). While one study has implicated IL-23 to have a 
protective role in a murine model of colitis (Becker et al. 2006), others have shown that 
IL-23 drives inflammatory TH17 responses (Lyakh et al. 2008, Yen et al. 2006) (reviewed 
in (Ahern et al. 2008)) and is a causative agent in a number of inflammatory disorders 
including joint inflammation (Murphy et al. 2003), intestinal inflammation (Yen et al. 
2006, Hue et al. 2006, Izcue et al. 2008, Kullberg et al. 2006, Uhlig et al. 2006), and 
psoriasis (Chan et al. 2006, Kopp et al. 2003). The recent identification of the IL23R as a 
gene that is associated with IBD risk has further increased clinical interest in IL-23 
inflammatory axis (Duerr et al. 2006).  
Importantly, both PP and LP DCs continuously transport self  and bacterial 
antigens, as well as live bacteria, to the mesenteric lymph nodes where they can modify 
systemic immune responses (Macpherson, Uhr 2004b, Trombetta, Mellman 2005, 
Huang et al. 2000, Fujita et al. 2006, Jang et al. 2006). Intestinal bacteria have been 
shown to induce lamina propria and mLN DCs to activate a maturation program that 
promotes subsequent conversion of naïve CD4+ T cells into regulatory T cells in a 
retinoic acid and TGF-β dependent manner (Sun et al. 2007, Coombes et al. 2007, 
Coombes, Powrie 2008, Baba et al. 2008). Intestinal DCs in the mLNs can subsequently 
target B and T lymphocytes back to the intestine by causing the upregulation of CCR9 
and α4β7 (Johansson-Lindbom et al. 2005, Mora et al. 2003, Mora et al. 2006, Stagg, 
Kamm & Knight 2002, Svensson et al. 2004). In summary, intestinal DCs have a 
predominantly tolerogenic phenotype that is thought to be mediated in part through 
signals from IECs or other immune cells as well as direct interactions with intestinal 
bacteria. This unique characteristic is thought to be important for maintaining tolerance 
to commensal bacterial-derived signals as well as other luminal antigens. 
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1.5 The influence of commensal-derived signals on immune cell 
development and homeostasis 
As discussed above, signals from intestinal bacteria appear to influence human and 
murine models of disease by modulating innate and adaptive immune responses. One 
model used to study the role of microbial signals in immune cell development is the 
germ-free mouse (reviewed in (Smith, McCoy & Macpherson 2007)). Germ-free mice are 
born and live in a sterile environment and are therefore free of exposure to live microbial 
signals (Macpherson, Harris 2004). As such, germ-free mice have been instrumental in 
dissecting the role of bacterial signals in the development of the immune system. 
Additionally, animals with altered intestinal communities, primarily achieved through the 
administration of oral broad-spectrum antibiotics, have provided a complimentary 
approach to germ-free studies and have identified key roles for bacterial signals in the 
regulation of immune cell homeostasis (Sekirov et al. 2008, Hill et al. 2009, Rakoff-
Nahoum et al. 2004, Zaph et al. 2008, Hall et al. 2008). In this section, we review 
findings from the germ-free and antibiotic-treatment mouse models that implicate 
commensal-derived signals in supporting normal physiology of the mammalian immune 
system. 
 
1.5.1 The influence of commensal-derived signals on intestinal morphology and 
function 
Germ-free and antibiotic-treated mice display a number of morphologic defects as 
compared to conventionally-reared animals. Perhaps most striking is the dramatic 
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enlargement of the cecum (an intestinal segment located between the distal small 
intestine and proximal colon) observed in these models. This enlargement is due in part 
to the accumulation of undegraded mucus glycoproteins that are produced by the 
intestinal epithelium and are normally degraded by glycoside hydrolases from intestinal 
bacteria (namely Peptostreptococcus micros and members of the genera Ruminococcus 
and Bifidobacterium) (Lindstedt, Lindstedt & Gustafsson 1965, Gustafsson, Midtvedt & 
Strandberg 1970, Hoskins et al. 1985, Carlstedt-Duke et al. 1986). Accordingly, cecal 
enlargement can be rapidly reversed through selective monoassociation with 
Peptostreptococcus micros (Carlstedt-Duke et al. 1986). Germ-free animals also 
accumulate bile acids in their cecum and large intestine which may contribute to cecal 
distention by causing osmotic imbalances across the epithelial wall (Eyssen, Parmentier 
& Mertens 1976). 
Characteristic histologic alterations in the architecture of the intestinal epithelium 
also occur in germ-free and antibiotic-treated animals. The villi of the cecum are longer 
and wider compared to conventionally-reared mice and morphologic studies in rats 
suggest that crypts are shorter and contain fewer cells in the germ-free as compared to 
conventionally-reared animals (Alam, Midtvedt & Uribe 1994). These changes in crypt 
architecture could also be in part due to decreased turnover of IECs that occurs in germ-
free as compared to conventionally-reared animals or due to anatomical defects 
discussed above (Abrams, Bauer & Sprinz 1963). 
In conventionally-reared animals, the intestine undergoes waves of peristalsis 
that help move luminal contents proximally to distally. Intestinal bacteria modify enteric 
nerve function and transient manipulations of intestinal communities can lead to 
persistent neuromuscular dysfunction and enteritis (Barbara, Vallance & Collins 1997). 
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Consistently, germ-free animals show defects in small intestinal peristalsis characterized 
by slower and less frequent migrating motor complexes as a result of reduced 
responsiveness to enteroendocrine cell products (Strandberg et al. 1966). Intestinal 
motility is important for the maintenance of intestinal bacterial communities as the 
ablation enteric neurons specifically in the jejunum and ileum resulted in bacterial 
overgrowth and patchy jejuno-ileitis containing foci of hemorrhagic necrosis (Bush et al. 
1998). Peristaltic defects can be reversed through conventionalization of germ-free 
animals suggesting that bacterial signals dynamically influence intestinal neuromuscular 
function (Husebye, Hellstrom & Midtvedt 1994). 
 
1.5.2 The influence of commensal-derived signals on gut-associated lymphoid tissues 
It is estimated that the intestinal mucosa of humans contains more lymphocytes, and 
produces more antibodies, than any other organ in the body (Mestecky, McGhee 1987). 
In mice, the majority of immune cells reside in gut-associated lymphoid tissues (GALT) 
which include the mLN, Peyer’s patches (PP), cecal patch and isolated lymphoid follicles 
(ILF) which occur along the length of the gastrointestinal (GI) tract with increasing 
frequency in the colon and rectum (Langman, Rowland 1986, Brandtzaeg et al. 1989). 
Germ-free mice display reduced intestinal lymphatic tissue and an 
underdeveloped lymphatic system as compared to conventionally-reared mice 
implicating commensal bacterial-derived signals in contributing to the development of 
these structures (Hudson, Luckey 1964, Hooijkaas et al. 1984). Specifically, PP numbers 
and cellularity are reduced, as are the number of ILFs (Bouskra et al. 2008, Cebra et al. 
1998). Defects in lymphoid tissue genesis are not limited to the immediate intestinal 
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compartment as mLNs are smaller, less cellular, and have fewer germinal centers in 
germ-free compared to conventionally-reared animals (Glaister 1973). Consistently, 
antibiotic treatment has been shown to decrease the cellularity of intestinal Peyer’s 
patches, implicating bacterial signals in the maintenance of intestinal lymphoid tissues 
(Yaguchi et al. 2006). These findings indicate that microbial signals are required for 
lymphoid tissue development and/or maintenance in the mammalian intestine. 
Several studies have begun to identify the bacterial-derived signals that 
contribute to the maintenance of intestinal lymphoid tissues. For example, the selective 
colonization of germ-free animals with intestinal bacteria results in the recovery of 
lymphoid structures in the intestinal compartment and the recovery of mLN size and 
cellularity (Hudson, Luckey 1964, Glaister 1973). Additionally, peptidoglycan from gram-
negative bacteria have been shown to be both necessary and sufficient to induce ILF 
formation in the mammalian intestine in a NOD1-dependent manner (Bouskra et al. 
2008). 
 
1.5.3 The influence of commensal-derived signals on dendritic cell and macrophage 
differentiation and function 
Signals from intestinal bacteria have both developmental and regulatory influences on 
intestinal APCs. Intestinal DCs have been shown to be present in reduced numbers in 
the intestine of germ-free compared to conventionally-reared animals (Haverson et al. 
2007, Williams et al. 2006). These defects appear to be isolated to the intestinal 
compartment as DCs from the spleen and mLNs of germ-free animals had normal 
surface marker expression and ability to stimulate T cell proliferation (Walton et al. 
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2006b). Intestinal DCs were recruited to the lamina propria upon monoassociation of 
germ-free animals with E. coli suggesting that intestinal bacteria influence the 
anatomical locations of intestinal DC populations (Haverson et al. 2007). 
 Monocyte/macrophage development is also influenced by signals from intestinal 
bacteria. Monocyte/macrophage numbers in the intestine were either normal or reduced 
in germ-free as compared to conventionally-reared animals (Williams et al. 2006, Zhang 
et al. 2008). In addition, systemic monocyte/macrophage numbers are reduced in germ-
free as compared to conventionally-reared animals (Zhang et al. 2008). Again, systemic 
and intestinal defects in monocytes/macrophage could be recovered upon 
monoassociation of germ-free animals with L. acidophilus and L. reuteri implicating 
signals from intestinal bacteria in the regulation of these cell types (Zhang et al. 2008). 
As discussed previously, intestinal APCs are thought to have a uniquely 
tolerogenic phenotype that is important for maintaining tolerance to oral antigens 
(reviewed in (Medzhitov 2007, Takenaka et al. 2007)). For example, intestinal CD11c+ 
lamina propria cells expressed TLR5 and proinflammatory cytokines in response to 
pathogenic bacteria, but not in response to beneficial bacteria (Uematsu et al. 2006). It is 
thought that the tolerogenic nature of intestinal APCs may be imparted directly or 
indirectly by select intestinal bacteria. For example, Lactobacillus rhamnosus has been 
shown to decrease TNFα production in LPS-activated macrophages in a contact-
independent manner, a phenomenon that is likely important for controlling pathogenic, 
proinflammatory immune responses (Iwasaki 2007, Pena, Versalovic 2003). Indeed, 
Crohn’s disease patients were found to have higher numbers of intestinal macrophages 
that expressed the innate-immune receptor CD14 and produce larger amounts of 
proinflammatory cytokines as compared to healthy controls (Kamada et al. 2008). These 
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cells expressed both macrophage (CD14, CD33, CD68) and DC (CD205, CD209) 
markers and evoked stronger TH1 and TH17 cell differentiation than non-CD14 
expressing macrophages suggesting that intestinal APCs that lack tolerogenic properties 
can contribute to inflammatory disease  (Kamada et al. 2009). In summary, maintenance 
of tolerogenic properties of antigen presenting cells may be in part mediated by 
interactions with commensal populations. 
 
1.5.4 The influence of commensal-derived signals on lymphoid-tissue inducer and 
natural killer cell differentiation and function 
Lymphoid-tissue inducer (LTi) cells are RORγt+ IL-7Rα+ innate leukocytes that induce 
lymph node development in the embryo through the production of lymphotoxin-β and 
TNF and the recruitment of circulating LTi cells, their precursors, and more mature 
lymphocytes (Colonna 2009). In adult mice, clusters of LTi cells are found in the 
cryptopatches of the small intestine, and in secondary lymphoid organs such as the 
spleen, where they participate in maintaining local lymphoid tissue anatomy (Colonna 
2009). LTi cells are an innate source of IL-17 and IL-22 (an IL-10-family member that 
contributes to epithelial-cell resistance and repair by inducing the production of 
antimicrobial proteins such as β-defensins, RegIIIγ, S100 calcium-binding proteins, and 
regenerating gene family proteins) (Takatori et al. 2009). Recently, CD4+ LTi cells were 
shown to promote innate immunity to Citrobacter rodentium infection in an IL-23-
dependent mechanism and IL-23-responsive innate lymphoid cells were found to be 
increased in inflammatory bowel disease implicating these cell types as important 
contributors to human disease (Geremia et al. 2011, Sonnenberg et al. 2011). The 
finding that lymphoid follicles are underdeveloped in germ-free mice has led some to 
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speculate that LTi cells might be regulated by bacterial signals; however, one study to 
date indicated that LTi cell numbers and function were similar in the mucosa of germ-
free as compared to conventional mice (Sanos et al. 2008). 
Nevertheless, an intriguing connection exists between LTi cells and another cell 
population known to be regulated by intestinal bacteria; namely, IL-22 producing 
intestinal Natural Killer (NK)-like (NK-22) cells. Intestinal NK-22 cells are found in the 
cryptopatches and lamina propria of adult mice where they are an important innate 
source of IL-22 (Sanos et al. 2008, Cella et al. 2008, Satoh-Takayama et al. 2008, Luci 
et al. 2009). Production of IL-22 by mucosal NK-22 cells may contribute to defense 
against the extracellular enteric pathogen Citrobacter rodentium as the partial depletion 
of mucosal NK-22 cells increased the mortality of infected mice (Cella et al. 2008, Satoh-
Takayama et al. 2008). In addition, NK-22 cells have been shown to mediate protection 
from experimental colitis supporting the hypothesis that these cells are involved in 
defense against assaults to the enteric mucosa (Zenewicz et al. 2008). 
LTi cells can differentiate into NK-like cells in vitro that express both LTi and NK 
cell receptors (Mebius, Rennert & Weissman 1997) (reviewed in (Vivier, Spits & Cupedo 
2009)). Additionally, human fetal LTi cells gave rise to NKp44+ cells that produced IL-17 
and IL-22 in vitro (Cupedo et al. 2009). However, questions remain as to the relationship 
between LTi cells and NK-22 cells in vivo as LTi cells develop independently of 
commensal-derived signals but are required for lymphoid tissue development, while 
lymphoid tissue development and the development of IL-22 producing intestinal NK cells 
are both dependent on bacterial signals. The dependence of NK-22 cells on RORγt 
expression further suggests that LTi cells and NK-22 cells may be related either 
developmentally or functionally (Colonna 2009). Intestinal LTi cells and NK-22 cells both 
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upregulate IL-22 production shortly after birth suggesting that colonization of the 
intestine drives IL-22 production by these cell types in humans and mice (Sanos et al. 
2008, Satoh-Takayama et al. 2008). Finally, absolute and relative numbers of NK-22 
cells were reduced in germ-free as compared to conventionally-reared mice (Sanos et 
al. 2008) further implicating signals from intestinal bacteria in NK-22 cell development. 
These findings suggest that signals from intestinal bacteria promote mucosal 
homeostasis in part by promoting the induction of IL-22 producing innate leukocytes. 
 
1.5.5 The influence of commensal-derived signals on B cell differentiation and 
function 
A typical intestinal lymphoid follicle has a germinal center, a B lymphocyte–rich 
peripheral zone, and a dome-shaped ―corona‖ containing B cells, CD4+ T cells, dendritic 
cells, and macrophages (Brandtzaeg et al. 1988) (Figure 4). APCs immediately under 
the epithelium are presumably active in uptake and killing of incoming pathogens as well 
as in processing, presentation, and perhaps storage of antigens. There is an intimate 
relationship between intestinal communities and B lymphocytes that reside in intestinal 
lymphoid structures. As discussed previously, the first immunological response to 
bacterial signals during colonization is IgA production and secretion into the intestinal 
lumen (Macpherson 2006, Klaasen et al. 1993). In fact, the large majority of B cells in 
the intestine are immunoglobulin A (IgA)-producing plasma cells which produce and 
secrete IgA into the intestinal lumen at an estimated rate of 0.8 grams per meter of 
intestine per day (Brandtzaeg et al. 1989, Goldblum, Hannson & Brandtzaeg 1996). This 
secretory immune response, which is characterized by class-switching of B cells from 
IgM to IgA production, is orchestrated through an intimate functional relationship 
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between secretory epithelia and local plasma cells and is mediated by TLRs through T-
cell dependent and independent mechanisms (Macpherson et al. 2000, He et al. 2007). 
For example, intestinal bacteria trigger T cell-independent IgA class switching in B cells 
through IEC secretion of cytokines including APRIL (He et al. 2007, Xu et al. 2007). In 
addition, IEC-derived TSLP and IL-10, produced in response to bacterial signals, may 
orchestrate local B cell responses (He et al. 2007, Xu et al. 2007, Astrakhan et al. 2007). 
Secretory IgA creates a first-line defense against mucosal compromise that is lost during 
IBD (Lodes et al. 2004, Brandtzaeg, Carlsen & Halstensen 2006). Together, these 
findings implicate early recognition of bacterial-derived signals and the subsequent 
modulation of B cell responses as important processes that promote normal mucosal 
homeostasis. 
There are several findings in germ-free mice that support a role for bacterial 
signals in B cell development. There are reduced numbers of plasma cells in the germ-
free small intestine which correlates with reduced IgA production (Glaister 1973, Crabbe 
et al. 1970). Systemically, there are also reduced numbers of germinal centers and 
plasma cells in germ-free mice which correlate with reduced systemic immunoglobulin 
levels (Hooijkaas et al. 1984, Gustafsson, Laurell 1959, Gordon, Brauckner-Kardoss 
1961, Wagner, Wostmann 1961, Ikari 1964, Sell 1964). Germ-free mice also show 
reduced antigen-specific immunoglobulins to some antigens (DNP-BSA, E. coli) but not 
others (RBC, phosphorylcholine, DNP-lys-Ficoll) (Horowitz et al. 1964, Ohwaki et al. 
1977, Etlinger, Heusser 1986). In general, these intestinal and systemic immunoglobulin 
defects are corrected upon conventionalization of germ-free animals suggesting that 
these defects are not developmental and that commensal-derived signals actively 
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maintain these aspects of B cell physiology (Crabbe et al. 1970, Gustafsson, Laurell 
1959, Wagner, Wostmann 1961, Moreau et al. 1978). 
One exception to the trend of reduced immunoglobulin levels is IgE. There are 
increased IgE bearing B cells in the Peyer’s patches of germ-free mice as well as 
increased serum IgE responses upon antibiotic treatment of conventionally-reared mice 
(Bashir et al. 2004, Durkin, Bazin & Waksman 1981). The IgE found in germ-free mice is 
composed of natural specificities and induced by a mechanism independent of MHC 
class II (MHC II) cognate help (McCoy et al. 2006). These findings suggest that in 
general, microbial signals act as an adjuvant to immunoglobulin responses with the 
exception of allergic IgE responses, where commensal-derived signals may play an 
immunoregulatory role. 
 
1.5.6 The influence of commensal-derived signals on CD8+ cytotoxic T cell 
differentiation and function 
The intestinal mucosa of conventionally-reared animals normally contains a large 
population of resident T lymphocytes.  In the conventionally-reared mouse intestine, 
CD4+ T cells are found primarily in the lamina propria while CD8+ T cells dominate in the 
intraepithelial compartment (Jabri, Ebert 2007). The development or homeostasis of 
CD8+ IELs is dependent on bacterial signals as MyD88-deficient and germ-free mice  
display reduced CD8+ T cell numbers the IEL compartment of the small intestine 
(Imaoka et al. 1996, Kawaguchi-Miyashita et al. 1996, Yu et al. 2006). Cytotoxic activity 
of IELs is impaired in both germ-free and antibiotic-treated mice, a phenotype that can 
be reversed through the administration of the TLR4 ligand LPS (Kawaguchi-Miyashita et 
al. 1996, Paulos et al. 2007). In germ-free mice, this cytotoxic defect was isolated to αβ 
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TCR-bearing IELs while the number and cytotoxicity of γδ TCR-bearing IELs was 
comparable between germ-free and conventionally-reared mice (Kawaguchi-Miyashita et 
al. 1996). These defects may be in part due to impaired clonal expansions of CD8αβ+ 
and CD8αα+ IELs (Helgeland et al. 2004).  
The systemic distribution of CD8+ T cells is also dependent on bacterial signals. 
Restricted-flora mice have a selective reduction in systemic plasmacytoid dendritic cells 
as a result of enhanced cytotoxic T lymphocyte activity that is not observed in germ-free 
mice (Fujiwara et al. 2008). Additionally, the liver is a site of activated CD8+ T cell 
sequestering and subsequent apoptosis during systemic immune responses, a 
phenomenon that is dependent on TLR4 ligands such as endotoxin from intestinal 
bacteria (John, Crispe 2005). Finally, animals colonized with nonpathogenic Clostridium 
sp. have reduced numbers of naïve, splenic CD8+ lymphocytes as compared to 
conventionally-reared controls suggesting that signals from intestinal bacteria play an 
active role in CD8+ lymphocyte regulation. Some of these effects may be a result of a 
lack of MyD88-dependent signaling as CD8-intrinsic MyD88-dependent signaling is 
important for CD8+ T cell survival and expansion (Huang et al. 2005, Rahman et al. 
2008). 
Though likely influenced by multiple immune cells in addition to CD8+ cytotoxic T 
cells, microbial stimulation can also result in tumorigenesis under some conditions. The 
first observation that microbial signals could influence tumor immunity came in the 18th 
century when Deidier reported a correlation between patient infection and the remission 
of malignant disease, a finding that eventually led to the use of LPS to treat primarily 
inoperable sarcoma with a cure rate of better than 10% (Garay et al. 2007). These early 
findings indicate that microbial signaling through TLRs is important for initiating or 
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sustaining anti-tumor immune responses (reviewed in (Rakoff-Nahoum, Medzhitov 
2009)). This hypothesis has now been supported by several studies in animal models 
and patients (Krieg 2007, Paulos et al. 2007, Apetoh et al. 2007, Yusuf et al. 2008). 
Animal models have provided additional insights into how commensal-derived 
signals influence tumor immunity. MyD88-deficient mice are protected against the 
development of spontaneous intestinal tumors in a model of familial associated 
polyposis (FAP) and germ-free animals have reduced intestinal tumorigenesis as 
compared to conventionally-reared animals following the same protocol of colorectal 
cancer induction (Rakoff-Nahoum, Medzhitov 2007, Vannucci et al. 2008). Similarly, 
hepatocellular carcinoma, the most common liver cancer, occurs mainly in males. This 
gender disparity is also seen in mice given the chemical carcinogen diethylnitrosamine 
and was shown to be dependent on MyD88-mediated increases in serum interleukin-6 
(IL-6) (Naugler et al. 2007). In humans, associations between intestinal bacteria and 
cancer risk have been explored and studies were performed to identify fecal bacterial 
communities associated with high colorectal cancer risk though they failed to provide 
conclusive results (Moore, Moore 1995, Benno et al. 1986, Finegold et al. 1975, Huycke, 
Gaskins 2004). In summary, clarifying the influence of bacterial signals in establishing 
normal cytotoxic immune capacities has led to exciting therapeutic possibilities but more 
research is needed to fully understand the role that signals from intestinal bacteria play 
in tumor-genesis and control. 
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1.6 The influence of commensal bacterial-derived signals on CD4+ T 
helper cell responses 
1.6.1 CD4+ T helper cells 
Protective adaptive immunity in mammals is dependent on the development and 
activation of antigen-specific CD4+ T cells by innate accessory cells such as DCs and 
macrophages. Innate accessory cells signal in cis and trans via the T cell receptors, co-
stimulatory molecules, Notch signaling and autocrine and paracrine cytokine signaling to 
specify the optimal helper T cell fate to combat the specific pathogen (Zhu, Yamane & 
Paul 2010). Helper T cells subsequently mobilize distinct innate and adaptive effector 
cells, as well as induce characteristic changes in non-immune cell types, important for 
host defense. T cell subsets are defined as T helper type (TH) 1, TH2, TH17 and 
regulatory T cells (Treg) based on their unique cytokine production profiles, transcription 
factor expression profiles and effector functions. In this section I discuss the influence of 
commensal bacterial-derived signals on the development and function of the TH subsets. 
 
1.6.2 The influence of commensal-derived signals on T helper 17 and regulatory T 
cell responses 
The differentiation of TH17 cells is dependent on the retinoic acid-related orphan receptor 
(RORγt), requires TGF-β and IL-6 or IL-21, and relies on IL-23 for TH17 cell maturation 
and survival (Korn et al. 2009). In the steady state, IL-17–producing cells are present in 
high numbers in lamina propria of the small intestine and the TH17-related cytokines IL-
22 and IL-17 play a role in host protection against extracellular pathogens (Kastelein, 
Hunter & Cua 2007, Dong 2008, Ivanov et al. 2008). Conventionally-reared animals 
44 
 
have TLR-independent ―spontaneous‖ IL-17 production in the lamina propria of their 
small intestine (Ivanov et al. 2008). Spontaneous IL-17 production was absent in germ-
free animals, suggesting that intestinal bacteria signal through a TLR-independent 
mechanism to promote TH17 cell development (Ivanov et al. 2008). One mechanism by 
which intestinal bacteria may regulate TH17 cell development independent of TLR 
signaling is through the production of other bioactive molecules such as metabolites 
(discussed above). Indeed, ATP has been shown to stimulate LP APCs to produce IL-6, 
IL-23, and TGF-β, resulting in TH17 cell differentiation (Atarashi et al. 2008). 
While TH17 cells are reduced in the small intestine of germ-free mice, more TH17 
cells have been observed in the large intestine of germ-free as compared to 
conventionally-reared mice (Zaph et al. 2008). In the large intestine, bacterial signals 
regulate TH17 cell development through bacterial-dependent production of the IL-17 
family cytokine IL-25 (IL-17E), which down regulates IL-17 production through the 
inhibition of IL-23 production by lamina propria macrophages (Zaph et al. 2008). These 
findings suggest that regulation of TH17 cell differentiation by commensal-derived signals 
is dependent on anatomical location along the intestine. Indeed, the small and large 
intestines are microbiologically and immunologically distinct sites. As discussed 
previously, there are site specific differences in intestinal bacterial communities along 
the length of the intestine. In addition, there are more intra-epithelial lymphocytes (IELs) 
and lamina-propria lymphocytes (LPLs) per epithelial cell in the small intestine, and the 
lymphocyte composition and migration to the small versus large intestine is differentially 
regulated (Ivanov et al. 2008, Cheroutre 2004). These fundamental differences may 
underlie differential regulation of TH17 cells in distinct anatomical sites. 
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Studies in antibiotic treated mice mirror those from germ-free mice and support a 
role for bacterial signals in the regulation of TH17 cell homeostasis. For example, mice 
treated with vancomycin have fewer TH17 CD4
+ T cells in the LP of the small intestine 
(Atarashi et al. 2008, Ivanov et al. 2008, Niess et al. 2008). Additionally, TH17 cell 
differentiation in the lamina propria of the small intestine has been shown to require 
specific intestinal bacteria, specifically, cytophaga-flavobacter-bacteroidetes (CFB) 
bacteria (Ivanov et al. 2008). This induction of TH17 cells was independent of TLR 
signaling, IL-21, or IL-23, but required TGFβ activation suggesting that specific intestinal 
bacteria regulates the TH17/Treg balance in the mammalian intestine. 
An intimate relationship exists in the intestinal mucosa between proinflammatory 
TH17 cells and CD4
+ regulatory T cells that play an important role in controlling TH17 cell 
responses (Belkaid, Tarbell 2009). Tregs are characterized as CD4+ CD25+ cells that 
express the forkhead box P3 transcription factor (FoxP3) and have been shown to 
suppress proliferation of effector T cells in vitro and to protect from autoimmune and 
other inflammatory diseases in several animal models. For example, mice carrying a 
loss-of-function mutation of FoxP3 completely lack Tregs and develop lethal 
autoimmune disease while Lactobacillus and Bifidobacterium strains have been shown 
to cause expansion of Tregs in the intestinal intraepithelial compartment and protect 
against experimental colitis (Brunkow et al. 2001, Roselli et al. 2009). These findings 
identify Foxp3 as a master regulator of Treg differentiation and function and identify 
Tregs as an important regulatory cell type that contributes to intestinal and systemic 
immune homeostasis.   
There are differing reports of the influence of bacterial signals on Treg 
development and function. Consist with studies that showed reduced FoxP3 mRNA in 
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CD4+ T cells from mLNs of germ-free mice, early studies in germ-free animals showed a 
selective reduction in the percentage of FoxP3+CD4+CD25+ T cells in the mLN of germ-
free mice  (Strauch et al. 2005, Ostman et al. 2006). In addition to reduced frequencies, 
it has been reported that Tregs from the mLN of germ-free animals did not suppress 
CD4+ T cell proliferation in vitro as well as Tregs from conventionally-reared animals 
(Ishikawa et al. 2008). Furthermore, Tregs from the mLN of germ-free mice produced 
less IL-10 and did not protect as well against disease in a transfer model of experimental 
colitis as compared to Tregs from conventionally-reared animals (Strauch et al. 2005). 
Recent studies have identified Clostridium species as important inducers of colonic 
regulatory T cells suggesting that specific commensal-derived signals are important for 
maintenance of this cell population (Atarashi et al. 2011). Others have shown that local 
and systemic Treg populations seem to be similar between conventionally-reared mice 
and mice with reduced commensal stimulation (Zaph et al. 2008, Ichinohe et al. 2011). 
Together, these results suggest that signals from intestinal bacteria are important for 
normal development and maintenance of Treg numbers and function in intestinal 
tissues. 
However, there seem to be different effects of bacterial-derived signals on other 
Treg populations. One study reported no change in the frequency of lamina propria 
CD4+FoxP3+ T cells from the colon of germ-free animals while another reported 
increased percentages of CD4+FoxP3+ in the small intestine (Zaph et al. 2008, Ivanov et 
al. 2008). These differing results could be due sampling Treg cell subsets from different 
anatomical locations (mLN vs. intestine). Additionally, these differences could be due to 
experimental methods, animal housing, diet, non-bacterial microbial stimulation, or Treg 
identification methods employed. 
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1.6.3 The influence of commensal-derived signals on the TH1/TH2 cell balance 
In humans, as in mice, two distinct patterns of cytokine secretion have been defined 
among CD4+ helper T-cell clones; type 1 helper type (TH) 1 cells, but not TH2 cells, 
produce IL-2, IFNγ, and TNFα, while TH2, but not TH1, cells produce IL-4, IL-5, IL-9 and 
IL-13 but not IL-2 or IFNγ (reviewed in (Abbas, Murphy & Sher 1996)).  These distinct 
immune responses are important for protective responses to distinct infectious agents; 
Th1 cell responses are protective against bacterial and protozoan infections while TH2 
cell responses act in resistance to helminths and ectoparasites.  
The influence of intestinal bacteria on TH2 cytokine-dependent inflammation has 
been of particular interest of late given recent epidemiological findings that antibiotic use 
in children results in significantly increased risk of developing allergic disease (Penders 
et al. 2007, Marra et al. 2009, Kummeling et al. 2007). There is also a strong 
experimental literature correlating states of reduced commensal stimulation with 
increased TH2 cytokine-dependent inflammation. For example, germ-free mice have 
impaired oral tolerance and increased levels of allergen-specific IgE compared to 
conventionally-reared mice (Sudo et al. 1997). TLR4 signaling is important for 
commensal bacterial-derived signals to promote oral tolerance as TLR4 deficient mice 
display similar levels of food allergy compared to mice treated with oral antibiotics 
(Bashir et al. 2004). Commensal bacterial-derived signals also seem to limit disease in 
models of allergic asthma. Antibiotic treatment resulted in the selective outgrowth of 
fungal microbes in the intestine and worse disease outcomes in an IL-13-dependent 
mechanism (Noverr et al. 2005). In some cases specific bacterial species have been 
shown to influence the development of TH2 cell responses. For example, treating 
animals with antibiotics during infancy promoted a shift in the TH1/TH2 balance towards a 
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TH2-dominant immunity, and this effect could be reduced by oral inoculation of mice with 
Enterococcus faecalis or Lactobacillus acidophilus (Oyama et al. 2001, Sudo et al. 
2002). Consistent with commensal-derived signals promoting TH1 cell environments, 
optimal induction of TH1 cell development in vitro by DCs required TLR2 signaling (Wang 
et al. 2006) and commensal-derived signals acts as adjuvants to promote immunity to 
the protozoan parasite Toxoplasma gondii (Benson et al. 2009). Additionally, there is 
evidence for DC-dependent CD4+ TH1 cell responses to commensal bacteria in normal 
human intestinal lamina propria (Howe et al. 2009). Despite these associations, the 
mechanisms by which the innate immune system recognizes commensal-bacterial 
derived signals and influences the development of TH2 cytokine-dependent allergic 
inflammation are not well understood. 
As discussed previously, DCs recognize commensal bacterial-derived signals to 
modulate subsequent adaptive T cell responses (Medzhitov 2007, Takenaka et al. 
2007). However, DCs have recently been shown to be insufficient to prime optimal TH2 
cell responses in select cases, implicating other innate immune cells in this role 
(Perrigoue et al. 2009, Sokol et al. 2009, Yoshimoto et al. 2009). In addition to their well-
established roles as innate effector cells, basophils have recently been shown to 
function as accessory cells by providing early sources of IL-4 and contributing to the 
initiation of CD4+ TH2 cell responses (Gessner, Mohrs & Mohrs 2005, Mohrs et al. 2005, 
Min et al. 2004). These findings implicate regulation of innate granulocyte populations as 
a potential mechanism by which commensal-derived signals may limit TH2 cytokine-
dependent inflammation. The following section reviews basophil development and 
effector functions as well as the recently appreciate roles for basophils in contributing to 
the development of optimal TH2 cell responses. 
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1.7 Basophils and the initiation and propagation of Type 2 cytokine-
dependent allergic inflammation 
Discovered in 1897, basophils are the least abundant granulocyte population making up 
less than 1% of peripheral blood leukocytes. Originally, basophils were thought to be 
redundant to mast cells as they also bind immunoglobulin (Ig)E and release histamine 
upon activation (Ishizaka et al. 1972). However, subsequent comparisons of basophils 
and mast cells revealed that these two granulocytes are distinct and differ in many 
aspects including their morphology, expression of surface markers, factors required for 
growth and differentiation, activation and signal transduction pathways and release of 
inflammatory mediators (MacGlashan et al. 1983, Siracusa et al. 2010). This section will 
discuss classical roles for basophils as key effector cells recruited to sites of tissue 
inflammation and the newly identified roles for basophils as innate cells that initiate and 
propagate optimal allergic TH2 cell responses. 
 
1.7.1 Basophil development and effector functions 
Basophils develop from bone marrow resident granulocyte-monocyte precursor cells 
(GMPs) which also give rise to the eosinophil and mast cell lineages (Arinobu et al. 
2005). Two basophil precursor cell types have been identified that reportedly give rise to 
mature basophils. The basophil precursor (BaP) is a bone marrow-resident population 
that exits the bone marrow upon differentiation into a mature basophil while the spleen-
resident basophil-mast cell precursor (BMCP) gives rise to both basophil and mast cell 
populations (Iwasaki, Akashi 2007). Expression of the transcriptions factors GATA-2 and 
CCATT enhancer-binding protein C/EBPα are important for basophil development 
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(Iwasaki, Akashi 2007) along with expression of IL-4 and IL-13 transcripts (Gessner, 
Mohrs & Mohrs 2005). Unlike mast cells, which are not considered mature until they 
enter a peripheral tissues site, basophils exit the bone marrow with a mature phenotype 
(Galli 2000) and are only thought to survive between 60-70 hours (Iwasaki, Akashi 2007, 
Mellblom 1980, Ohnmacht, Voehringer 2009). As such, circulating basophil populations 
are likely continuously replenished by precursor populations (Ohnmacht, Voehringer 
2009).  
Classically, basophils are recognized as innate effector cells that are recruited to 
sites of tissue inflammation upon activation. One of the primary routes of basophil 
activation is crosslinking of immunoglobulins bound to the cell surface. Basophils 
express the high affinity IgE receptor (εεR1α), which in turn binds natural and antigen-
specific IgE from the serum. Upon cross-linking of FcεRIα, basophils release multiple 
signaling molecules including histamine, leukotrienes, cytokines and chemokines that 
contribute, along with mast cells, to the clinical sequelae of immediate hypersensitivity 
reactions (Schroeder 2009). Basophils also express the IgG receptor FcγR and have 
been shown to be the major cell type responsible for some immunoglobulin-G-mediated 
immediate hypersensitivity reactions in some settings (Tsujimura et al. 2008, Ohnmacht 
et al. 2010). In addition to immediate hypersensitivity, basophils have been shown to 
contribute to chronic IgE-mediated allergic inflammation in mice (Ohnmacht et al. 2010, 
Obata et al. 2007). In this model, basophils were not required for the immediate- or late-
phase responses to subcutaneous antigen administration, but were necessary for the 
subsequent edema and recruitment of eosinophilic and neutrophilic infiltrates to the site 
of antigen injection. These findings suggest that basophils mediate the recruitment of 
other innate effector cells to inflammatory sites. Finally, basophils have been shown to 
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be activated by IgD, a class of antibody the function of which remains unclear. Produced 
in the upper respiratory tract of mammals and implicated in immunity to respiratory 
pathogens, IgD-mediated activation of basophils resulted in the production of IL-4, anti-
microbial peptides, B cell-activating factor and the induction of class switching of B cells 
to IgM, IgD and IgA isotypes (Chen et al. 2009). Together, these findings identify several 
pathways of basophil activation by immunoglobulins that result in diverse effector 
functions. 
Other avenues to basophil activation include cytokines, proteases, TLRs, 
complement proteins and super-antigens. IL-3 is a T cell-derived cytokine and a potent 
regulator of basophil responses. Though basophils represent a relatively small 
proportion of circulating immune cells in the steady-state, circulating basophil 
populations can expand dramatically in response to IL-3 (Lantz et al. 1998, Lantz et al. 
2008, Shen et al. 2008, Ohmori et al. 2009). IL-3 has been shown to both increase 
basophil survival and act on bone marrow-resident basophil precursors to increase the 
population of circulating basophils (Lantz et al. 1998, Lantz et al. 2008, Ohmori et al. 
2009). Additionally, IL-3 augments IL-4 and IL-13 production by purified human 
basophils following activation by IgE (Gibbs et al. 1996, MacGlashan et al. 1994). 
However, while these studies identify an important role for IL-3 in mediating basophil 
responses, IL-3-IL-3R signaling is not absolutely essential for basophil development or 
survival as IL-3 receptor-deficient mice display near normal circulating basophil 
frequencies (Lantz et al. 1998). Consistent with other cytokines or molecules supporting 
steady-state basophil homeostasis, IL-18 and IL-33, which are produced by innate 
immune cells including macrophages and epithelial cells in response to allergic and 
parasitic stimuli (Kroeger, Sullivan & Locksley 2009, Pecaric-Petkovic et al. 2009), have 
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been shown to enhance basophil survival and augment basophil cytokine production 
(Kroeger, Sullivan & Locksley 2009, Yoshimoto et al. 1999). 
Another mechanism of basophil activation is via proteases that are thought to 
directly activate basophils independently of immunoglobulins or cytokines. This 
mechanism of basophil activation presumably evolved to respond to proteases secreted 
from helminth parasites, but plays an active role in basophil responses to allergic stimuli. 
For example, papain, a cysteine protease and potent allergen associated with 
occupational allergy in humans (Novey et al. 1979) and TH2 cell responses in mice 
(Sokol et al. 2008), is capable of directly inducing IL-4 and IL-6 production from bone 
marrow-derived murine basophils (Sokol et al. 2008). Additionally, the house dust mite 
(HDM) protease Derp1 induces production of IL-4, IL-5 and IL-13 from a human basophil 
cell line (Phillips et al. 2003). In both the case of papain and Derp1, activation of 
basophils is dependent on protease activity (Sokol et al. 2008, Phillips et al. 2003), and 
in the case of Derp1, may result from functional mimicry of the TLR4 receptor complex 
(Trompette et al. 2009). Consistent with basophils contributing to HDM-induced allergic 
inflammation, depletion of basophils via treatment with a monoclonal antibody targeting 
CD200R resulted in reduced HDM-elicited TH2 cytokine-responses (Hammad et al. 
2010). One mechanism by which basophils may sense protease activity is via protease-
activated receptors (PARs), a family of receptors known to activate innate and adaptive 
immune cells in response to infectious or allergic stimuli (Shpacovitch et al. 2008). 
However, PAR expression has not been detected in murine basophils implicating other 
receptors or molecular mechanisms in the activation of basophils by proteases (Falcone, 
Morroll & Gibbs 2005). 
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Finally, additional molecular signals known to influence innate basophil response 
include TLR ligands, complement proteins and super-antigens. While basophils are 
reported to express TLR1, TLR2, TLR4, TLR6 and TLR9, only TLR2 ligands have been 
shown to activate basophils directly (Siracusa et al. 2010, Sabroe et al. 2002, Bieneman 
et al. 2005, Komiya et al. 2006). Specifically, lipopolysaccharide treatment of purified 
human basophils resulted in their production of IL-4 and IL-13 (Sabroe et al. 2002, 
Bieneman et al. 2005). Human basophils also express receptors to the complement 
proteins CR1, CR3, CR4 and CD88 and produce histamine in response to C5a (Hook, 
Siraganian & Wahl 1975, Siraganian, Hook 1976). Finally, direct, non-specific activation 
of basophils by super-antigens has been reported. For example, the gp120 glycoprotein 
of HIV interacts with the VH3 region of IgE to induce IL-4 and IL-13 production from 
human basophils (Patella et al. 2000) while the IPSE/alpha-1 glycoprotein from 
Schistosoma mansoni eggs induces IgE-dependent, antigen-independent IL-4 
production by murine basophils in vivo (Schramm et al. 2007). Together, these findings 
identify important roles for basophils as innate effector cell populations that contribute to 
immunity to parasitic infections and pathology of inflammatory diseases. 
 
1.7.2 Synergistic roles for basophils and dendritic cells in the initiation of TH2 cell 
responses 
As discussed previously, dendritic cells (DCs) are perhaps the most efficient initiators of 
adaptive immune responses and represent an important link between the innate and 
adaptive immune systems (Trombetta, Mellman 2005). Consistently, mouse models 
indicate that DCs contribute to the development of TH2 cell-dependent immunity and 
inflammation. For example, DCs exposed to S. mansoni egg antigen (SEA) preparations 
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promote TH2 cell differentiation in vitro and in vivo (Marshall, Pearce 2008), an 
immunologic outcome that may be mediated by low dose stimulation of the TCR 
(Steinfelder et al. 2009). Another mechanism by which TH2 responses are initiated may 
be through direct modulation of DC activity by helminth-derived signals. For example, 
excretory-secretory products from Heligmosomoides polygyrus and Nippostrongylus 
brasiliensis, but not T. muris, can directly suppress DC production of IL-12p40 
(Massacand et al. 2009). Recently, loss-of-function studies have shown DC populations 
to be critically important for the development of optimal TH2 cell responses to some 
stimuli. For example, depletion of DCs early in the immune response against S. mansoni 
resulted in impaired TH2 cell development and increased production of IFN-γ by CD4
+ T 
cells (Phythian-Adams et al. 2010). Additionally, DCs are sufficient to induce protective 
immunity to T. muris when interferon γ is blocked with a neutralizing antibody (Perrigoue 
et al. 2009). Finally, a FcεRIα-expressing inflammatory DC sub-type were found to be 
necessary and sufficient for the induction of TH2 immunity and allergic airway disease 
using two murine asthma models, while other innate immune cell types including 
basophils played a supporting role (Hammad et al. 2010, van Rijt et al. 2005).  
Despite findings that indicate that DCs are necessary for TH2 cell induction under 
some conditions, there is a growing body of evidence suggesting that DCs, when acting 
independently from other innate cell types, are not sufficient for the induction of optimal 
TH2 cytokine responses. For example, restriction of MHCII expression to CD11c
+ cells 
was found to be insufficient for optimal induction of protective immunity to T. muris 
(Perrigoue et al. 2009). Similarly, DCs were not required for TH2 cell induction in 
response to papain while basophils were found to be critically required (Sokol et al. 
2009). Together, these results suggest that cognate, MHCII-dependent interactions 
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between T cells and CD11c- cell populations contribute to the development of optimal 
TH2 cell responses. 
In addition to their well-established roles as late phase innate effector cells, 
basophils have also recently been shown to function as important accessory cells by 
providing early sources of IL-4 and contributing to the initiation and/or propagation of 
CD4+ TH2 cell responses (Gessner, Mohrs & Mohrs 2005, Mohrs et al. 2005, Min et al. 
2004). Human basophils can produce more IL-4 per cell than activated TH2 cells (Mitre 
et al. 2004) and murine studies indicate that basophil-derived IL-4 contributes to TH2 cell 
development in the presence of antigen and dendritic cells (Hida et al. 2005, Oh et al. 
2007). Together, these findings identify basophils as an innate cell population that can 
produce IL-4 and augment TH2 cell differentiation in vitro. In addition, studies in murine 
disease models have identified a role for basophils in promoting TH2 cell responses in 
vivo. For example, environments enriched for basophils, via continuous IL-3 treatment or 
deficiency in  the interferon regulatory factor 2, result in preferential differentiation of TH2 
cells (Hida et al. 2005, Oh et al. 2007). Consistent with basophils influencing T cell 
responses, IL-4 expressing basophils are recruited from the circulation to draining lymph 
nodes in response to infectious (Perrigoue et al. 2009) or allergic stimuli (Sokol et al. 
2008) where they augment TH2 cell differentiation. Critically, TH2 cell responses are 
reduced upon basophil depletion in multiple allergy models including papain (Sokol et al. 
2008) and house dust mite allergen (Hammad et al. 2010), indicating that basophils 
contribute to the development of optimal TH2 cell responses in these settings. 
Finally, in addition to being an innate source of IL-4, murine and human studies 
have demonstrated that basophils express MHC class II, endocytose soluble antigen, 
express MHC II and co-stimulatory molecules, and in select cases can act as antigen 
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presenting cells that promote antigen-specific TH2 cell differentiation (Perrigoue et al. 
2009, Sokol et al. 2009, Yoshimoto et al. 2009). Consistently, basophils have been 
shown to promote TH2 cell differentiation in vitro and in vivo (Sokol et al. 2009, 
Yoshimoto et al. 2009). Furthermore, adoptive-transfer of antigen-pulsed basophils into 
MHC II-deficient hosts indicated that basophils were sufficient to promote antigen-
specific TH2 cell differentiation (Yoshimoto et al. 2009). Finally, adoptive-transfer of 
basophils increased TH2 cell differentiation and immunity to T. muris, as well as TH2 cell 
responses to S. mansoni egg preparations in vivo (Siracusa et al. In Press, Perrigoue et 
al. 2009). Together, these data indicate that in addition to providing innate IL-4 that 
augments DC-dependent TH2 cell development, basophils can support the initiation or 
propagation of antigen-specific TH2 cell responses in an MHC II-dependent manner. 
These recently appreciated roles for basophils in augmenting TH2 cell responses and 
TH2 cytokine-mediated allergic inflammation have led to corollary studies in humans and 
models of human disease. For example, basophils were found to be activated by self-
reactive IgE antibodies and recruited to lymph nodes where they promoted TH2 cell 
differentiation in a model of lupus nephritis (Charles et al. 2010). Patients with systemic 
lupus erythematous were found to have elevated self-reactive IgE levels and activated 
basophils that express MHC II and were associated with disease activity and active 
lupus nephritis (Charles et al. 2010). Together, these results identify basophils as an 
innate granulocyte population that contributes to the development of optimal TH2 
cytokine-dependent allergic inflammation and is correlated with human TH2 cytokine-
mediated diseases. However, the potential influence of commensal bacterial-derived 
signals on these and other innate granulocytes known to contribute to allergic TH2 cell 
responses is not characterized.  
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Chapter 2: The influence of antibiotic treatment on 
commensal bacterial communities of the intestine 
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2.1 Abstract 
Despite widespread use of antibiotics, few studies have measured their effects on the 
burden or diversity of bacteria in the mammalian intestine. This chapter describes the 
development of an oral antibiotic treatment protocol and the characterization of its 
effects on murine intestinal bacterial communities. Antibiotic administration resulted in a 
ten-fold reduction in the amount of intestinal bacteria present and sequencing of 16S 
rDNA segments revealed significant temporal and spatial effects on luminal and 
mucosal-associated communities including reductions in luminal Firmicutes and 
mucosal-associated Lactobacillus species, and persistence of bacteria belonging to the 
Bacteroidetes and Proteobacteria phyla. This comprehensive temporal and spatial 
metagenomic analyses provides a resource and framework to test the influence of 
bacterial communities in murine models of human disease. 
 
2.2 Introduction 
The human intestine is colonized by 100 trillion microorganisms belonging to each of the 
three domains of life (Eckburg, Lepp & Relman 2003). Of these, bacteria are the most 
abundant—the colon is home to approximately 1011 to 1014 bacterial cells per mL of stool 
(Whitman, Coleman & Wiebe 1998) and has a diversity of at least 1000 species (Ley, 
Peterson & Gordon 2006). Through recent advances in surveying non-culturable 
intestinal communities using 16S ribosomal DNA (16S rDNA) sequencing (Pace, Olsen 
& Woese 1986) and microarray-based methods, it has become clear that the major 
bacterial phyla in the mammalian intestine include Bacteroidetes (Bacteroidetes class), 
Firmicutes (Clostridia class), Proteobacteria (Alpha, Beta, Gamma, and Epsilon classes), 
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Actinobacteria, and Fusobacteria (Palmer et al. 2007, Eckburg et al. 2005). Some 
intestinal bacteria are mutualists that promote normal mammalian physiology including 
proper digestion (Hooper, Midtvedt & Gordon 2002), metabolism (Backhed et al. 2004), 
epithelial cell function (Artis 2008), angiogenesis (Stappenbeck, Hooper & Gordon 
2002), enteric nerve function (Husebye, Hellstrom & Midtvedt 1994), and immune 
system development (Hill, Artis 2010). While bacterial communities promote normal 
immune homeostasis, patients with inflammatory bowel disease (IBD) (Frank et al. 2007) 
and atopic allergies (Bjorksten et al. 2001) have altered intestinal communities, 
indicating that microbial communities might influence the pathogenesis of these 
diseases (Marra et al. 2009, Strober, Fuss & Blumberg 2002). 
Antibiotic treatment has the adverse effect of altering intestinal microbial 
communities (Hoban 2003) and antibiotic exposure is linked to increased risk of 
Clostridium difficile colitis (De La Cochetiere et al. 2008) and asthma (Marra et al. 2009, 
Kummeling et al. 2007, Wickens et al. 1999) in humans. In keeping with these findings, 
antibiotic treatment in animal model systems has identified complex pro-inflammatory 
and immunoregulatory roles for intestinal communities in modulating intestinal cytokine 
responses (Zaph et al. 2008, Hall et al. 2008, Mazmanian, Round & Kasper 2008), in 
altering resistance to enteric pathogens (Sekirov et al. 2008, Hall et al. 2008, Stecher et 
al. 2007, Garner et al. 2009, Croswell et al. 2009), in maintaining mucosal homeostasis 
(Rakoff-Nahoum et al. 2004, Kang et al. 2008), and in controlling allergic inflammation 
(Bashir et al. 2004). However, while the use of oral broad-spectrum antibiotics in 
humans and animal models is common, knowledge of how antibiotics influence intestinal 
bacterial communities is limited. 
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Previous studies using culture and fluorescence in situ hybridization based 
methods have provided some insights into antibiotic effects on a limited subset of 
intestinal bacteria (Sekirov et al. 2008, Miller, Bohnhoff 1963). More recently, molecular 
based examination of antibiotic treatment in humans showed effects on intestinal 
communities, but was confounded by inter-individual variability (Dethlefsen et al. 2008). 
Animal models have proven well-suited for metagenomic studies because they allow for 
control of host genetic background, feeding practices, and antibiotic administration. In 
one such study of bacterial recovery after antibiotic perturbation, single-antibiotic effects 
were characterized at the phylum level at a single time point and anatomic location 
(Antonopoulos et al. 2009). Other groups have reported the general effects of oral 
antibiotic treatment on intestinal bacteria, including significant changes to lactobacilli, 
enterococci/group D streptococci, Firmicutes, Bacteroidales, or segmented filamentous 
bacteria, depending on the specific antibiotic and treatment protocol (Sekirov et al. 2008, 
Stecher et al. 2007, Garner et al. 2009, Croswell et al. 2009). However, the interpretation 
of these studies is limited as in-depth temporal and spatial analysis of the effects of 
antibiotic treatment on microbial communities was not undertaken. 
In this chapter, we characterized the effects of two different antibiotic treatment 
protocols on murine intestinal bacterial communities and immune cell homeostasis. We 
found that published protocols involving administration of multiple antibiotics (ampicillin, 
gentamicin, metronidazole, neomycin, and vancomycin) in drinking water altered 
intestinal microbiota, but were complicated by the development of severe dehydration in 
the host. For this reason, we developed an oral gavage-based protocol that facilitated 
controlled antibiotic dosing without the development of dehydration. Using DNA bar-
coding and pyrosequencing of 16S rDNA gene segments, we examined temporal effects 
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of antibiotics on bacterial communities and found significant reductions in the frequency 
of bacteria belonging to the Firmicutes phylum and persistence of the Bacteroidetes and 
Proteobacteria phyla over time. Additionally, we performed spatial analysis of luminal 
and mucosal-associated bacterial communities following antibiotic treatment and found 
significant effects in the cecum, proximal colon, and distal colon including reductions in 
mucosal-associated Lactobacillus species. 
 
2.3 Methods 
2.3.1 Animals 
Conventionally reared, six to eight week old female C57BL/6 mice were obtained from 
Charles River Laboratory and maintained in a specific pathogen–free facility. Animals 
were housed by litter and fed autoclaved LabDiet 5010 mouse chow (LabDiet, 
Richmond, IN) and autoclaved water. Germ-free animals were maintained in plastic 
isolator units and fed autoclaved LabDiet 5021 mouse chow (LabDiet, Richmond, IN) 
and autoclaved water. Isolators were checked weekly and consistently cultured negative 
for microbial contaminants. All experiments were approved by and performed following 
the guidelines of the University of Pennsylvania Institutional Animal Care and Use 
committee. 
 
2.3.2 Antibiotic Treatment 
For continuous antibiotic treatment, animals were provided with autoclaved drinking 
water, or autoclaved drinking water supplemented with ampicillin (1 mg/mL), gentamicin 
(1 mg/mL), metronidazole (1 mg/mL), neomycin (1 mg/mL), and vancomycin (0.5 
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mg/mL). For antibiotic treatment by oral gavage, animals had access to autoclaved food 
and water and were subjected to oral gavage daily for ten days with 200 μL of 
autoclaved water or autoclaved water supplemented with ampicillin (1 mg/mL), 
gentamicin (1 mg/mL), metronidazole (1 mg/mL), neomycin (1 mg/mL), and vancomycin 
(0.5 mg/mL). 
 
2.3.3 16S rDNA sample acquisition and quantification of 16S rDNA 
Stool pellet, luminal content, and washed mucosal-associated tissue samples were 
collected and total DNA was extracted using the QIAamp® DNA Stool Mini Kit (stool 
pellet/luminal samples)(Qiagen, Inc., Valencia, CA) or the DNeasy Blood and Tissue Kit 
(tissue samples)(Qiagen, Inc., Valencia, CA). Quantification of 16S rDNA was performed 
by real-time RT-PCR using degenerate bacterial 16S rDNA specific primers (5’–
AGAGTTTGATCCTGGCTCAG-3’;forward), (5’-CTGCTGCCTYCCGTA-3’;reverse), (5'-
FAM-TA+ACA+CATG+CA+AGTC+GA-BHQ1-3'; probe; + precedes the position of LNA 
base). 
 
2.3.4 DNA manipulations 
16S rRNA gene fragments were obtained as previously described (McKenna et al. 
2008). Samples were amplified using 8 nucleotide-barcoded primer pairs (BSF8; 5´-
AGAGTTTGATCCTGGCTCAG-3´), (BSR357; 5´-CTGCTGCCTYCCGTA-3´). 50 μL 
PCR reactions were carried out using the AmpliTaq System (Applied Biosystems, Inc., 
Foster City, CA) (Buffer II, 2 mM MgCl2, 200 μM each dNTP, 10 μM each primer, 0.1 
mg/mL BSA, 100 ng (stool) or 500 ng (tissue) of template, 2.5 units polymerase).   Cycle 
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parameters: 1 minute 95° C, 20 cycles (stool pellet and luminal samples) or 25 cycles 
(tissue samples) of 30 secs at 95° C, 30 secs at 56° C, and 90 secs at 72° C, final 
extension at 72° C for 8 minutes. PCR products were gel purified using the QIAquick® 
Gel extraction kit (Qiagen, Inc., Valencia, CA). 100 ng of each amplicon was pooled and 
subjected to pyrosequencing. 
 
2.3.5 Bioinformatic analysis 
Sequence quality was accessed and samples with >100 sequences were carried 
through to subsequent analyses. Sequences were inserted into the 16S rRNA gene tree 
(Hugenholtz 2002) using parsimony insertion implemented in ARB. The tree constructed 
using ARB was used to carry out UniFrac analysis to compare global community 
structure as described previously (Lozupone, Knight 2005, Lozupone, Hamady & Knight 
2006, Lozupone et al. 2007). Taxonomic assignments for each sequence were obtained 
using RDP Classifier (Wang et al. 2007). 
 
2.3.6 Histology, stool protein extraction, western blot 
At necropsy, cecal tissue sections were removed and fixed in 4% paraformaldehyde 
(PFA) and paraffin-embedded. 5 μm sections were cut and stained with hematoxylin and 
eosin (H&E). Crypt morphology was quantified using ―NIS Elements BR‖ imaging 
software (Nikon, Melville, NY). Fecal protein isolation was performed as previously 
described (Artis et al. 2004). Samples were equalized by protein content, analyzed by 
SDS-PAGE, and immunoblotted for RELMβ using a polyclonal rabbit anti-murine RELMβ 
antibody (PeproTech, Rocky Hill, NJ). Blots were visualized using ECLTM (Amersham, 
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Piscataway, NJ) and band intensity was quantified using ―UN-SCAN-IT‖ (Silk Scientific, 
Inc., Orem, UT). 
 
2.3.7 Statistics 
UniFrac analysis: Regression analysis was performed on day 0-9 stool pellet samples 
from naïve or antibiotic-treated animals.  Pyrosequencing analysis: The frequencies of 
bacterial group compared using a Mann-Whitney test. Each mouse was treated as a 
biological replicate. 
 
2.4 Results 
2.4.1 Administration of antibiotics in drinking water alters bacterial communities but 
results in severe dehydration 
Antibiotic treatment has been used extensively to probe the effects of microbial signals 
in disease, including murine models of intestinal inflammation (Rakoff-Nahoum et al. 
2004, Zaph et al. 2008, Hall et al. 2008, Kang et al. 2008) and allergy (Bashir et al. 2004, 
Noverr et al. 2004). However, to date there has been limited analysis of how oral 
antibiotics specifically influence intestinal bacterial communities. We sought to 
characterize the effects of published antibiotic treatment protocols on intestinal bacterial 
communities through analysis of bacterial 16S rDNA compositions. Following published 
protocols, conventionally reared animals were given access to autoclaved water or 
autoclaved water containing ampicillin, gentamicin, metronidazole, neomycin, and 
vancomycin (Sekirov et al. 2008, Bashir et al. 2004, Rakoff-Nahoum et al. 2004, Zaph et 
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al. 2008, Hall et al. 2008, Kang et al. 2008). Stool pellets were collected at day 10 post-
treatment initiation and total DNA was extracted for quantitative analysis of 16S 
ribosomal DNA (16S rDNA) genes by real-time RT-PCR. We observed a greater than 
two log reduction in bacterial 16S rDNA after ten days of antibiotic treatment as 
compared to control-treated animals (Figure 5a). 
To examine the effects of antibiotics on the composition of bacterial communities 
in stool pellets, we used 454/Roche pyrosequencing of 16S rDNA segments and 
determined taxonomic assignments for each sequence using RDP Classifier. Antibiotic 
administration resulted in reduced frequencies of bacteria belonging to the Bacteroidetes 
phylum (Bacteroidaceae family) and Firmicutes phylum (Lachnospiraceae family). 
Antibiotic administration also resulted in increased frequencies of other members of the 
Firmicutes phylum (Leuconostocaceae and Streptococcaceae families) as well as 
members of the Proteobacteria phylum (Enterobacteriaceae and Moraxellaceae families) 
(Figure 5b, H2O vs. ABX). 
We next investigated the origin of the bacterial 16S rDNA present in stool pellets 
after antibiotic treatment. To determine whether these sequences represented a living 
community that persisted after antibiotic treatment, we analyzed stool pellets from germ-
free animals and found bacterial community sequences similar to those present in stool 
pellets from antibiotic-treated animals (Figure 5b). We hypothesized that antibiotic 
treatment reduced intestinal bacteria to levels at which residual DNA in autoclaved food 
became the major contributor of 16S rDNA sequences. To test this, DNA was extracted 
from sterile mouse chow and 16S communities were shown to be indistinguishable from 
those found in stool pellets from antibiotic-treated or germ-free animals (Figure 5b) 
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indicating that stool pellets from these animals were contaminated with bacterial 16S 
rDNA normally present in autoclaved food. 
 
 
Figure 5: Antibiotic delivery in drinking water modulates intestinal communities but results in 
animal dehydration 
(a) 16S rDNA gene copies as quantified by real-time RT-PCR from stool pellets collected from 
naïve (H2O, n=5) or antibiotic-treated (ABX; n=5) animals (±S.E.M). (b) Family-level phylogenetic 
classification of 16S rDNA frequencies in stool pellets collected from naïve animals (H2O; n=5), 
antibiotic-treated animals (ABX; n=5), germ-free animals (GF; n=3), or autoclaved animal food 
(Chow; n=3). (c) Weights of animals fed unsupplemented (H2O; n=4) or antibiotic-supplemented 
(ABX; n=4) water (***P≤0.001; ±S.E.M.). Antibiotic-treated animals were switched to 
unsupplemented water at day 14 (dashed line). 
 
We further sought to investigate the effects of antibiotics on intestinal immune 
homeostasis. Unfortunately, we found that animals fed antibiotics in drinking water 
rapidly showed signs of dehydration including weight loss, decreased skin turgor, and 
hard stools while animals fed autoclaved water showed no signs of dehydration (Figure 
5c). Similar antibiotic treatment protocols without gentamicin or with added sweetener 
also resulted in dehydration (data not shown).  These data reveal an adverse effect of 
antibiotic treatment that confounds the interpretation of the effects of antibiotics on 
immune cell homeostasis (Guseinov, Guseinova 2008). 
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2.4.2 Development of a new, broad-spectrum antibiotic treatment regimen that 
prevents animal dehydration 
We developed an alternative protocol in which animals were orally gavaged with 
autoclaved water or autoclaved water containing ampicillin, gentamicin, metronidazole, 
neomycin, and vancomycin once daily for ten days. Daily weights and stool pellet 
samples were taken and animals were sacrificed on day 10 for histologic, microbiologic, 
and immunologic analyses. Animals treated with antibiotics by oral gavage maintained 
their body weight (Figure 6a) and displayed no signs of dehydration. Treated animals 
also developed loose stools (data not shown) as seen with antibiotic treatment in human 
patients (Rohde, Bartolini & Jones 2009). 
To examine the effects of this treatment regimen on intestinal bacteria, 16S rDNA 
copy number was quantified in stool pellet samples using real-time RT-PCR. We 
observed an initial increase in 16S rDNA copies in stool pellets from antibiotic treated 
animals at day one post treatment initiation suggesting a flushing of bacterial DNA into 
the stool, likely representing dead bacteria (Figure 6b, day 1). After nine days, we 
observed a ten-fold reduction in total 16S rDNA in stool pellets of treated animals 
(Figure 6b) consistent with a reduction in total bacterial load.  
We next undertook gross anatomic and histologic analyses of antibiotic-treated 
animals. Treated animals displayed characteristic enlarged ceca, similar to those seen in 
germ-free animals (Figure 6c) (Thompson, Trexler 1971), as well as expansion of the 
lamina propria and enterocyte hyperplasia resulting in increased intestinal villus width 
and length (Figure 6d,e). Further, examination of RELMβ, a protein secreted from 
intestinal goblet cells in response to intestinal colonization (Wang et al. 2005), showed a 
trend towards reduction at day one that reached statistical significance by day five (P ≤ 
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0.001) and day nine (P ≤ 0.005) post-treatment initiation (Figure 6f). Thus, antibiotic 
treatment by oral gavage resulted in bacterial depletion without dehydration, and this 
was accompanied by anatomic, histologic, and immunologic changes characteristic of 
reduced microbial stimulation. 
 
2.4.3 Antibiotic treatment results in two phases of bacterial community restructuring 
The temporal effects of antibiotic treatment on bacterial communities were examined 
using pyrosequencing of bacterial 16S rDNA gene segments. We analyzed 49,994 
sequences from 144 samples representing stool pellet, luminal, and mucosal-associated 
bacterial communities originating from the cecum, proximal large intestine, and distal 
large intestine of nine animals (four naïve and five antibiotic-treated). To characterize the 
global effects of antibiotic treatment on the full intestinal microbiome, bacterial 
communities were compared in control-treated or antibiotic-treated animals by 
quantifying similarities based on phylogenetic distances using UniFrac as described 
previously (Lozupone, Knight 2005, Lozupone, Hamady & Knight 2006, Lozupone et al. 
2007). UniFrac distances were calculated in two different ways, using only 
presence/absence information (unweighted) or taking into account the abundance of 
each bacterial lineage (weighted) and Principal Coordinate Analysis was used to cluster 
communities along orthogonal axes of maximal variance. 
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Figure 6: Antibiotic administration by gavage mimics molecular, anatomic, histologic, and 
immunologic characteristics of reduced microbial stimulation without animal dehydration 
(a) Weights of animals gavaged with unsupplemented (H2O; n=4) or antibiotic supplemented (ABX; n=5) 
water (±S.E.M.). (b) 16S rDNA gene copies as quantified from stool pellets collected before (day 0) or over 
the course of antibiotic treatment (days 1, and 9) (n=5; (±S.E.M.). (c) Cecal images from control-treated 
(H2O), day 10 antibiotic-treated (ABX), or germ-free (GF) animals (bar, 1 cm). (d) Photomicrographs of 
hematoxylin-and-eosin-stained cecal sections from control-treated (H2O), day 10 antibiotic-treated (ABX), 
or germ-free (GF) animals showing expansion of the lamina propria and enterocyte hyperplasia in ceca 
from antibiotic-treated and germ-free animals (bar, 50 µm). (e) Quantification of cecal villus length and 
width from control-treated (H2O; n=4), day 10 antibiotic-treated (ABX; n=5), or germ-free (GF; n=3) 
animals (***P≤0.001; ±S.E.M). (f) Quantification of RELMβ protein in stool pellets by western blot over 
the course of antibiotic treatment (n=5) (**P≤0.01; ±S.E.M). 
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In unweighted UniFrac analysis, the first coordinate separated the stool pellet, 
luminal, and mucosal-associated samples on the basis of antibiotic treatment, and 
explained 26.8% of the variance (Figure 7a). Weighted UniFrac analysis also separated 
samples on the basis of antibiotic treatment, with 75.4% of the variance represented by 
the first principal coordinate (Figure 7b). These findings indicated that antibiotic 
treatment resulted in new luminal and mucosal-associated bacterial communities that 
were distinct from those seen in control-treated animals both in the proportions of the 
different groups and in the types of bacteria present. Treated samples grouped tightly in 
our weighted analysis with respect to the second coordinate axis (Figure 7b, 14.1% of 
group variance) indicating that intestinal communities in treated animals were more 
similar than those existing prior to treatment. 
To examine the temporal effects of antibiotic treatment analysis of stool pellets 
was utilized. Stool pellet analysis is both non-invasive and representative of luminal 
community composition (Eckburg et al. 2005), allowing for longitudinal analyses. We 
found that samples from day zero and day one had distinct graphical locations in both 
unweighted and weighted UniFrac analyses (Figure 7a,b). This finding indicated an 
initial shift in community structure that occurred quickly after initiation of antibiotic 
treatment. Furthermore, unweighted and weighted UniFrac analyses revealed that the 
second and third coordinates, respectively, separated longitudinal pellet samples on the 
basis of treatment day (Figure 7c,d) indicating a second, more gradual change in 
community structure over time. This trend reached statistical significance in antibiotic-
treated (P ≤ 0.0001, unweighted and weighted) but not control-treated animals. In 
summary, UniFrac analysis of bacterial communities from control-treated or antibiotic-
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treated animals revealed a dramatic shift in community structure that occurred quickly 
after antibiotic initiation, followed by a more gradual alteration in community structure 
over time. 
 
Figure 7: UniFrac analysis of restructuring of bacterial communities over time 
(a) Unweighted or (b) weighted UniFrac analysis of stool pellet, luminal content or mucosal-associated 
samples from control- or antibiotic-treated animals. (c) Unweighted or (d) weighted UniFrac analysis of 
stool pellet samples from control-treated (H2O; n=4) or antibiotic-treated (ABX; n=5) animals from day 1 
to day 9 post-treatment initiation. Colored symbols represent treatment day, white squares represent 
means, red line represents linear regression analysis (±S.E.M., significance determined by regression 
analysis). 
 
ABX
Day 1 2 3 4 5 6 7 8 9
H2O
Pellets unweighted
Day
treatment: H2O treatment: ABX
P
C
A
2
 7
.3
%
1 2 3 4 5 6 7 8 9
–0.3
–0.2
–0.1
0.0
0.1
0.2
0.3
0.4
1 2 3 4 5 6 7 8 9
 = 0.6428
0.0001
 = 0.1454
0.0661
Day
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
P
C
A
3
 3
.2
%
treatment: H2O treatment: ABX
Pellets weighted
–0.12
–0.10
–0.08
–0.06
–0.04
–0.02
0.00
0.02
0.04
0.06
0.08
0.10
 = 0.7347
0.0001
 = 0.0106
0.6322
dc
–0.4 –0.3 –0.2 –0.1 0.0 0.1 0.2 0.3 0.4
PCA1 - 26.8%
–0.4
–0.3
–0.2
–0.1
0.0
0.1
0.2
0.3
P
C
A
2
 5
.6
%
Unweighted UniFrac
Pellet
Luminal
Mucosal
H2O ABX
–0.3 –0.2 –0.1 0.0 0.1 0.2 0.3 0.4
PCA1 - 75.4%
–0.3
–0.2
–0.1
0.0
0.1
0.2
0.3
0.4
P
C
A
2
 1
4
.1
%
Weighted UniFrac
Pellet
Luminal
Mucosal
H2O ABX
ba
72 
 
2.4.4 Antibiotic treatment causes reductions in Firmicutes with the persistence of 
Bacteroidetes and Proteobacteria phyla over time 
Phylogenetic placements allow the identification of bacterial taxa affected by antibiotic 
treatment. Temporal analysis of stool pellet samples revealed a significant shift in 
community composition on day one post-antibiotic treatment initiation (Figure 8a,b) that 
was not observed in control-treated animals (data not shown). The timing of this shift is 
consistent with the flushing of 16S rDNA into stool observed during quantitative analysis 
(Figure 6b, day 1) and the graphical separation between day zero and day one samples 
from treated animals in UniFrac analyses (Figure 7a,b). These findings indicate that 
even short antibiotic courses can result in dramatic alterations to intestinal bacterial 
communities. Temporal analysis of stool pellet samples over the course of treatment 
further revealed a gradual change in bacterial proportions over time (Figure 8a) that was 
consistent with the gradual alteration in community structure observed by UniFrac 
(Figure 7c,d). 
After nine days of antibiotic treatment, there were several statistically significant 
differences between stool pellets from antibiotic-treated and control-treated animals. 
These included reductions in the Porphyromonadaceae family, Marinilabilia genus, 
Bacteroidales order, Bacteroidetes phylum, Weissella genus, Butyrivibrio genus, 
Lachnospiraceae incertae sedis genus, Lachnospiraceae family, Anaerotruncus genus, 
Ruminococcaceae incertae sedis genus, Ruminococcaceae family, and TM7 genera 
incertae sedis (P values listed in Figure 8b; groups significantly reduced shaded in red). 
Upon antibiotic treatment, there were increases in the frequency of bacteria belonging to 
the Bacteroides genus, Parabacteroides genus, Prevotella genus, Prevotellaceae family, 
Xylanibacter genus, Erysipelotrichaceae incertae sedis, and Akkermansia genus (P 
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values listed in Figure 8b; groups significantly increased shaded in green). We did not 
detect any statistically significant differences in bacterial frequencies over the course of 
treatment in stool pellets from control-treated animals (data not shown). In summary, we 
found that antibiotic treatment caused significant changes in stool pellet bacterial 
communities and that these changes occurred in at least two phases, one that occurred 
immediately after initiating treatment and one that progressed over the course of 
treatment. 
 
Figure 8: Metagenomic analysis of restructuring of intestinal bacterial communities over time 
(a) Genus-level phylogenetic classification of 16S rDNA frequencies in stool pellets collected from control-
treated (H2O; n=4) or antibiotic-treated (ABX; n=5) animals from day 0 to day 9. (b) Average frequency of 
bacterial groups before (antibiotic day 0) or during (antibiotic day 1 and 9) antibiotic treatment. Mann-
Whitney P values of changes in group frequency with antibiotic treatment. Frequency reductions on 
antibiotic treatment shown in red, increases shown in green, non-significant changes blank. 
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2.4.5 Antibiotic treatment results in significant alterations to luminal and mucosal-
associated bacterial communities along the length of the colon 
Bacterial communities are distinct along the length of the intestinal tract (Eckburg et al. 
2005), and between luminal and mucosal sites (Zoetendal et al. 2002). Therefore, we 
analyzed the spatial effects of antibiotic treatment on luminal bacterial communities 
longitudinally along the colon (cecum, proximal colon, distal colon) (Figure 9a). In the 
lumen, antibiotic treatment was associated with lower frequencies of bacteria belonging 
to the Porphyromonadaceae family, Alistipes genus, Marinilabilia genus, Rikenellaceae 
family, Bacteroidales order, Bacteroidetes phylum, Mucispirillum genus, Butyrivibrio 
genus, Coprococcus genus, Lachnospiraceae incertae sedis, Lachnospiraceae family, 
Anaerotruncus genus, Faecalibacterium genus, Ruminococcaceae incertae sedis, 
Ruminococcaceae family and Clostridiales order (P values listed in Figure 9b; groups 
significantly reduced shaded in red). Antibiotic treatment also resulted in significant 
increases in the frequency of bacteria belonging to the Bacteroides genus, 
Parabacteroides genus, Prevotella genus, Xylanibacter genus, Burkholderiales order, 
Enterobacter genus, and Akkermansia genus (P values listed in Figure 9b; groups 
significantly increased shaded in green). 
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Figure 9: Antibiotics modify luminal bacterial communities along the length of the colon 
(a) Genus- level phylogenetic classification of 16S rDNA frequencies in luminal samples collected from control-treated (H2O; n=4) or 
day 10 antibiotic-treated (ABX; n=5) animals from the cecum (Ce), proximal colon (Prox) or distal colon (Dist). (b) Average frequency 
of bacterial groups in samples from control-treated (H2O; n=4) or antibiotic-treated (antibiotic day 10; n=5) animals. Mann-Whitney 
P values of changes in group frequency with antibiotic treatment. Frequency reductions on antibiotic treatment shown in red, 
increases shown in green, non-significant changes blank. 
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Ruminococcaceae family, and the Clostridiales order as compared to samples from 
control-treated animals (P values listed in Figure 10b; groups significantly reduced 
shaded in red). Upon antibiotic treatment, there were also significant increases in the 
frequency of mucosal-associated bacteria belonging to the Bacteroides genus, 
Parabacteroides genus, Prevotella genus, Prevotellaceae family, Xylanibacter genus, 
and the Burkholderiales order (P values listed in Figure 10b; groups significantly 
increased shaded in green). We were unable to amplify enough sequences from 
proximal colon mucosal-associated samples for statistical analysis. In summary, 
phylogenetic analyses revealed significant changes to luminal and mucosal-associated 
bacterial communities following antibiotic treatment. 
 
Figure 10: Antibiotics modify mucosal-associated bacterial communities along the length of 
the colon 
(a) Genus- level phylogenetic classification of 16S rDNA frequencies in mucosal-associated samples collected from control-treated 
(H2O; n=4) or day 10 antibiotic-treated (ABX; n=5) animals from the cecum (Ce), proximal colon (Prox) or distal colon (Dist). (b) 
Average frequency of bacterial groups in samples from control-treated (H2O; n=4) or antibiotic-treated (antibiotic day 10; n=5) 
animals. Mann-Whitney P values of changes in group frequency with antibiotic treatment. Frequency reductions on antibiotic 
treatment shown in red, increases shown in green, non-significant changes blank. 
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2.5 Discussion 
This chapter describes the development of an antibiotic treatment protocol that 
significantly alters intestinal bacterial communities and immune cell homeostasis without 
animal dehydration. Deep sequencing was employed to quantify temporal and spatial 
antibiotic effects on intestinal bacterial communities and show significant changes in 
several bacterial groups that correlate with altered cytokine production by CD4+ T 
lymphocytes in intestinal-associated lymphoid tissues. 
Animals were initially treated with antibiotics in drinking water in a similar manner 
to previously published protocols (Sekirov et al. 2008, Bashir et al. 2004, Rakoff-
Nahoum et al. 2004, Zaph et al. 2008, Hall et al. 2008, Kang et al. 2008). This treatment 
protocol reduced intestinal bacteria to the extent that DNA from food composed the 
majority of recovered 16S rDNA sequences. However, this protocol was associated with 
animal dehydration that may complicate the interpretation of subsequent immunologic 
studies (Guseinov, Guseinova 2008). These findings also highlight the presence of 
sterile microbial-derived signals and emphasize the importance of controlling for DNA 
contamination from food in future immunologic and metagenomic studies. As an 
alternative, acute administration of broad-spectrum antibiotics by gavage was employed, 
while allowing animal access to untreated drinking water; more closely mimicking 
antibiotic administration in humans. Animals treated by gavage did not show signs of 
dehydration and developed loose stools similar to known consequences of antibiotic 
treatment in patients (Rohde, Bartolini & Jones 2009). Antibiotic treatment by oral 
gavage reduced absolute bacterial numbers and mimicked anatomic, histologic, and 
immunologic characteristics of reduced bacterial stimulation. 
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Temporal and spatial analyses of antibiotic effects on bacterial communities were 
carried out using pyrosequencing of bacterial 16S rDNA gene segments. UniFrac 
analysis revealed that samples from antibiotic treated animals grouped separately from, 
and clustered more tightly than, samples from control-treated animals indicating that 
antibiotic treatment promoted a novel community structure that was more similar 
between antibiotic-treated as compared to control-treated animals. Day one stool pellet 
samples from treated animals grouped closely with later time points consistent with an 
initial, fast phase of community alteration. This finding was emphasized in temporal 
analysis of stool pellet bacterial frequencies during treatment and suggests that even 
short exposure to oral antibiotics creates distinct intestinal bacterial communities. 
UniFrac and frequency analyses of stool pellet communities over the course of antibiotic 
treatment further revealed progressive alterations in community structure, indicating that 
intestinal bacterial communities are continuously modified over the course of antibiotic 
treatment. 
The influence of antibiotic treatment by oral-gavage on stool bacterial 
communities was noticeably different from that observed during antibiotic administration 
in animal drinking water. For example, sequences from the Bacteroidetes group 
represented a relatively small proportion of sequences recovered from mice treated 
continuously with antibiotics while a higher proportion of Bacteroidetes sequences were 
recovered from animals treated with antibiotics by gavage. These differences likely arise 
due to differences in the duration of treatment (four weeks vs. ten days), in the method 
of antibiotic administration (continuous vs. gavage), in animal hydration state 
(physiologic vs. non-physiologic), and in the relative contribution that 16S rDNA from 
food makes to measured bacterial frequencies (higher with more efficient microbial 
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depletion). This finding highlights the importance of controlling for 16S rDNA in food in 
future metagenomic studies. 
Previous studies have shown that antibiotic-treated animals develop allergic 
responses (Bashir et al. 2004) and antibiotic use in children is associated with increased 
risk of developing asthma later in life (Marra et al. 2009). In addition, early colonization 
with Bacteroides fragilis has been implicated as a risk factor for asthma development in 
humans (Vael et al. 2008). As such, the effects of antibiotic treatment on members of the 
Bacteroidies phylum were examined. Members of the Bacteroidies phylum, namely the 
Bacteroidales order, represented 60-70% of intestinal bacteria in control-treated animals. 
After one day, these bacteria represented a combined frequency of greater than 95% in 
samples from antibiotic-treated but not control-treated animals, and subsequently 
stabilized at a frequency of approximately 90% in all sampled compartments. 
Outgrowths of the Bacteroidies phylum were not observed in previous metagenomic 
studies that examined recovery of intestinal microbiota after antibiotic exposure 
(Antonopoulos et al. 2009), likely representing differences in antibiotic type and 
administration and highlighting the utility of temporal analyses in metagenomic studies. It 
is intriguing to speculate that rapid increases in Bacteroidies frequency after antibiotic 
initiation may be responsible for associations between early antibiotic exposure in 
humans and increased susceptibility to allergic inflammation. 
Significant reductions in the frequency of bacteria belonging to the Firmicute 
phylum were also detected in samples from antibiotic-treated as compared to control-
treated animals. This bacterial phylum has been shown to be present in an increased 
frequency in obese patients as compared to healthy individuals (Ley et al. 2006) and 
may provide the host an enhanced ability to extract energy from otherwise indigestible 
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dietary polysaccharides (Turnbaugh et al. 2006). As such, antibiotic treatment may result 
in a reduced capacity for energy harvest by the host which has implications for 
prolonged antibiotic treatment in patients. In addition, these findings highlight a possible 
role for antibiotics as a means of modulating intestinal bacterial communities in future 
treatments for obesity (Ley et al. 2006). 
Consistent with previous studies, increased frequencies of Enterobacteriaceae, 
as well as other members of the Proteobacteria phyla were detected in samples from 
antibiotic-treated as compared to control-treated animals (Antonopoulos et al. 2009). 
The Enterobacteriaceae include a number of nosocomial pathogens, with considerable 
antibiotic resistance, including Escherichia, Enterobacter, and Salmonella. Given that 
DNA transfer between intestinal bacteria plays a role in shaping bacterial communities 
(Ley, Peterson & Gordon 2006, Grasselli et al. 2008) and in the development of 
pathogenic, antibiotic-resistant organisms (Karami et al. 2007), Enterobacteriaceae that 
survive in an antibiotic exposed intestine may act as a clinically relevant reservoir that 
could seed subsequent infections with antibiotic resistant bacteria. Outgrowth of C. 
difficile, a common cause of antibiotic-associated colitis that is thought to colonize the 
intestine when indigenous microbiota are disrupted by antibiotic use (De La Cochetiere 
et al. 2008), was not observed as a result of our antibiotic treatment protocol. However, 
this result is not unexpected as metronidazole and vancomycin, two antibiotics 
commonly used to treat C. difficile colitis in humans, were included in the antibiotic 
cocktails used in this study. 
Analyses were extended to spatial examinations of antibiotic effects along the 
length of the intestine, and between luminal and mucosal-associated bacterial 
communities. It was found that luminal and stool pellet bacterial communities from naïve 
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animals were similar, suggesting that examination of stool pellets is an adequate, rough 
approximation of luminal communities (Eckburg et al. 2005). However, naïve animals 
displayed significantly higher frequencies of Lactobacillus species in mucosal-associated 
as compared to luminal communities, suggesting that distinct bacterial communities at 
different anatomical locations may be relevant for mammalian physiology. 
Upon antibiotic treatment, there were significant changes to both luminal and 
mucosal-associated bacterial communities including increases in the Bacteroidies and 
Proteobacter phyla, and reductions in the Firmicute phylum. In particular, significant 
reductions in the frequency of mucosal-associated Lactobacillus species were observed 
in antibiotic-treated as compared to control-treated animals. Lactobacillus species have 
been used as ―probiotic‖ bacteria with mixed effectiveness in treating human diseases 
(Betsi, Papadavid & Falagas 2008, Kozuch, Hanauer 2008). It may therefore be useful to 
examine whether reductions in this potentially beneficial mucosal-associated bacterial 
group are responsible for changes in immune homeostasis observed following antibiotic 
treatment. 
In summary, this chapter describes the development and characterization of a 
new antibiotic treatment protocol that modifies intestinal microbiota without animal 
dehydration. Deep sequencing analysis showed that antibiotic treatment causes 
significant temporal and spatial alterations in bacterial groups that have been implicated 
to have causative or therapeutic roles in human diseases. It is hoped that these findings 
will provide a resource and framework for analysis and manipulation of intestinal 
microbial communities in murine models of human infection and disease. 
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Chapter 3: Commensal Bacterial-Derived Signals 
Limit Allergic Inflammation in Mice 
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3.1 Abstract 
The prevalence and severity of allergic diseases have been increasing in the U.S. and 
U.K. for more than fifty years. Recently, experimental and epidemiologic studies have 
implicated commensal bacteria that colonize mammalian mucosal surfaces in influencing 
T helper type 2 (TH2) cytokine-mediated inflammation and allergic disease. However, the 
mechanisms by which the innate immune system recognizes commensal bacterial-
derived signals and influences the development of TH2 cell responses are poorly 
understood. The data presented in this chapter indicate that commensal bacterial-
derived signals limit serum immunoglobulin E (IgE) levels and steady-state circulating 
basophil populations, innate granulocytes implicated in the initiation and propagation of 
TH2 cell responses. Consistent with dysregulated steady-state basophil responses 
contributing to exaggerated allergic responses, antibiotic (ABX) treatment of mice 
resulted in exaggerated basophil-mediated skin and airway inflammation, and the 
development of enhanced basophil-dependent TH2 cell responses. Together, these 
results indicate that commensal-derived signals act to limit steady-state circulating 
basophil responses and the development of basophil-mediated allergic inflammation. 
 
3.2 Introduction 
Allergic diseases have reached pandemic levels (Eder, Ege & von Mutius 2006) and 
represent a significant source of morbidity, mortality and healthcare cost (Bahadori et al. 
2009). These chronic inflammatory diseases are characterized by interleukin (IL)-4, IL-5, 
IL-9 and IL-13 production by CD4+ T helper type 2 (TH2) cells, immunoglobulin E (IgE) 
production by B cells, and the recruitment of effector cells to sites of tissue inflammation 
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(Mowen, Glimcher 2004, Holgate 2008). It is thought that susceptibility to TH2 cytokine-
dependent allergic inflammation is determined by polymorphisms in mammalian genes 
(Vercelli 2008) and environmental factors including diet and exposure to pollutants or 
infectious agents (Gilliland 2009, Zeiger 2003, Ege et al. 2011). However, the specific 
genetic and environmental stimuli that enhance allergy susceptibility, and how these 
factors contribute to the development of allergic disease, are an ongoing field of 
research. 
The human intestine is colonized by 100 trillion microorganisms belonging to 
each of the three domains of life (Eckburg, Lepp & Relman 2003). Of these, bacteria are 
the most abundant – the colon is home to trillions of commensal bacteria (Whitman, 
Coleman & Wiebe 1998) with a diversity of at least 1,000 species (Ley, Peterson & 
Gordon 2006). Epidemiologic studies have identified associations between alterations in 
the composition of commensal bacterial communities and the development of allergic 
disease. For example, infants who develop allergies display altered commensal 
populations early in life (Kalliomaki et al. 2001), and children who have undergone 
treatment with broad-spectrum antibiotics are at an increased risk of developing allergic 
diseases (Marra et al. 2009, Kummeling et al. 2007). Studies in animal model systems 
have corroborated these findings and shown that commensal bacterial-derived signals 
limit the development of TH2 cytokine-mediated allergic inflammation (Bashir et al. 2004, 
Noverr et al. 2005, Noverr et al. 2004, Herbst et al. 2011). However, the innate immune 
cells that are influenced by commensal bacterial-derived signals and modulate the 
development of allergic TH2 cytokine-dependent inflammation remain poorly 
characterized (Lambrecht, Hammad 2010, Paul, Zhu 2010). 
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Recently, granulocytes including mast cells, eosinophils and basophils have 
been shown to express MHC class II (Charles et al. 2010, Skokos et al. 2003, Padigel et 
al. 2007), be potent sources of IL-4 and, depending on the stimulus, contribute to the 
development of optimal TH2 cytokine responses (Gessner, Mohrs & Mohrs 2005, Mohrs 
et al. 2005, Min et al. 2004). Given the proposed role for commensal bacteria in 
influencing allergy susceptibility, and the identification of granulocytes as innate cells 
that promote TH2 cytokine-mediated inflammation, we sought to test whether 
commensal-derived signals influence granulocyte homeostasis or allergen-induced TH2 
cell responses. 
In this chapter, oral delivery of broad-spectrum antibiotics was employed to 
interrogate the influence of commensal bacterial-derived signals on circulating basophil 
populations. Both deletion of bacterial communities through the use of germ-free mice, 
and depletion of bacterial communities using antibiotic treatment, were associated with 
elevated serum IgE levels, increased circulating basophil populations and exaggerated 
basophil-mediated TH2 cytokine-dependent allergic inflammation. These findings identify 
basophils as an important innate immune cell population that is expanded in the 
circulation of antibiotic-treated or germ-free mice and may contribute to exaggerated TH2 
cytokine-mediated allergic inflammation in these models. 
 
3.3 Methods 
3.3.1 Animals 
BALB/c or C57BL/6 mice were purchased from Jackson or Charles River Laboratories. 
Germ-free mice were provided by the Penn Gnotobiotic Mouse Facility. BaS-TRECK 
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mice were obtained from M. Kubo, IL-4/eGFP reporter mice were obtained from M. 
Mohrs. All mice used were 8–24 weeks of age. Conventional animals were bred and 
housed in specific pathogen-free conditions at the University of Pennsylvania. All 
experiments were performed under Institutional Animal Care and Use Committee 
(IACUC) approved protocols and in accordance with the guidelines of the IACUC of the 
University of Pennsylvania. 
 
3.3.2 Reagents and Treatments 
For antibiotic treatment, mice were fed autoclaved water or autoclaved water 
supplemented with ampicillin (0.5 mg/mL), gentamicin (0.5 mg/mL), metronidazole (0.5 
mg/mL), neomycin (0.5 mg/mL), and vancomycin (0.25 mg/mL) continuously via water 
bottle for four weeks. In the occasional event of poor animal oral hydration, both control 
and antibiotic water was supplemented with artificial sweetener. For MC903, mice were 
treated daily for 7 days on the ear with 10 µL of ethanol or ethanol containing 2 nMol of 
MC903 (Tocris Bio. Sci.) as described previously (Li et al. 2006). For house dust mite 
(HDM) allergen-induced airway inflammatoin, mice were treated on day 0, 7, 14 
intranasally with 50 µL of PBS or PBS containing 100µg of D. pteronyssinus extract 
(Greer) and sacrificed on day 17 as described previously (Hammad et al. 2010). For 
papain, mice were injected subcutaneously in contralateral footpads with 50 ul of PBS or 
PBS containing 50 µg of papain (Calbiochem) as described previously (Sokol et al. 
2008) and were sacrificed on D3 or D4 post injection for basophil or TH2 cell analysis. 
For basophil depletion by anti-FcεRIα treatment, mice were treated by intraperitoneal 
injection (i.p.) with 10 µg of MAR1 or isotype antibody (eBioscience) on D-3, -2, -1. For 
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basophil depletion by diphtheria toxin (DT) treatment, littermate control or BaS-TRECK 
mice were treated with 750 ng DT i.p. on day -2 and D0 prior to papain exposure. 
 
3.3.3 Flow Cytometry 
Blood, spleen, lung, bronchoalveolar lavage, ears or lymph nodes were collected at 
necropsy, lungs and ears were digested with collagenase and dispase, homogenized by 
passing through a 70 μm nylon mesh filter, purified of red blood cells by histopaque 
(Sigma-Aldrich) or RBC lysis, and stained with anti-mouse fluorochrome-conjugated 
monoclonal antibodies against B220, CD3ε, CD4, CD8, CD11c, CD19, CD40, CD45.1, 
CD49b, CD69, CD80, CD86, CD117, FcεRIα, FcγR, Gr-1, IgE, IL-4, MHC-I or MHC-II 
(BD Bioscience, BioLegend, eBioscience). Cells were acquired on a FACSCanto II or 
LSR II with DiVa software (BD Bioscience) and analyzed with FlowJo software (version 
8.7.1; Tree Star). 
 
3.3.4 Culture, ELISA and Histology 
Tissues were harvested and single cell suspensions were made. LNs were cultured for 
2-4 days at 200-250,000 cells in 200ul of complete media in the presence or absence of 
αCD3 and αCD28 (0.5-1.0 µg/mL). For intracellular cytokine analysis, cells were 
stimulated for 4 hours in the presence of 50 ng/mL phorbol 12-myristate 13-acetate 
(Sigma-Aldrich) and 750 ng/mL ionomycin (Sigma-Aldrich) in the presence of 10 µg/mL 
Brefeldin A (Sigma-Aldrich), treated with Fix/Perm (eBioscience), and stained 
intracellularly. IgE and IL-4 from serum or cell-free culture supernatants were assayed 
by sandwich ELISA (BD Bioscience). At necropsy, skin or lung tissue sections were 
removed and fixed in 4% paraformaldehyde and embedded in paraffin. 5 µM sections 
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were cut and stained with hematoxylin and eosin. Orthokeratosis was quantified with NIS 
Elements BR imaging software (Nikon). 
 
3.3.5 Statistics 
Results shown as mean ± standard deviation for individual animals. Statistical 
significance was determined by two-tailed Mann-Whitney test or unweighted means 
analysis two-way ANOVA as indicated. Results were considered significant at P ≤ 0.05 
(*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). 
 
3.4 Results 
3.4.1 Commensal bacteria limit serum IgE levels and circulating basophils 
As reported previously, oral antibiotic treatment (ABX) resulted in significant increases in 
serum IgE levels (Sudo et al. 1997, McCoy et al. 2006) (Figure 11a). As IgE influences 
granulocyte homeostasis (Kalesnikoff et al. 2001, Kitaura et al. 2003), we investigated 
whether ABX-induced elevations in IgE were associated with alterations in the frequency 
or number of circulating eosinophils, mast cells or basophils. ABX-treatment did not alter 
blood eosinophil (Figure 11b,c) or mast cell populations (Figure 11d,e). However, 
frequencies and numbers of basophils (identified as non-B, non-T (NBNT), CD117-, 
CD49b+, FcεRIα+) were significantly increased in the blood (Figure 11f,g) and spleen 
(Figure 11h,i) of ABX-treated compared to conventionally (CNV)-reared mice. Further, 
basophils from ABX-treated mice displayed increased levels of surface-bound IgE 
compared to controls (Figure 12a), while expression of other surface markers (CD69, 
CD123, CD200R, FcεRIα, FcγR, Gr1) were unaltered (Figure 12b). 
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Figure 11: Elevated steady-state serum IgE levels and circulating basophils in antibiotic-treated 
mice 
(a) Serum IgE from conventionally-reared (CNV) or antibiotic-treated (ABX) mice as measured by ELISA. (b) Flow 
cytometric analysis of blood eosinophils from CNV or ABX mice. Numbers adjacent to outlined areas indicate percent 
cells in each gate. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (c) Number of eosinophils per mL of blood from CNV 
or ABX mice. (d) Flow cytometric analysis of peritoneal cavity (PECS) mast cells from CNV or ABX mice. Gated on CD3
-
, 
CD4
-
, CD8
-
, CD19
-
 cells. (d) Number of mast cells isolated from the PECS of CNV or ABX mice. (e) Flow cytometric 
analysis of blood basophils from CNV or ABX mice. Numbers adjacent to outlined areas indicate percent cells in each 
gate. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (f) Number of basophils per mL of blood from CNV or ABX mice. 
(g) Flow cytometric analysis of spleen basophils from CNV or ABX mice. (h) Number of spleen basophils from CNV or 
ABX mice. Data representative of three or more independent experiments (mean ± S.D.; CNV, n=5-18; ABX, n=5; *, P ≤ 
0.05). 
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Figure 12: Increased surface-bound IgE on basophils from antibiotic-treated mice 
(a) Mean fluorescence intensity of surface IgE on blood basophils from conventionally-reared (CNV) or antibiotic-
treated (ABX) mice as determined by flow cytometry. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
, CD49b
+
, FcεRIα
+
 cells. 
(b) Mean fluorescence intensity of surface CD69, CD123, CD200R, FcεRIα, FcγR and Gr1 on blood basophils from CNV 
or ABX mice as determined by flow cytometry. Data representative of three or more independent experiments 
(Negative = negative cell population). 
 
ABX treatment does not eliminate all commensal bacteria (Hill et al. 2009). To 
investigate whether steady-state levels of IgE or basophil populations were altered in the 
absence of live microbial stimuli, germ-free (GF) mice were employed (Smith, McCoy & 
Macpherson 2007). Consistent with the effects of ABX treatment, GF mice exhibited 
increased serum IgE levels (Figure 13a), increased frequencies and numbers of 
basophils in the blood (Figure 13b,c) and spleen (Figure 13d,e), and increased 
basophil-surface-bound IgE levels (Figure 13f) compared to CNV-reared mice. 
Consistent with commensal-derived signals being sufficient to limit serum IgE levels and 
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circulating basophil populations, conventionalization of GF mice resulted in reductions in 
serum IgE levels (Figure 13g), and blood and spleen basophil populations (Figure 
13h,i). Collectively, these data indicate that commensal bacterial-derived signals limit 
serum IgE levels and circulating basophil populations in the steady-state. 
 
Figure 13: Elevated steady-state serum IgE levels and circulating basophils in germ-free mice 
(a) Serum IgE from conventionally-reared (CNV) or germ-free (GF) mice as measured by ELISA. (b) Flow cytometric 
analysis of blood basophils from CNV or GF mice. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (c) Number of 
basophils per mL of blood from CNV or GF mice. (d) Flow cytometric analysis of spleen basophils from CNV or GF 
mice. (e) Number of spleen basophils from CNV or GF mice. (f) Mean fluorescence intensity of surface-bound IgE on 
blood basophils from CNV or GF mice as determined by flow cytometry. (g) Serum IgE from CNV, GF or 
conventionalized germ-free (GF-CNV) mice as measured by ELISA. (h) Frequency of blood basophils from CNV, GF or 
GF-CNV mice. (i) Frequency of spleen basophils from CNV, GF or GF-CNV mice. Data representative of three or more 
independent experiments (mean ± S.D.; CNV, n=5-18; GF, n=3-10; CNV-GF, n=3; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 
0.001). Experiments performed in collaboration with Dmytro Kobuley. 
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3.4.2 Commensal bacteria limit basophil-mediated allergic skin inflammation 
Given the enhanced frequencies and numbers of circulating steady-state basophils in 
ABX-treated mice, we next examined whether commensal-derived signals influence 
basophil effector function in vivo. Basophils contribute to the development of atopic 
dermatitis-like lesions in mice exposed to the vitamin D3 analogue MC903 (Li et al. 
2006, Siracusa et al. In Press). To test whether commensal-derived signals influence 
MC903-elicited inflammation, CNV-reared or ABX-treated mice were exposed to MC903, 
and IgE levels, basophil responses and skin inflammation were examined. Compared to 
controls, MC903 exposure in ABX-treated mice resulted in significantly elevated serum 
IgE levels and blood basophil populations (Figure 14a,b), increased recruitment of 
basophils to inflamed skin (Figure 14c), and increased skin basophil surface-bound IgE 
levels (Figure 14d). Concurrently, compared to CNV-reared controls, ABX-treated mice 
displayed evidence of enhanced atopic dermatitis-like changes (Figure 14e) 
characterized by significantly more orthokeratosis compared to CNV-reared mice 
(Figure 14f), a pathological finding associated with atopic dermatitis in patients (Lobitz, 
Dobson 1956). Together, these results indicate that commensal bacterial-derived signals 
limit the development of basophil-mediated inflammation of the skin. 
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Figure 14: Exaggerated MC903-induced skin inflammation in antibiotic-treated mice 
(a) Serum IgE from conventionally-reared (CNV) or antibiotic-treated (ABX) mice treated with MC903 for 7 days as 
measured by ELISA. (b) Frequency of blood basophils from CNV or ABX mice treated with MC903 for 7 days. (c) Flow 
cytometric analysis of skin basophils from control (EtOH) or MC903-treated, CNV or ABX mice. Gated on CD3
-
, CD4
-
, 
CD8
-
, CD19
-
, CD117
-
, CD45.1
+
 cells. (d)  Mean fluorescence intensity of IgE on ear basophils from MC903-treated CNV 
or ABX mice. (e) Histological sections of skin from CNV or ABX mice treated for 7 days with ethanol (EtOH) or MC903 
and stained with hematoxylin and eosin (H&E) (Bar = 100 µM). Arrow indicates orthokeratosis. (f) Orthokeratosis of 
skin from MC903-treated CNV or ABX mice. Data representative of two or more independent experiments (mean ± 
S.D.; CNV, n=2-5; ABX, n=1-5; *, P ≤ 0.05; **, P ≤ 0.01). Experiments performed in collaboration with Brian Kim. 
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3.4.3 Commensal bacteria limit basophil-mediated allergic airway inflammation 
Basophils also contribute to allergic airway responses to inhaled house dust mite 
allergen (HDM) (Hammad et al. 2010). To test whether commensal-derived signals 
influenced the development of HDM-induced airway inflammation, CNV-reared or ABX-
treated mice were exposed to HDM and TH2 cell responses, systemic and local innate 
cell responses, and airway inflammation were examined. Compared to CNV-reared 
mice, ABX-treated mice displayed increased HDM-elicited TH2 cell responses in the 
draining mediastinal lymph node (LN) as determined by the IL-4/eGFP reporter system 
(Mohrs et al. 2005) (Figure 15a), increased mediastinal LN TH2 cell-derived IL-4 
responses (Figure 15b), and increased blood basophil responses (Figure 15c).  
Concurrently, compared to CNV-reared controls, ABX-treated mice displayed increased 
HDM-elicited bronchoalveolar lavage (BAL) and lung eosinophil responses (Figure 15d) 
and exaggerated airway inflammation (Figure 15e) characterized by exaggerated 
cellular infiltrates and airway destruction. Together, these findings indicate that 
commensal-derived signals limit basophil-mediated allergic inflammation in the lung. 
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Figure 15: Exaggerated HDM-induced airway inflammation in antibiotic-treated mice 
(a) Flow cytometric analysis of day 18 mediastinal lymph node (MLN) IL-4/eGFP
+
CD4
+
 TH2 cells from conventionally-
reared (CNV) or antibiotic-treated (ABX) mice treated with PBS or house dust mite (HDM) antigen. Gated on CD8
-
, 
CD19
-
, CD4
+
 cells. (b) IL4 in in supernatants of MLN cell cultures from CNV or ABX mice treated with HDM as 
measured by ELISA. (c) Flow cytometric analysis of blood basophils from control CNV or ABX mice treated with PBS or 
HDM. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (d) Frequency of eosinophils in bronchoalveolar lavage or lung 
samples from HDM-treated CNV or ABX mice. (e) Histological sections of lungs from CNV or ABX mice treated with 
PBS or HDM and stained with H&E (Large Bar = 100 µM; Small Bar = 20 µM). Arrows indicate eosinophil infiltrates. 
Data representative of two or more independent experiments (mean ± S.D.; CNV, n=2-5; ABX, n=2-5).  
 
3.4.4 Commensal bacteria limit basophil-mediated TH2 cell responses 
In addition to their roles as effector cells, basophils are recruited to draining LNs early in 
the response to infectious (Perrigoue et al. 2009) or allergic (Yoshimoto et al. 2009, 
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Sokol et al. 2008) stimuli where they cooperate with DCs to promote optimal TH2 cell 
responses (Perrigoue et al. 2009, Sokol et al. 2009, Yoshimoto et al. 2009). To test 
whether ABX-treated mice exhibited altered allergen-induced TH2 cell responses, CNV-
reared or ABX-treated IL-4/eGFP reporter mice were exposed to papain, a cysteine 
protease associated with occupational allergy in humans (Novey et al. 1979) and TH2 
cell responses in mice (Sokol et al. 2008). Following PBS-treatment, similar frequencies 
of basophils (Figure 16a) and IL-4/eGFP+CD4+ TH2 cells (Figure 16b) were observed in 
the LNs of CNV-reared or ABX-treated mice. However, following exposure to papain, 
ABX-treated mice exhibited increased frequencies of LN basophils (Figure 16c) and IL-
4/eGFP+CD4+ TH2 cells (Figure 16d) compared to controls. Depletion of basophils by 
administration of anti-FcεRIα antibody (Sokol et al. 2008) resulted in a reduction in the 
frequency of LN basophils (Fig. 16e), and reduced frequencies (Fig. 16f) and numbers 
(Fig. 16g) of papain-elicited IL-4/eGFP+CD4+ TH2 cells, indicating that basophils 
contribute to the exaggerated TH2 cell responses observed in ABX-treated mice. 
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Figure 16: Exaggerated Papain-induced TH2 cell responses in antibiotic-treated mice 
(a) Flow cytometric analysis of day 3 popliteal LN (pLN) basophils from conventionally-reared (CNV) or antibiotic-
treated (ABX) mice treated with PBS and Isotype control antibody. Numbers adjacent to outlined areas indicate 
percent cells in each gate. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (b) Flow cytometric analysis of day 4 pLN IL-
4/eGFP
+
CD4
+
 TH2 cells from CNV or ABX mice treated with PBS and Isotype control antibody. Gated on CD8
-
, CD19
-
 
cells. (c) Flow cytometric analysis of day 3 pLN basophils from CNV or ABX mice treated with Papain and Isotype 
control antibody. (d) Flow cytometric analysis of day 4 pLN IL-4/eGFP
+
CD4
+
 TH2 cells from CNV or ABX mice treated 
with Papain and Isotype control antibody. (e) Flow cytometric analysis of day 3 pLN basophils from CNV or ABX mice 
treated with Papain and anti-FcεRIα (αFcεRIα) antibody. (f) Flow cytometric analysis of day 4 pLN IL-4/eGFP
+
CD4
+
 TH2 
cells from CNV or ABX mice treated with Papain and αFcεRIα antibody. (g) Number of day 4 pLN IL-4/eGFP
+
CD4
+
 TH2 
cells from CNV or ABX mice treated with PBS or Papain and Isotype control (-) or αFcεRIα (+) antibody (means of three 
experiments ± S.D.; CNV-PBS-ISO, n=4-5; CNV-PAP-ISO, n=4-5; ABX-PBS-ISO, n=5; ABX-PAP-ISO, n=5-8; CNV-PAP-
αFcεRIα, n=2; ABX-PAP-αFcεRIα, n=2-6;  significance determined by 2 way ANOVA). Data representative of three or 
more independent experiments ((mean ± S.D.; CNV, n=2-5; ABX, n=2-5; ǂ, P ≤ 0.06; *, P ≤ 0.05). Experiments 
performed in collaboration with Mark Siracusa. 
 
3.4.5 Basophils contribute to exaggerated TH2 cell responses in antibiotic-treated 
mice 
Inflammatory dendritic-cells (DCs) are important for the development of optimal TH2 cell 
responses to some allergens (Hammad et al. 2010). To investigate the influence of 
commensal-derived signals on DC populations, DCs were examined in CNV-reared or 
ABX-treated mice. Steady-state DC frequencies were similar between CNV-reared or 
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ABX-treated mice (data not shown), as was DC expression of MHC-I, MHC-II, CD40, 
CD80, CD86, or FcεRIα (Figure 17a,b), indicating that commensal-derived signals do 
not significantly influence circulating DC populations in the steady-state. 
 
Figure 17: Antibiotic treatment does not influence dendritic cell surface phenotype in mice 
(a) Mean fluorescence intensity of surface MHC-I, MHC-II, CD40, CD80, CD86 and FcεRIα on splenic DCs from 
conventionally-reared (CNV) or antibiotic-treated (ABX) mice as determined by flow cytometry. Gated on CD3
-
, CD4
-
, 
CD8
-
, CD19
-
, MHC-II
+
, CD11c
+
 cells. (b) Mean fluorescence intensity of MHC-I, MHC-II, CD40, CD80, CD86 and FcεRIα 
on splenic DCs from CNV or ABX mice. Data representative of three or more independent experiments (mean ± S.D.; 
CNV, n=5; ABX, n=5). Experiments performed in collaboration with Michael Abt. 
 
As inflammatory DCs express FcεRIα (Hammad et al. 2010), we next examined 
whether commensal-derived signals influence allergen-induced non-basophil FcεRIα+ 
cell populations in the LN. Papain-elicited LN non-basophil FcεRIα+ cell populations were 
similar between CNV-reared or ABX-treated mice (Figure 18a) and ABX-treatment did 
not significantly influence non-basophil FcεRIα+ cell populations expressing MHC-II or 
CD40 (Figure 18b,c), indicating that non-basophil FcεRIα+ cell responses are not 
significantly influenced by commensal-derived signals in this setting. As inflammatory 
DCs express FcεRIα, and have been shown to be influenced by anti-FcεRIα antibody 
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treatment (Hammad et al. 2010), we examined the effect of anti-FcεRIα antibody 
treatment on LN non-basophil FcεRIα+ cell populations. Compared to Isotype treated 
controls, we did not observe a significant difference in papain-elicited non-basophil 
FcεRIα+ cell populations in the LNs of CNV-reared or ABX-treated mice upon anti-
FcεRIα antibody treatment (Figure 18a), nor did we find a significant effect of anti-
FcεRIα antibody treatment on non-basophil FcεRIα+ cell populations expressing MHC-II 
or CD40 (Figure 18c,b). Together, these findings indicate that neither steady-state DC 
responses, nor papain-elicited non-basophil FcεRIα+ LN cell responses, are significantly 
dysregulated in ABX-treated compared to CNV-reared mice. 
 
Figure 18: Anti-FcεRIα treatment does not influence non-basophil FcεRIα+ lymph node antigen 
presenting cells in antibiotic-treated mice 
(a) Flow cytometric analysis of pLN CD49b
-
 FcεRIα
+
 cells from conventionally-reared (CNV) or antibiotic-treated (ABX) 
mice treated with Papain and isotype or αFcεRIα antibody. Numbers adjacent to outlined areas indicate percent cells 
in each gate. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (b) Frequencies of pLN CD49b
-
, FcεRIα
+
, MHC-II
+
 cells 
from CNV or ABX mice treated with Papain and isotype or αFcεRIα antibody. (c) Frequencies of pLN CD49b
-
, FcεRIα
+
, 
CD40
+
 cells from CNV or ABX mice treated with Papain and isotype or αFcεRIα antibody. Data representative of two or 
more independent experiments (mean ± S.D.; CNV, n=2-3; ABX, n=2-3).  
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Due to concerns that αFcεRIα treatment might be influencing FcεRIα+ 
inflammatory DC populations, we adopted a loss-of-function approach complementary to 
anti-FcεRIα antibody treatment by utilizing a diphtheria toxin (DT)-dependent basophil 
depletion mouse system (BaS-TRECK) (Siracusa et al. In Press). ABX-treatment 
resulted in increased frequencies of circulating basophils (Figure 19a) and frequencies 
(Figure 19b) and numbers (Figure 19c) of papain-elicited TH2 cells in the LN compared 
to CNV-reared mice. Importantly, DT-treatment resulted in efficient depletion of 
basophils (Figure 19a) and reductions in the frequency (Figure 19b) and number 
(Figure 19c) of papain-elicited TH2 cells in BaS-TRECK but not control mice. Together, 
these data indicate that basophils contribute to the exaggerated allergen-induced TH2 
cell responses observed in ABX-treated mice. 
 
Figure 19: Basophils contribute to exaggerated TH2 cell responses in antibiotic-treated mice 
(a) Flow cytometric analysis of blood basophils from conventionally-reared (CNV) or antibiotic-treated (ABX), control 
or BaS-TRECK mice treated with diphtheria toxin (DT). Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (b) Flow 
cytometric analysis of pLN CD4+ TH2 cells from CNV or ABX, control or BaS-TRECK mice treated with papain and DT. 
Gated on CD8
-
, CD19
-
, CD4
+
 cells. (c) Number of day 4 pLN CD4
+
, IL-4
+
 TH2 cells from CNV (-) or ABX (+), control (-) or 
BaS-TRECK (+) mice treated with PBS (-) or Papain (+) and DT. Data representative of two independent experiments 
(Control, n=2-3; BaS-TRECK, n=1-3; TH2 cells determined by expression of IL-4 or IL-5). Experiments performed in 
collaboration with Mario Noti. 
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3.5 Discussion 
Although the prevalence and severity of allergic diseases have been increasing in the 
U.S. and U.K. for the past fifty years (Eder, Ege & von Mutius 2006), the genetic (Vercelli 
2008) and environmental (Gilliland 2009, Zeiger 2003, Ege et al. 2011) factors that 
influence allergy susceptibility are not well understood. Recently, epidemiologic (Marra 
et al. 2009, Kummeling et al. 2007, Kalliomaki et al. 2001) and experimental (Bashir et 
al. 2004, Noverr et al. 2005, Noverr et al. 2004, Herbst et al. 2011) studies have 
identified associations between alterations in the composition of commensal bacterial 
communities and the development of allergic TH2 cytokine-dependent inflammation. 
However, the influence of commensal bacterial-derived signals on innate immune cells 
known to influence the development of TH2 cytokine-dependent inflammation remain 
poorly characterized (Hill, Artis 2010, Lambrecht, Hammad 2010, Paul, Zhu 2010). 
Data in this chapter identify a role for commensal bacterial-derived signals in 
limiting steady-state serum IgE levels and circulating basophil populations. These 
findings are of particular interest given that basophils have recently been shown to 
express MHC class II (Charles et al. 2010, Skokos et al. 2003, Padigel et al. 2007), be 
potent sources of IL-4 and, depending on the stimulus, contribute to the development of 
optimal TH2 cytokine-dependent allergic inflammation (Gessner, Mohrs & Mohrs 2005, 
Mohrs et al. 2005, Min et al. 2004). An alternative explination for the elevations in 
basophils observed in ABX-treated mice is the depletion of another cell population. 
Germ-free and antibiotic treated mice are considered to be lymphpenic, supporting this 
hypothesis (Hudson, Luckey 1964, Hooijkaas et al. 1984). However, there are lines of 
evidence that suggest that the elevations in circulating basophils we observe are not a 
consequence of depletion of another cell population. First, basophil numbers as well as 
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frequencies were significantly elevated in ABX-treated compared to CNV-reared mice. 
Second, a stringent gating strategy was utlilized to ensure that T and B cells were 
excluded from our basophil plots, minimizing the likelihood that lymphpenia would 
influence our results. Third, increases were selective to basophils as eosinophil and 
mast cell populations were not apparently influenced by ABX-treatment. Finally, ABX-
treated mice displayed elevated basophil responses in three models of allergic 
inflammation. Together, these results suggest that commensal bacterial-derived signals 
act to actively limit circulating basophil populations in the steady-state. 
Basophils from ABX-treated mice did not display alterations in surface 
phenotype, suggesting that commensal-derived signals influence quantitative rather than 
qualitative aspects of basophil biology. However, this does not exclude the possibility 
that functional heterogeneity exists between basophils from CNV-reared or ABX-treated 
mice. Additionally, antibiotic-treated mice displayed exaggerated basophil-mediated skin 
inflammation in an innate model of atopic-dermatitis and allergic airway inflammation in a 
model of asthma. While these findings are consistant with primarirly quantative 
alterations to basophil biology in ABX-treated mice, functional heterogeneity between 
basophils from CNV-reared or ABX-treated mice could also be contributing to these 
phenotypes. Together, these findings suggest that in addition to limiting circulating 
basophil populations in the steady-state, commensal bacterial-derived signals act to limit 
basophil-mediated allergic responses. 
In addition to their roles as effector cells, basophils are recruited to draining LNs 
early in the response to infectious (Perrigoue et al. 2009) or allergic (Yoshimoto et al. 
2009, Sokol et al. 2008) stimuli where they cooperate with DCs to promote optimal TH2 
cell responses (Perrigoue et al. 2009, Sokol et al. 2009, Yoshimoto et al. 2009). Data in 
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this chapter indicate that ABX-treated mice display elevated basophil LN recruitment and 
exaggerated LN TH2 cell responses to allergens compared to CNV-reared mice. Non-
basophils APC populations did not seem to be significantly influenced by commensal 
bacterial-derived signals in our experimental systems. Importantly, basophils were 
shown to contribute to the development of exaggerated allergen-induced TH2 cell 
responses using two methods of basophil depletion. In both systems, depletion of 
basophils in ABX-treated mice reduced TH2 cell numbers to levels similar to those seen 
in CNV-reared mice, however, TH2 cell frequencies were consistently slightly higher 
upon basophil depletion in ABX-treated compared to CNV-reared mice. These findings 
suggest that cell types other than basophils may be contributing to the exaggerated TH2 
cell frequencies observed in ABX-treated mice. Together, these findings indicate that 
commensal bacterial-derived signals limit disease in models of basophil effector 
function, and basophil-mediated TH2 cell responses. Together, they identify basophils as 
a potential therapeutic target to prevent the development or propagation of allergic 
diseases in patients. 
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Chapter 4: Regulation of circulating basophil 
populations by immunoglobulin E 
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4.1 Abstract 
Data presented in Chapter 3 identified a role for commensal bacterial-derived signals in 
limiting serum immunoglobulin E (IgE) levels, steady-state circulating basophil 
populations, and basophil-mediated TH2 cytokine-dependent allergic inflammation. 
However, the mechanisms through which commensal-derived signals limit circulating 
basophil populations is not understood. This chapter describes a previously 
unrecognized axis of basophil homeostasis that is mediated by IgE. Serum IgE levels 
correlated with circulating basophil populations in CNV-reared and ABX-treated mice, as 
well as human patients with hyperimmunoglobulinemia E syndrome. Steady-state serum 
IgE levels and circulating basophil populations were dysregulated by B cell-intrinsic 
deletion of MyD88, providing insights into one cell-intrinsic mechanism by which 
commensal-derived signals may influence circulating basophil populations. 
 
4.2 Introduction 
Data in Chapter 3 identified a previously unappreciated role for commensal bacterial-
derived signals in limiting serum IgE levels, circulating steady-state basophil populations, 
and basophil-mediated allergic inflammation. IgE sensitizes mast cells and basophils by 
binding to the high affinity IgE receptor (FcεRIα) and, upon re-exposure to the IgE-
specific antigen, causes the release of cytokines, chemokines, and other chemical 
mediators that result in the pathological and clinical sequelae of immediate 
hypersensitivity reactions (Galli et al. 2005, Kalesnikoff, Galli 2008). Additionally, recent 
findings suggest that IgE may influence granulocyte homeostasis in the absence of an 
antigen. For example, IgE has been shown to upregulate the expression of FcεRIα on 
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mast cells and basophils (Lantz et al. 1997, Yamaguchi et al. 1997), and FcεRIα 
expression on basophils positively correlates with serum IgE levels in human blood 
(Saini et al. 2000). Antigen-independent immunoregulatory roles for IgE are supported 
by studies in humans and animal models that indicate that IgE is spontaneously 
produced at low levels in the absence of allergic or infectious stimuli (Gould, Sutton 
2008). Induced by a mechanism independent of MHC class II cognate help, the function 
of so termed ―natural‖ IgE is not well understood, although it has been hypothesized to 
provide a link between the innate immune system and the initiation and/or propagation of 
allergic responses (McCoy et al. 2006). 
 Data presented in this chapter identify a previously unappreciated role for IgE in 
influencing basophil homeostasis. Serum IgE levels were found to correlate with 
circulating basophil populations in CNV-reared and ABX-treated mice, as well as human 
patients with hyperimmunoglobulinemia E syndrome. Steady-state serum IgE levels and 
circulating basophil populations were elevated following B cell-intrinsic deletion of 
MyD88, providing insights into one cell-intrinsic mechanism by which commensal-
derived signals may influence serum IgE levels and circulating basophil populations. 
Together, these results provide therapeutically relevant insights into the cellular and 
molecular mechanisms by which commensal bacterial-derived signals influence 
susceptibility to allergic disease. 
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4.3 Methods 
4.3.1 Animals 
BALB/c, C57BL/6 or Rag1-/- mice were purchased from Jackson or Charles River 
Laboratories. Germ-free mice were provided by the Penn Gnotobiotic Mouse Facility. Il4-
/- mice were obtained from P. Scott, Igε-/- mice were obtained from H. Oettgen, NOD1-/- 
mice were obtained from J. Weiser, Myd88-/- mice were provided by D. LaRosa. All mice 
used were 8–24 weeks of age. Conventional animals were bred and housed in specific 
pathogen-free conditions at the University of Pennsylvania. All experiments were 
performed under Institutional Animal Care and Use Committee (IACUC) approved 
protocols and in accordance with the guidelines of the IACUC of the University of 
Pennsylvania. 
 
4.3.2 Reagents and Treatments 
For antibiotic treatment, mice were fed autoclaved water or autoclaved water 
supplemented with ampicillin (0.5 mg/mL), gentamicin (0.5 mg/mL), metronidazole (0.5 
mg/mL), neomycin (0.5 mg/mL), and vancomycin (0.25 mg/mL) continuously via water 
bottle for four weeks. In the occasional event of poor animal oral hydration, both control 
and antibiotic water was supplemented with artificial sweetener. For IgE transfer, Rag1-/- 
or Igε-/- mice were treated i.p. with 50 µg of control IgG or IgE (BD Bioscience) daily for 
seven days. For IgE depletion, mice were treated i.p. with 200 µg of control IgG or 
Omalizumab (Genentech) daily for seven days. For CpG treatment, mice were treated 
i.p. once weekly during the course of ABX treatment with 100 µl of PBS containing 100 
µg of control GpC-Phos (5’-ZOOFZEFEOZZOOZEFEZOZT-3’) or CpG-Phos (5’-
ZOOFZEFOEZZOOZEFOEZZT-3’). 
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4.3.3 Flow Cytometry and ELISA 
Blood, spleen or bone marrow were collected at necropsy, homogenized by passing 
through a 70 μm nylon mesh filter, purified of red blood cells by histopaque (Sigma-
Aldrich) or RBC lysis, and stained with anti-mouse fluorochrome-conjugated monoclonal 
antibodies against B220, CD3ε, CD4, CD8, CD19, CD49b, CD117, CD123, CD200R, 
FcεRIα, IgE, IgM (BD Bioscience, BioLegend, eBioscience). Human blood samples were 
obtained from DOCK8- or control patients with participant consent, assent, and/or 
parental consent as appropriate under protocols approved by the Children's Hospital of 
Philadelphia and the Ludwig Maximilians University Institutional Review Boards. PBMCs 
were isolated by Ficoll (GE) gradient and stained with anti-human fluorochrome-
conjugated monoclonal antibodies against CD11c, CD19, CD117, CD123, FcεRIα, IgE 
or TCR (BD Bioscience, eBioscience) and fixed with 4% PFA. Cells were acquired on a 
FACSCanto II or LSR II with DiVa software (BD Bioscience) and analyzed with FlowJo 
software (version 8.7.1; Tree Star). Cells were sorted with a FACSAria (BD Bioscience). 
Purified B or T cells were transferred by intraperitoneal injection into Rag1-/- recipients 
and allowed to reconstitute for 6-8 weeks. Murine IgE was assayed by sandwich ELISA 
(BD Bioscience). Human IgE levels were determined by sandwich ELISA or chart 
review. 
 
4.3.5 Statistics 
Results shown as mean ± standard deviation for individual animals. Statistical 
significance was determined by two-tailed Mann-Whitney test or unweighted means 
analysis two-way ANOVA as indicated. Results were considered significant at P ≤ 0.05 
(*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). 
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4.4 Results 
4.4.1 Serum IgE levels correlate with circulating basophil populations in antibiotic-
treated mice 
Previous reports demonstrated that IgE regulates mast cell homeostasis (Kalesnikoff et 
al. 2001, Kitaura et al. 2003) and IgE has been hypothesized to have similar effects on 
basophils (Xiang, Moller & Nilsson 2006). Based on the observation that serum IgE 
levels were increased in ABX-treated mice (Figure 11a), the relationship between 
elevated IgE levels and increased basophil populations observed in ABX-treated mice 
was examined. Serum IgE levels significantly correlated with circulating basophil 
numbers in CNV-reared or ABX-treated mice (Figure 20a), suggesting that IgE 
produced by B cells may influence basophil homeostasis. To test whether the increase 
in circulating basophils observed in ABX-treated mice was dependent on lymphocytes, 
recombination activating gene 1-deficient mice (Rag1-/-) (Mombaerts et al. 1992) were 
employed. Consistent with a role for IgE produced by B cells in regulating basophil 
homeostasis, blood basophil frequencies and numbers were similar between CNV-
reared and ABX-treated Rag1-/- (Figure 20b,c) or GF Rag1-/- (Figure 20d,e) mice. As IL-
4 is necessary for IgE production by B cells (Kopf et al. 1993, Delphin, Stavnezer 1995), 
IL-4-deficient mice (Il4-/-) were utilized to test the influence of IL-4 on IgE levels and 
basophil responses in ABX-treated mice. ABX-treatment of wild-type (WT) mice resulted 
in increased serum IgE levels (Figure 20f) and blood basophils (Figure 20g). In 
contrast, IgE was not detected in Il4-/- mice (Figure 6f) and ABX-treatment of Il4-/- mice 
had no effect on the frequency or number of blood basophils compared to CNV-reared 
controls (Figure 20g,h) suggesting that IL-4-induced IgE production by B cells 
contributes to the increased basophil responses observed in ABX-treated mice. 
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Figure 20: Serum IgE levels correlate with circulating basophils in mice 
(a) Statistical correlation of blood basophil number and serum IgE concentration (linear regression; r2 = 0.432, P = 
0.038). (b) Flow cytometric analysis of blood basophils from conventionally-reared (CNV) or antibiotic-treated (ABX) 
Rag1
-/-
 mice. Numbers adjacent to outlined areas indicate percent cells in each gate. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, 
CD117
-
 cells. (c) Number of basophils per mL of blood from CNV or ABX Rag1
-/-
 mice. (d) Flow cytometric analysis of 
blood basophils from CNV or germ-free (GF) Rag1
-/-
 mice. (e) Number of basophils per mL of blood from CNV or GF 
Rag1
-/-
 mice. (e) Serum IgE from CNV or ABX, wild-type (WT) or Il4
-/-
 mice as measured by ELISA (n.d., not detected). 
(f) Flow cytometric analysis of blood basophils from CNV or ABX, WT or Il4
-/-
 mice. (g) Number of basophils per mL of 
blood from CNV or ABX Il4
-/-
 mice. Data representative of three or more independent experiments (mean ± S.D.; CNV, 
n=2-5; ABX, n=2-5; GF, n=6; **, P ≤ 0.01). 
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4.4.2 Regulation of circulating basophil populations by commensal bacteria is 
mediated by IgE 
To directly test the role of IgE in mediating commensal bacterial-dependent regulation of 
basophil responses, IgE-deficient (Igε-/-) mice were utilized. While ABX-treatment of WT 
mice resulted in increased serum IgE levels (Figure 21a) and blood basophils (Figure 
21b,c), IgE was not detected in Igε-/- mice (Figure 21a) and blood basophil populations 
were not significantly different between CNV-reared or ABX-treated Igε-/- animals 
(Figure 21b,c). Together, these results indicate that IgE is necessary to mediate the 
exaggerated steady-state basophil responses observed in ABX-treated mice. To test 
whether IgE was sufficient to promote the population expansion of circulating basophils, 
Rag1-/- mice were treated with monoclonal IgE and blood basophil populations were 
examined. Compared to controls, IgE transfer into Rag1-/- mice resulted in recovery of 
serum IgE levels (Figure 21d) and significantly elevated frequencies and numbers of 
blood basophils (Figure 21e,f). Collectively, these gain- and loss-of-function approaches 
identify IgE as an important regulator of peripheral basophil responses in mice. 
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Figure 21: IgE is necessary and sufficient to regulate circulating basophil populations in mice 
(a) Serum IgE from conventionally-reared (CNV) or antibiotic-treated (ABX), wild-type (WT) or Igε
-/-
 mice as measured 
by ELISA (n.d., not detected). (b) Flow cytometric analysis of blood basophils from CNV or ABX, WT or Igε
-/-
 mice. (c) 
Number of basophils per mL of blood from CNV or ABX Igε
-/-
 mice. (d) Serum IgE from IgG (-) or IgE (+) treated Rag1
-/-
 
mice as measured by ELISA (n.d., not detected). (e) Flow cytometric analysis of blood basophils from IgG or IgE 
treated Rag1
-/-
 mice. (f) Number of basophils per mL of blood from IgG or IgE treated Rag1
-/-
 mice. Data 
representative of three or more independent experiments (mean ± S.D.; CNV, n=4-5; ABX, n=3-5; IgG, n=4; IgE, n=4; *, 
P ≤ 0.05.). 
 
4.4.3 Serum IgE levels and circulating basophil populations correlate in patients with 
hyperimmunoglobulinemia E syndrome 
Human patients with loss-of-function polymorphisms in the dedicator of cytokinesis 8 
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et al. 2009, Zhang et al. 2009) characterized by recurrent infections, increased 
susceptibility to atopic eczema, and average serum IgE levels 10 times higher than 
found in control patients (Grimbacher, Holland & Puck 2005). Based on the identification 
of a role for IgE in regulating basophil responses in mice, we hypothesized that elevated 
serum IgE levels resulting from genetic alteration in DOCK8- patients would be 
associated with increased circulating basophil populations in these individuals. In 
collaboration with Dr. Jordan Orange (CHOP) and Dr. Ellen Renner (Ludwig Maximilians 
University), we examined serum IgE levels and circulating basophil populations in 
DOCK8- patients. DOCK8- patients displayed elevated serum IgE levels compared to 
controls (Grimbacher, Holland & Puck 2005) (Figure 22a). Human blood basophils 
(identified as TCRβ-, CD11c-, CD19-, CD117-, CD123+, FcεRIα+) comprised 
approximately 1% of NBNT compartment of controls (Figure 22b,d). In contrast, in four 
of five DOCK8- patients examined basophils comprised approximately 3% of the NBNT 
compartment (Figure 22c,d). Further, basophils isolated from DOCK8- patients 
exhibited increased surface-bound IgE compared to controls (Figure 22e). These data 
are consistent with IgE influencing basophil homeostasis in humans, and suggest that 
elevated basophil responses in DOCK8- patients may contribute to the increased 
susceptibility to atopic diseases observed in these patients. 
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Figure 22: Serum IgE and basophils correlate in human patients and anti-IgE treatment 
reduces serum IgE levels and circulating basophil populations in mice 
(a) Serum IgE levels from control (Ctrl) patients or patients with polymorphisms in DOCK8 (DOCK8-) (mean ± S.D.; Ctrl, 
n=15; DOCK8-, n=7). (b) Identification of blood basophils from control patients by flow cytometric analysis as TCRβ-, 
CD11c-, CD19-, CD117-, FcεRIα+, CD123+ cells. Numbers adjacent to outlined areas indicate percent cells in each gate. 
(c) Analysis of blood basophils from DOCK8- patients. (d) Frequency of basophils in blood from control or DOCK8- 
patients (mean ± S.D.; Ctrl, n=8; DOCK8-, n=4). (e) Mean fluorescence intensity of surface-bound IgE on blood 
basophils from control or DOCK8- patients. (f) Serum IgE from conventionally-reared (CNV) or germ-free (GF) mice 
treated with control (-) or Omalizumab (Omab;+) antibody as measured by ELISA. (g) Flow cytometric analysis of 
blood basophils from CNV or GF mice treated with control or Omalizumab antibody. Gated on CD3-, CD4-, CD8-, 
CD19-, CD117- cells. (h) Number of basophils per mL of blood from CNV or GF mice treated with control or 
Omalizumab antibody. Data representative of two or more independent experiments (mean ± S.D.; CNV, n=2-3; GF, 
n=2-3; **, P ≤ 0.01; ***, P ≤ 0.001). 
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Omalizumab is a monoclonal, humanized mouse anti-human IgE-specific 
antibody and FDA approved anti-allergy drug (Pace et al. 2011, Holgate et al. 2009). To 
test whether Omalizumab treatment influenced circulating basophil populations, CNV-
reared or GF mice were treated with Omalizumab or control antibody and serum IgE 
levels and blood basophils were examined. As Omalizumab decreases FcεRIα 
expression on basophils (Lin et al. 2004), basophils were identified as NBNT, CD117-, 
CD49b+, CD200R+ cells (Shiratori et al. 2005). Omalizumab treatment of GF mice 
resulted in reductions in serum IgE levels (Figure 22f), and reduced frequencies and 
numbers of blood basophils (Figure 22g,h). Together, these results identify Omalizumab 
as a potential therapeutic intervention to limit IgE-mediated increases in circulating 
basophils. 
 
4.4.4 MyD88-dependent commensal-derived signals limit serum IgE levels and 
circulating basophil populations 
It has been hypothesized that commensal bacterial-derived signals influence allergic 
responses by signaling through pattern recognition receptors (PRRs) (Bashir et al. 2004, 
Noverr et al. 2005). To interrogate the molecular mechanisms through which 
commensal-derived signals influence serum IgE levels and circulating basophil 
responses, mice deficient in myeloid differentiation primary response gene 88 (Myd88-/-), 
a critical adaptor molecule that regulates signaling through multiple PRRs (Schnare et al. 
2001), were utilized. As previously reported, CNV-reared Myd88-/- mice exhibited 
significantly increased serum IgE levels compared to littermate controls (Schnare et al. 
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2001) (Figure 23a). Associated with dysregulated IgE responses, compared to controls, 
Myd88-/- mice displayed increased frequencies and numbers of peripheral basophils 
(Figure 23b,c) and increased basophil-surface-bound IgE levels (Figure 23d) indicating 
that MyD88 signaling pathways are important for limiting these responses. Nucleotide-
binding oligomerization domain-containing protein 1 (NOD1) is a MyD88-independent 
intracellular PRR that mediates innate and adaptive immunity by recognizing commensal 
bacterial-derived signals (Clarke et al. 2010). To test whether NOD1 influenced steady-
state circulating basophil populations, serum IgE levels and circulating basophils were 
examined in control or NOD-1-deficient (Nod1-/-) mice. Neither serum IgE levels (Figure 
23e) nor blood basophils were elevated in Nod1-/- compared to control mice (Figure 
23f,g), indicating that NOD1 does not significantly influence steady-state serum IgE 
levels or circulating basophil responses. To examine whether a MyD88-dependent 
commensal bacterial-derived signal was sufficient to limit circulating basophils, ABX-
treated mice were treated with CpG (Bashir et al. 2004, Hall et al. 2008), and serum IgE 
levels and circulating basophil populations were examined. CpG treatment of ABX-
treated mice resulted in reductions in serum IgE levels (Figure 23h) and blood basophil 
frequencies and numbers (Figure 23i,j). Together, these findings implicate MyD88-
dependent commensal bacterial-derived signals in limiting serum IgE levels and 
circulating basophil populations. 
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Figure 23: MyD88-/- mice exhibit elevated serum IgE levels and circulating basophil populations 
(a) Serum IgE from conventionally-reared (CNV) Myd88
+/+
 (+/+) or Myd88
-/-
 (-/-) mice as measured by ELISA. (b) Flow 
cytometric analysis of blood basophils from CNV Myd88
+/+
 or Myd88
-/-
 mice. Numbers adjacent to outlined areas 
indicate percent cells in each gate. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (c) Number of basophils per mL of 
blood from CNV Myd88
+/+
 or Myd88
-/-
 mice. (d) Mean fluorescence intensity of surface-bound IgE on blood basophils 
from CNV Myd88
+/+
 or Myd88
-/-
 mice as determined by flow cytometry (mean ± S.D.; Myd88
+/+
, n=4; Myd88
-/-
, n=4). 
(e) Serum IgE levels from control (WT) or Nod1
-/-
 mice as measured by ELISA. (f) Flow cytometric analysis of blood 
basophils from control or Nod1
-/-
 mice. (g) Number of basophils per mL of blood from control (WT) or Nod1
-/-
 mice 
(mean ± S.D.; WT, n=2-4; Nod1
-/-
, n=3-4). (h) Serum IgE from antibiotic-treated (ABX) mice treated with control or CpG 
as measured by ELISA. (i) Flow cytometric analysis of blood basophils from CNV or ABX mice treated with control or 
CpG. (j) Number of basophils per mL of blood from CNV or ABX mice treated with control or CpG. Data representative 
of two or more independent experiments (mean ± S.D.; CNV, n=2-5; ABX, n=3-5; *, P ≤ 0.05). 
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MyD88-dependent signaling in B cells can inhibit IgE class switching in vitro (Liu 
et al. 2003). To test whether B cell-intrinsic MyD88-dependent signaling influenced IgE 
production or basophil homeostasis in vivo, chimeras were generated by sorting and 
adoptively transferring B or T cells from Myd88+/+ or Myd88-/- mice into Rag1-/- recipients 
(Figure 24a). Compared to controls, mice that received Myd88-/- B cells with Myd88+/+ T 
cells displayed elevated serum IgE levels (Figure 24b), increased frequencies (Figure 
24c) and numbers (Figure 24d) of blood basophils, and increased basophil-surface-
bound IgE levels (Figure 24e). Together, these results indicate that B cell-intrinsic 
MyD88-dependent signaling limits steady-state serum IgE levels and circulating basophil 
responses in vivo and implicates B cell-intrinsic recognition of commensal bacterial-
derived signals in mediating commensal-regulation of circulating basophils and basophil-
mediated TH2 cytokine-dependent allergic inflammation. 
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Figure 24: B cell-intrinsic deletion of MyD88 results in elevated serum IgE levels and circulating 
basophil populations 
(a) Experimental diagram of sort and transfer of Myd88
+/+
 or Myd88
-/-
, B or T cells into Rag1
-/-
 recipients. (b) Serum IgE 
from Rag1-/- mice reconstituted with Myd88
+/+
 or Myd88
-/-
, B or T cells as measured by ELISA. (c) Flow cytometric 
analysis of blood basophils from Rag1
-/-
 mice reconstituted with Myd88
+/+
 or Myd88
-/-
, B or T cells. Numbers adjacent 
to outlined areas indicate percent cells in each gate. Gated on CD3
-
, CD4
-
, CD8
-
, CD19
-
, CD117
-
 cells. (d) Number of 
basophils per mL of blood from Rag1
-/-
 mice reconstituted with Myd88
+/+
 or Myd88
-/-
, B or T cells. (e) Mean 
fluorescence intensity of surface-bound IgE on blood basophils from Rag1
-/-
 mice reconstituted with Myd88
+/+
 or 
Myd88
-/-
, B or T cells as determined by flow cytometry. Data representative of three or more independent 
experiments (mean ± S.D.; +/+B +/+T, n=1-4; +/+B -/-T, n=5-12; -/-B +/+T, n=4-12; *, P ≤ 0.05). 
 
4.5 Discussion 
Data in Chapter 3 identified a previously unreconized role for commensal bacterial-
derived signals in limiting steady-state serum IgE levels, circulating basophil populations, 
and basophil-mediated allergic inflammation. However, the mechanisms by which 
commensal bacterial-derived signals limit circulating basophil populations are not known. 
Data presented in this chapter indicate that elevations in circulating basophil populations 
observed upon antibiotic treatment of mice are critically dependent on IgE. This finding is 
consistent with findings from other groups that indicate that IgE influences granulocyte 
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homeostasis in the absence of an antigen (Lantz et al. 1997, Yamaguchi et al. 1997, 
Saini et al. 2000). Though presented in the context of allergy here, the observation that 
IgE alone is sufficient to increase the frequency and number of circulating basophils 
implies that regulation of basophils by IgE is likely relevant in immunity to helminth 
parasitic infections that are characterized by high serum IgE levels (Perona-Wright et al. 
2008). 
 Data presented in this chapter also indicate that B cell-intrinsic MyD88 
dependent signaling limits serum IgE levels and circulating basophil populations. It is 
interesting to note that while serum IgE levels and circulating basophil frequencies and 
numbers were significantly elevated in mice that received Myd88-/- B cells with Myd88+/+ 
T cells compared to controls, there was variation in these peramaters within 
experimental groups. One potential explination for this variation is that IgE is not acting 
directly on basophils to mediate their population expansion, but rather is acting indirectly 
via one or more additional cell types or signaling molecules. Additionally, the TLR9-
dependent commensal-derived signal CpG was found to be sufficient to limit serum IgE 
levels and circulating basophil populations in ABX-treated mice. CpG also reduced 
circulating basophil populations in CNV-reared mice suggesting that either the CpG-
dependent pathways that limit these phenotypes are not saturated in CNV-reared mice, 
or that CpG is influencing circulating basophils through additional mechanisms other 
than suppression of serum IgE levels. Commensal-derived signals have been shown to 
influence B cell homeostasis in other contexts. For example, class switching of B cells to 
the IgA isotype and subsequent secretion of IgA into the intestinal lumen is dependent 
on commensal-derived signals (Macpherson, Slack 2007). Interestingly, this effect is 
mediated through both T cell-dependent and –independent mechanisms (Renshaw et al. 
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1994, Macpherson et al. 2000, Macpherson, Uhr 2004a, Bergqvist et al. 2006) indicating 
that innate recognition of commensal-derived signals is fundamental to B cell physiology. 
However, unlike commensal-regulation of IgA responses which are limited to mucosal 
tissues, a lack of commensal-regulation of IgE results in systemic elevations in serum 
IgE levels (Macpherson, Uhr 2004a). 
Over the past decade, advances in therapeutics for asthma and other allergic 
diseases have been considerable, however, reliable interventions designed to prevent 
the development of allergic diseases or the progression from one to multiple allergies 
are yet to become a reality.  Data presented in this chapter indicate that serum IgE 
levels and blood basophil populations correlate in human patients with hyper-IgE 
syndrome, and that treatment with Omalizumab reduces IgE-mediated increases in 
circulating basophil populations. Additionally, data presented here indicate that steady-
state serum IgE levels and circulating basophil populations were limited by B cell-
intrinsic MyD88 signaling pathways, providing insights into one cell-intrinsic mechanism 
by which commensal-derived signals may influence serum IgE levels. Together, these 
results provide therapeutically relevant insights into the cellular and molecular 
mechanisms by which commensal bacterial-derived signals regulate circulating basophil 
populations in the steady-state, and subsequently influence the development of TH2 
cytokine-mediated inflammation in response to an allergen. 
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Chapter 5: Summary, discussion and future 
directions 
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5.1 The influence of commensal bacteria on allergic inflammation 
It has been nearly fifty years since the first examinations of TH2 cytokine-dependent 
immune responses in germ-free animals performed by Wescott and colleagues using the 
murine helminth parasite Nippostrongylus brasiliensis (Wescott, Todd 1964). Despite 
this, subsequent study of the influence of commensal-derived signals on the 
development and/or progression of TH2 cytokine-mediated inflammation required 
technical advances in microbiology and immunology. It was not until the early 1980’s, 
when Wannemuehler et. al. described an impaired ability for germ-free mice to induce 
systemic tolerance to oral antigens (Wannemuehler et al. 1982), that this field again 
began to garner attention. Wannemuehler went on to show that LPS, a commensal 
bacterial-derived signal from gram negative bacteria, was sufficient to induce oral 
tolerance to systemically administered sheep erythrocytes in germ-free animals 
(Wannemuehler et al. 1982). Sudo et. al. expanded on these initial observations using 
an OVA oral tolerance model by showing that germ-free mice develope robust total IgE, 
and OVA-specific IgE and IgG1 but not IgG2a responses compared to conventionally-
reared mice (Sudo et al. 1997). Sudo went on to show that exaggerated Ig response in 
OVA-challenged mice correlated with increased production of IL-2, IL-4 and TGF-β by 
splenocytes when cultured with OVA antigen. 
Subsequent mechanistic studies focused on identifying the specific microbial-
derived signals and their receptors responsible for promoting oral tolerance. TLR4-
defective mice were shown to have elevated allergic responses to peanut allergens co-
administered orally with cholera toxin (Bashir et al. 2004). Antibiotic treatment of TLR4-
sufficient mice recapitulated the elevated IgE levels seen in TLR-4-defective mice 
suggesting that commensal-derived LPS contributed to steady-state tolerance to food 
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antigens (Bashir et al. 2004). These results are consistent with Wannemuehler initial 
observation that LPS could induce oral tolerance in germ-free animals (Wannemuehler 
et al. 1982). The failure of oral tolerance induction in germ-free mice was also found to 
correlate with the absence of Peyer’s patch T cells (Maeda et al. 2001), however, 
subsequent studies indicated that antigen-specific T cell tolerance to oral OVA was 
intact in germ-free mice (Walton et al. 2006a). Together, these findings indicated that 
commensal bacterial-derived signals influenced humoral oral tolerance more strongly 
than cellular oral tolerance, and prompted subsequent studies of how the innate immune 
system senses and responds to commensal-derived signals to influence allergic 
responses.  
Beyond the field of oral tolerance, the majority of progress made in 
understanding the role that commensal-derived signals play in modulating allergic 
immune responses have come in the past 10 years from epidemiologic studies of human 
patients. Kalliomäki et. al. identified associations between alterations in commensal-
bacterial populations and the subsequent development of allergic disease (Kalliomaki et 
al. 2001) and allergic patients were shown to have altered commensal bacterial 
community structure in the intestine compared to healthy controls (Penders et al. 2007). 
These findings implicate commensal bacterial-derived signals in influencing susceptibility 
to allergic disease in humans. More recently, antibiotic exposure in children was shown 
to significantly correlate with increased risk of developing asthma or eczema (Marra et 
al. 2009, Kummeling et al. 2007, Verhulst et al. 2008) suggesting that normal 
commensal-bacterial communities are important for protecting against the development 
allergies. 
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Despite these epidemiologic advances, mechanistic understandings of the 
mechanisms by which commensal-bacterial derived signals influence TH2 cytokine-
dependent allergic inflammation using animal models have been lacking. In one nice 
study Noverr and colleagues used an allergic airway model to show that antibiotic 
treatment of conventionally-reared mice resulted in exaggerated IL-13-mediated airway 
inflammation (Noverr et al. 2005). Similar results were obtained using the ovalbumin-
aluminum  allergic airway model (Herbst et al. 2011). However, these studies provide 
only limited understanding of the mechanisms by which the innate immune system 
recognizes commensal bacterial-derived signals and modulates the development of 
allergic TH2 cytokine-dependent allergic inflammation. 
 
5.2 The influence of antibiotics on intestinal bacteria 
One limitation of previous studies that utilized antibiotic treatment in animal models is 
that they did not include a thorough characterization of the influence antibiotic treatment 
has on commensal bacterial communities. We therefore first carried out an in depth 
characterization of the effects of oral antibiotic treatment bacterial communities that 
colonize the murine intestine. Because a large percentage of intestinal bacteria are 
anaerobes that lack the enzymes necessary for the detoxification of oxygen, we opted 
for 454 deep sequencing molecular biologic methods in lieu of classical culture-based 
methods (Adlerberth, Wold 2009). 
We initially adopted an antibiotic treatment protocol similar to previously 
published protocols (Sekirov et al. 2008, Bashir et al. 2004, Rakoff-Nahoum et al. 2004, 
Zaph et al. 2008, Hall et al. 2008, Kang et al. 2008). While this treatment protocol was 
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highly effective and reduced intestinal bacteria to the extent that DNA from food 
composed the majority of recovered 16S rDNA sequences, it was associated with animal 
dehydration that could complicate the interpretation of subsequent studies (Guseinov, 
Guseinova 2008). This finding highlights the need for minimizing or controlling for 
unintentional side-effects of antibiotic treatment that may confound results and 
interpretations. For example, in addition to potential for dehydration, commensal-derived 
signals have been shown to modulate nutrition and metabolism (Ley et al. 2005, Bollyky 
et al. 2009), fundamental aspects of mammalian physiology that likely influence the 
immune system. The utilization of both gain and loss of function approaches, such as 
conventional mouse strains deficient in innate pattern recognition receptors, can 
complement antibiotic-treated and germ-free mouse models to help control for some of 
these effects. 
To circumnavigate potential complications of dehydration, acute administration of 
broad-spectrum antibiotics by gavage was employed, while allowing animal access to 
untreated drinking water; more closely mimicking antibiotic administration in humans. 
Antibiotic treatment by oral gavage reduced absolute bacterial numbers and mimicked 
anatomic, histologic and immunologic characteristics of reduced bacterial stimulation 
observed in germ-free mice. UniFrac analysis of bacterial communities indicated that 
antibiotic treatment promoted a novel community structure in the intestine that was more 
similar between antibiotic-treated samples as compared to samples from control-treated 
animals. Importantly, temporal analysis of stool pellet bacterial communities during 
treatment revealed a fast restructuring in community structure after only one day of 
antibiotic treatment. These findings indicate that even short exposure to oral antibiotics 
dramatically alters intestinal bacterial communities of the murine intestine and supposes 
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that similarly short courses of antibiotics in patients (days to weeks) might also 
significantly alter commensal community structure. 
Early colonization with Bacteroides fragilis has been implicated as a risk factor 
for asthma development in humans (Vael et al. 2008). As such, the effects of antibiotic 
treatment on members of the Bacteroidies phylum were examined. Members of the 
Bacteroidies phylum, namely the Bacteroidales order, represented 60-70% of intestinal 
bacteria in control-treated animals. After one day, these bacteria represented a 
combined frequency of greater than 95% in samples from antibiotic-treated but not 
control-treated animals, and subsequently stabilized at a frequency of approximately 
90% in all sampled compartments. It is intriguing to speculate that rapid increases in 
Bacteroidies frequency after antibiotic initiation may be responsible for associations 
between early antibiotic exposure in humans and increased susceptibility to allergic 
inflammation.  
Naïve animals displayed significantly higher frequencies of Lactobacillus species 
in mucosal-associated as compared to luminal communities and Lactobacillus species 
were significantly reduced in frequency with antibiotic treatment. Lactobacillus species 
have been cited as ―probiotic‖ bacteria with mixed effectiveness in treating human 
diseases (Betsi, Papadavid & Falagas 2008, Kozuch, Hanauer 2008). It may therefore 
be useful to examine whether reductions in this potentially beneficial mucosal-associated 
bacterial group are related to changes in immune cell homeostasis observed following 
antibiotic treatment. The mucosal-associated anatomical location of this bacterium also 
suggests that colonization of this anatomical location may be relevant for the beneficial 
host effects of this species. This is consistent with recent observations that segmented 
filamentous bacteria exist in an intimate relationship with the intestinal epithelium where 
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they regulate TH17 and Treg cell populations (Gaboriau-Routhiau et al. 2009, Ivanov et 
al. 2009, Wu et al. 2010, Kriegel et al. 2011). Together, these findings indicate that 
antibiotic treatment results in temporal and spatial alterations to bacterial communities 
that colonize the mammalian intestine. 
 
5.3 Basophils as a mediator of commensal-bacterial effects  
Antibiotic-treated and germ-free mice were found to have elevated steady-state serum 
IgE levels and a selective population expansion of circulating basophils compared to 
conventionally-reared mice. Interestingly, elevations in basophils were limited to the 
blood and spleen, and were not observed in tissue or lymphoid tissues, indicating that 
steady-state effects of commensal-derived signals on basophils are compartmentalized 
to these anatomical sites. These findings are of particular interest given that basophils 
can be directly activated by allergens and contribute to the development of optimal TH2 
cytokine-dependent allergic inflammation (Gessner, Mohrs & Mohrs 2005, Mohrs et al. 
2005, Min et al. 2004). Additionally, and perhaps more importantly, basophils have been 
shown to function as accessory cells by providing early sources of IL-4 and contributing 
to the initiation and/or propagation of CD4+ TH2 cell responses (Hida et al. 2005, Oh et 
al. 2007). Finally, basophils have been shown to endocytose soluble antigen, express 
MHC II and co-stimulatory molecules, and in select cases, act as antigen presenting 
cells that promote antigen-specific TH2 cell differentiation (Perrigoue et al. 2009, Sokol et 
al. 2009, Yoshimoto et al. 2009). Regardless of whether basophils are sufficient to 
initiate and/or propagate TH2 cell responses, their ability to augment TH2 cell 
differentiation in response to an allergic stimulus identifies basophils as a key player 
determining whether an encounter with an allergen results in the development of a TH2 
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cell response. As such, the observation that basophils are selectively expanded in 
antibiotic-treated or germ-free mice provides a mechanism to explain correlations 
between antibiotic treatment and increased susceptibility to allergic diseases in human 
patients. 
 We tested whether the elevations in steady-state basophils observed in 
antibiotic-treated mice contributed to the development of allergic inflammation using 
three basophil-mediated allergy models. Antibiotic-treated mice displayed exaggerated 
basophil responses and inflammation in a skin model of MC903-induced atopic 
dermatitis. Additionally, antibiotic-treated mice displayed exaggerated basophil 
responses and lung inflammation using a house dust mite-elicited allergic airway model. 
In both cases, basophils may be contributing to the development of TH2 cytokine-
mediated inflammation by either by augmenting the development of the TH2 cell 
response or by being recruited to the site of tissue inflammation where they may be 
exerting more classical effector cell functions such as the release of histamine, 
leukotrienes, cytokines or chemokines. The differential contribution of basophils to the 
allergic inflammation observed in these models was not directly tested here, and could 
be explored in future studies. 
 To directly test whether the elevated steady-state basophil responses observed 
in antibiotic-treated mice were contributing to the development of TH2 cell responses, we 
utilized the protease allergen papain. ABX-treated mice displayed elevated basophil LN 
recruitment and exaggerated LN TH2 cell responses to papain compared to CNV-reared 
mice. Non-basophil APC populations were not significantly influenced by antibiotic-
treatment in our experimental systems, however, they may contribute to exaggerated 
allergic responses in antibiotic-treated or germ-free mice in other settings. Basophils 
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were shown to be critical contributors to the exaggerated allergen-induced TH2 cell 
responses observed in antibiotic-treated mice using two methods of basophil depletion. 
Together, these findings indicate that commensal-derived signals limit basophil effector 
function and basophil-mediated TH2 cell responses, and identify basophils as a potential 
therapeutic target, the manipulation of which may prevent the development or 
propagation of allergic diseases in patients. 
 
5.4 Regulation of circulating basophil populations by IgE 
Natural IgE is produced in the absence of allergic stimuli and lacks antigen specificity, 
implicating IgE in functions other than antigen detection. Consistent with this hypothesis, 
IgE has been found to influence multiple aspects of granulocyte homeostasis in the 
absence of an antigen including regulation of surface protein expression, cell survival, 
and cell adhesion (Galli et al. 2005, Xiang, Moller & Nilsson 2006, Kitaura et al. 2005). 
We found that steady-state serum IgE levels correlate with circulating basophil 
populations in mice with reduced commensal stimulation and humans with hyper-IgE 
syndrome. IgE was found to be critical for elevations in circulating basophils observed 
with antibiotic treatment of mice, and IgE was sufficient to elevate murine circulating 
basophil populations. Although presented in the context of allergy here, the observation 
that IgE alone can increase the frequency and number of circulating basophils implies 
that regulation of basophils by IgE is likely relevant in immunity to helminth parasitic 
infections that are characterized elevations in serum IgE (Perona-Wright et al. 2008). 
 We found that B cell-intrinsic MyD88 dependent signaling limits serum IgE levels 
and circulating basophil populations in vivo and CpG was found to be sufficient to limit 
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serum IgE levels and circulating basophil populations. These findings implicate direct 
detection of commensal-derived signals by B cells in limiting IgE class switching and 
production, raising the question as to where B cells interact with commensal-derived 
signals. One possibility is that B cells circulate through intestinal-associated 
compartments such as the lamina propria where they are exposed to commensal 
bacterial-derived signals (Figure 25). Alternatively, B cells may encounter commensal-
derived signals trafficked to the mesenteric lymph nodes by dendritic cells or other 
mechanisms. Finally, commensal-derived signals may be present systemically at high 
enough levels to impart effects on B cell populations. 
5.5 Final thoughts 
Over the past decade, advances in therapeutics for asthma and other allergic diseases 
have been considerable, however, reliable interventions designed to prevent the 
development of allergic diseases or the progression from one to multiple allergies are yet 
to become a reality.  Data presented in this thesis indicate that commensal-derived 
signals limit serum IgE levels and circulating basophil populations in the steady-state. 
Antibiotic-treated mice displayed exaggerated TH2 cytokine-dependent inflammation in 
two models of basophil-mediated allergic disease and basophils were shown to 
contribute directly to the development of exaggerated TH2 cell responses in this setting. 
Together, these results provide therapeutically relevant insights into one mechanism by 
which commensal bacterial-derived signals influence susceptibility to the development of 
a TH2 cell response, and to TH2 cytokine-dependent allergic inflammation. It is hoped 
that identification of this commensal-basophil-TH2 cell axis will stimulate studies by other 
investigators aimed at exploiting this knowledge to develop new preventative or 
therapeutic approaches for allergic diseases. 
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Figure 25: Summary of thesis 
Commensal bacterial-derived signals act via B cell-intrinsic, MyD88-dependent signaling pathways to limit B cell 
production of IgE. B cells may detect commensal signals in intestinal compartments (1) or systemically (2). (3) In the 
absence of commensal signals, B cells produce increased amounts of IgE which enters the circulation. (4) IgE acts to 
expand the number of circulating basophils in the steady-state. (5) In the event of allergen exposure, basophils are 
recruited to draining lymph nodes or sites of tissue inflammation where they contribute to the generation of TH2 cell 
responses and/or TH2 cytokine-dependent allergic inflammation. Adapted from (Hill, Artis 2010). 
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